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Type 1 diabetes (T1D) is resulted from a self-destruction of insulin-secreting 
pancreatic β-cells, but the exact etiology remains unknown despite evidence indicating 
interaction between environmental and genetic factors. For the genetically predisposed 
individuals of T1D, islet autoantibodies are used for predicting the likelihood of T1D in 
the future, however, neither the appearance nor the titer can indicate the extent of the 
destruction of β-cells or quantify the remaining β-cell mass. Therefore, additional 
biomarkers are needed to monitor the health status of β-cell and the development of T1D.  
Dysregulation of lipid metabolism exists in distinctive disease states. Several 
studies suggested lipids as a potential biomarker for T1D and the dysregulated profiles of 
lipids in T1D blood serum could predict the seroconversion of autoantibody positivity. 
However, many of the potential T1D lipid markers reported to date have not been 
validated in independent cohorts, and the structural identifications are ambiguous as only 
the total number of carbon atoms and double bonds in the fatty acyl chains were reported. 
There is no detailed structural information reported for the lipid species regarding the 
fatty acyl compositions and the location of C=C double bond- those fine structural details 
can determine the biological functions of lipids and help to elucidate the pathogenic 
mechanism of T1D. Based on these, we hypothesize that 1) lipid markers that either shed 
from diseased pancreatic β-cells or as a systemic response to autoimmune attack exist in 
 
 
human serum; 2) dysregulation of lipid markers can predate the appearance of islet 
autoantibodies. Using advanced lipidomics tools and longitudinally collected sera from a 
well characterized T1D cohort, the primary goal of this project is to identify a panel of 
serum lipid markers correlated to T1D progression, with unambiguous characterization of 
their molecular structures.  
In this dissertation, we are focusing on the following aims: 1) Create a 
comprehensive human serum lipid library for high throughput LC-MS based lipidomics 
analysis; 2) Identify candidate lipid markers to T1D progression through quantitative 
profiling of the temporal changes of serum lipids in T1D cohorts; and 3) 
Comprehensively characterize the structures of the lipid markers. These aims were 
addressed in four projects that employed advanced instrumentation, sophisticated data 
analysis tools and precious human samples longitudinally collected from a T1D cohort. 
The first project generated a comprehensive library contains LC retention time and 
accurate mass of each lipid molecular species, and will be used for accurate and speedy 
identification of serum lipids in T1D subjects. In addition, this library can be 
implemented for an accurate and high throughput analysis of human serum lipids related 
to other diseases. The second and third project focused on development of Ozone-
induced dissociation (OzID) on a high resolution MS to determine unambiguously the 
C=C double bond positions in unsaturated lipids. This technique is based on a highly 
selective gas phase reaction between C=C and ozone. We achieved high efficiency of 
OzID in both direct infusion- and RPLC-based workflows to effectively elucidate C=C 
 
 
unsaturation in complex biological samples.  Using the methodologies developed in the 
first three projects, the last project profiled temporal changes of lipidome in a T1D 
cohort, and identified a list of  candidate lipid markers. These lipid markers showed a 
distinct profile prior to appearance of T1D as compared to healthy controls.  
 
 
 
IDENTIFICATION AND COMPREHENSIVE STRUCTURAL 
CHARACTERIZATION OF SERUM LIPID MARKERS  
TO TYPE 1 DIABETES PROGRESSION  
 
by 
 
 
Ngoc H.M. Vu 
 
 
 
A Dissertation Submitted to  
the Faculty of The Graduate School at  
The University of North Carolina at Greensboro  
in Partial Fulfillment  
of the Requirements for the Degree  
Doctor of Philosophy 
 
 
Greensboro 
2019 
 
 
 
Approved by 
 
 
 
________________ 
Committee Chair 
  
ii 
 
 
 
 
 
 
 
 
 
 
To my dear family, thank you for always be there for me and for raising me the way I am. 
To Uncle Toan and Aunty Lan Anh’s family, without you, I wouldn’t be where I am. 
Thank you for nurturing me and for believing in this kid……. To Grandama, I did it! 
Thank you!.....To my best friends, Thank you for counting the days for me and for 
assisting me with this journey….To some one special, Thank You, sincerely! I wouldn’t 
be where I am without the love and support! 
  
iii 
 
APPROVAL PAGE 
 
 
This dissertation, written by NGOC H. M. VU, has been approved by the 
following committee of the Faculty of The Graduate School at The University of North 
Carolina at Greensboro. 
 
      Committee Chair  _____________________ 
Committee Members _____________________ 
   _____________________ 
_____________________ 
 
 
 
___________________________ 
Date of Acceptance by Committee  
 
 
_________________________ 
Date of Final Oral Examination 
iv 
 
ACKNOWLEDGMENTS 
 
 
I would like to thank Drs. Nadja Cech, Nicholas Oberlies, and Norman Chiu for 
offering their guidance, expertise and precious time as committee members of my 
dissertation committee; Dr. Monica Narvaez-Rivas for training me in mass spectrometry 
and providing advices on my projects; Dr. Daniel Todd for assisting me in the mass 
spectrometry facility; Rodell Barrientos for his unsolicited support on my projects; 
Cherie Turner and Wendy Helton, for their thoughtful supports; all the faculty and staff 
of the Department of Chemistry and Biochemistry, and Center for Translational 
Biomedical Research for all the love and support. In addition, I want to thanks the 
collaborators for assisting me with samples, analysis and advice to finish the study: Dr. 
Kevin Giles, Dr. Jeff Brown, Dr. Marian Rewers and Dr. Wei Sha. 
I especially want to express my gratitude to the Zhang research group including 
the past and current members for their continuous support. Thank you, Dr. Qibin Zhang 
for taking a faith in me, a newly-unexperienced student, to train me throughout my PhD 
journey.  
This research was supported by the following grants from the NIH to Dr. Zhang: 
R21 GM104678 and R01DK114345. 
v 
 
TABLE OF CONTENTS 
Page 
 
LIST OF TABLES ............................................................................................................ vii 
 
LIST OF FIGURES ......................................................................................................... viii 
 
CHAPTER 
 
 I. INTRODUCTION OF TYPE 1 DIABETES AND THE NEED OF  
 ADDITIONAL BIOMARKERS ......................................................................1 
 
  Background ..................................................................................................1 
  Current Biomarkers In Prediction of T1D ...................................................2 
  Lipids As Potential Biomarkers For T1D ....................................................3 
  Conclusions ..................................................................................................5 
 
 II. REVIEW OF LIPIDOMICS WORKFLOW: SAMPLE  
 PREPARATION, SEPARATION AND  
 MASS SPECTROMETRIC ANALYSIS  ........................................................7 
 
   Introduction ..................................................................................................7 
   Total Lipid Extraction Methods .................................................................10 
   Major Separation Techniques Used In Lipidomics ...................................13 
   Mass Spectrometric Analysis Of Lipids ....................................................18 
   Conclusion And Future Directions ............................................................27 
 
 III. ACCURATE MASS AND RETENTION TIME LIBRARY OF  
  SERUM LIPIDS FOR TYPE 1 DIABETES RESEARCH ............................29 
 
 Introduction ................................................................................................29 
 Materials and Methods ...............................................................................32 
 Results ........................................................................................................36 
 Discussion ..................................................................................................50 
 
 IV. OZONE-INDUCED DISSOCIATION ON A TRAVELING  
 WAVE HIGH RESOLUTION MASS SPECTROMETER  
 FOR DETERMINATION OF DOUBLE BOND  
 POSITION IN LIPIDS ...................................................................................55 
 
 Introduction ................................................................................................55 
 Experimental  .............................................................................................58 
vi 
 
 Results and Discussions .............................................................................61 
 Conclusions ................................................................................................73 
 
 V. SERUM ISOMERIC LIPID IDENTIFICATION  
 FACILITATED BY LIQUID CHROMATOGRAPHY-  
 OZONE INDUCED DISSOCIATION- 
 MASS SPECTROMETRY .............................................................................76 
 
 Introduction ................................................................................................76 
 Materials and Methods ...............................................................................78 
 Results  .......................................................................................................80 
 Discussion ..................................................................................................91 
 
 VI. IDENTIFICATION OF SERUM LIPID MARKERS TO  
 TYPE 1 DIABETES PROGRESSION ...........................................................94 
 
   Introduction ................................................................................................94 
   Experimental Section .................................................................................96 
   Results ......................................................................................................100 
   Discussion ................................................................................................113 
 
 VII. CONCLUDING REMARKS .............................................................................117 
 
REFERENCES ................................................................................................................120 
 
APPENDIX A. SUPPLEMENTARY TABLE ................................................................136 
  
 
 
 
vii 
LIST OF TABLES 
Page 
Table 1. Lipid Categories and The Number of Structures Listed  
 from the LIPID MAPS Database ........................................................................8 
 
Table 2. A Panel of Lipids with Significant Differences in T1D  
 Group as Compared to the AB and  
 Healthy Control Groups ................................................................................ 106 
 
Table 3. List of Candidate Lipids with a Temporal Change Across 
 all the Subjects and Samples ..........................................................................109 
 
Table 4. List of Candidate Markers that can Predict the  
 Appearance of Islet Autoantibodies after The Age of Three .........................111 
 
 
 
 
 
 
viii 
LIST OF FIGURES 
Page 
Figure 1. The Progression of T1D based on Time and The  
 Beta-Cell Mass .................................................................................................2 
 
Figure 2. Standard Lipidomic Workflow including The Components  
 of Sample Collection, Sample Preparation,  
 Data Acquisition, and Data Processing ............................................................9 
 
Figure 3. A Mixture of Organic Solvent (chloroform/methanol) was  
 Added into The Sample, Vortexed, Incubated, and  
 Centrifuged before Partition into Different Phases,  
 Resulting Lipids Dissolved in The Bottom Layer,  
 while The Middle Layer is The Protein and Top  
 Layer is Water-Soluble Substances ................................................................11 
 
Figure 4. General Structure and "building blocks" of Lipids ............................................13 
 
Figure 5. Mechanism of Electrospray Ionization ...............................................................18 
 
Figure 6. Summary of The Levels of Structural Identification  
 in Lipids using PC 38:1 as an Example .........................................................23 
 
Figure 7. Mechanism of The Ozonolysis Reaction ............................................................25 
 
Figure 8. OzID-MS Spectra of PC (16:0/18:1). .................................................................27 
 
Figure 9. The Revolution of OzID-MS over the last 10 years ...........................................27 
 
Figure 10. Workflow to Create The Accurate Mass  
 and Time Tag Library for Serum Lipids .....................................................36 
 
Figure 11. Mixed-Mode LC-ELSD Chromatograms Obtained  
 from Total Lipid Extract of Human Sera .....................................................38 
 
Figure 12. MS/MS Spectra of PC 16:1/18:2 in  
 a), Positive ion Mode and b), Negative ion Mode ........................................40 
 
Figure 13. Plots Showing Dependences of RPLC Retention Times  
 of Saturated Lipids to The Total Number of Carbon,  
 each Panel is a Different Lipid Class  
 (TG, SM, PC, Cer, and LPC) ........................................................................43 
 
 
 
ix 
Figure 14. Plots Showing Dependences of RPLC Retention Times  
 of Unsaturated Lipids to The Total Numbers of Carbon,  
 with each Panel Showing a Different Lipid Class  
 (TG, SM, and PC) or Degree of Unsaturation (1 to 4) .................................45 
 
Figure 15. Relative Distribution of Lipid Species contained  
 in The Serum Lipid Library .........................................................................47 
 
Figure 16. Individual Lipid Molecular Species Identified in Human Sera,  
 Plotted with Their Respective m/z and Retention Time  
 (min) on the RPLC ........................................................................................48 
 
Figure 17. Number of Lipid Species identified from a T1D Serum Sample .....................49 
 
Figure 18. Schematic of The Traveling Wave Q-TOF Mass  
  Spectrometer (Synapt G2) Modified to Allow  
  OzID in The Trap and Transfer Cells. ..........................................................62 
 
Figure 19. OzID-MS Spectra of FAME C18:2 (10E,12Z)  
 under Different MS Settings ........................................................................63 
 
Figure 20. OzID-MS Spectra of PC (16:0/18:1(9Z)) under  
 Different MS Settings ..................................................................................64 
 
Figure 21. Effects of Changing Traveling Wave Height and  
 Wave Velocity on OzID Efficiency; 
 A, Trap Wave Height Effect;  
 B, Trap Wave Velocity Effect;  
 C, Transfer Wave Height Effect; 
 D, Transfer Wave Velocity Effect. ...............................................................66 
 
Figure 22. Diagrams Illustrate The Transmission of Ions Through  
 The Trap Cell in The TriWave Region and The Effect  
 to Gas Phase Ozonolysis by Changing Trap  
 Entrance Voltage and Trap DC Voltage  .....................................................67 
 
Figure 23. Effects on Changing Trap Entrance and Trap DC  
 on OzID Efficiency: A, Trap DC Effect; B, Trap  
 Entrance Effect .............................................................................................69 
 
 
 
 
 
 
 
x 
Figure 24. OzID-MS Spectrum of (A) PC (16:0/18:1(9Z)) and  
 (B) PC (18:1(9Z)/16:0) Obtained Under Optimized  
 OzID Settings Settings: Trap Wave Height = 0.2 V,  
 Trap Wave Velocity = 8 m/s, Transfer Wave  
 Height = 0.4 V and Transfer Wave Velocity = 247 m/s,  
 Trap Entrance = 7 V and Trap DC = 0.2 V. ................................................71 
 
Figure 25. OzID-MS Spectrum of (A) PC (18:1(9Z)/18:1(9Z))  
 and (B) PC (18:1(9E)/18:1(9E)) Obtained Under  
 Optimized OzID Settings Settings: Trap Wave  
 Height =0.2 V, Trap Wave Velocity = 8 m/s,  
 Transfer Wave Height = 0.4 V and Transfer  
 Wave Velocity = 247 m/s, Trap Entrance = 7 V 
 and Trap DC = 0.2 V. ..................................................................................74 
 
Figure 26. Schematic of Traveling Wave Q-TOF HDMS Synapt G2 MS  
 Modified to Allow OzID to Replace Nitrogen  
 Gas in IMS Cell ............................................................................................80 
 
Figure 27. Analysis of PC (16:0/18:1(n-9)) in A) OzID-MS of IMS  
 cell Under The Default Setting and B) Under The  
 Optimization Setting with Ozone as The Mobility Gas  
 (setting listed in the method). ......................................................................81 
 
Figure 28. XIC of The Targeted Lipid Standards at The Known m/z ................................85 
 
Figure 29. A) XIC of m/z at 784 was extracted (solid black line),  
 and XIC of OzID Products at m/z 674, 676 and m/z 636  
 (color coded lines), Represented for Parent Ion PC (18:1_18:2)  
 and PC (16:0_20:3), respectively at 12.00 min and 12.27 min;  
 B) OzID-MS spectra of PC (18:1_18:2) Showed The Result of  
 Two Possible Double Bond Positions on a Fatty Acyl Contains a  
 Mono-unsaturated DB at n-6 and n-9 at m/z 716 and m/z 674,  
 while a pair of ions at m/z 676 and 716 indicated a  
 polyunsaturared double bonds at n-6 and 9 on the other  
 acyl; C) OzID-MS spectra of PC(16:0_20:3(n-6,9,12)).  ...........................87 
 
Figure 30. LC-OzID-MS of PC 18:0_18:1 ........................................................................90 
 
Figure 31. LC-OzID-MS of LPC 18:1 ...............................................................................91 
 
Figure 32. The Overal Work Flow of The AMT Approach.  ............................................97 
 
 
 
 
xi 
Figure 33. Hierarchical Clustering Plots Showing Age Dependence  
 of Serum Lipidome, using Lipids Identified from  
 Healthy Control Samples in Positive Ionization Mode ..............................101 
 
Figure 34. Hierarchical Clustering Plots Showing Age Dependence  
 of Serum Lipidome, using Lipids Identified from  
 Healthy Control Samples in Negative Ionization Mode ............................103 
 
Figure 35. Volcano Plot Revealed a Significant Different Level of  
 Lipids when comparing T1D with Control at the  
 1st Time Point ............................................................................................104 
 
Figure 36. Volcano Plot Revealed a Significant Different Level of  
 Lipids when comparing AB with Control at the  
 Time Point 2 ..............................................................................................105 
 
Figure 37. PLS-DA Plot showing Separation between T1D (red) and  
 non-T1D groups at <3 years age, the Latter contains  
 both AB and Healthy Controls  (blue) .......................................................107 
 
Figure 38. The Average Lipid Level of Potential Markers listed in Table 2 ...................108 
 
Figure 39. Temporal Change of PI 22:5/18:0 and PC 18:0/20:3  
 Recorded in Negative Ion Mode ................................................................109 
 
Figure 40. OPLS-DA Scores Plot of Control and non-control  
 group (AB and T1D) ..................................................................................110 
 
  
 
 
 
1 
CHAPTER I 
INTRODUCTION OF TYPE 1 DIABETES AND THE NEED OF ADDITIONAL  
BIOMARKERS 
Background 
Diabetes mellitus is a multifactorial and heterogeneous disorder that affects 415 
million people worldwide and resulted in 1.6 million deaths in 2016,  which is higher 
than the number of deaths from HIV and Malaria.1 In total, diabetes gives rise to nearly 
$545 billion annual health care cost, with more than $100 billion from the United States 
alone.2, 3  While Type 2 diabetes is more prevalent worldwide and constitutes 90% of the 
diabetic population, Type 1 diabetes (T1D), although occurs in <10% of the diabetics and 
mostly occurring in developed countries, is one of the most common chronic diseases in 
children, especially under the age of 5. There are approximately 1.25 million people in 
the United States with T1D, led to $14.4 billion in healthcare cost.4, 5 
T1D is an autoimmune disease resulted from destruction of insulin-secreting 
pancreatic β cells, which can be triggered by environmental factors, such as diabetogenic 
enterovirus on genetically susceptible individuals; however, despite many decades of 
research, the exact etiology remains unknown.6-8  It is commonly recognized that the 
progression of this disease depends on the remaining number of active b-cells, as 
illustrated in Figure 1.8-10 In general, about half of the T1D subjects carry susceptible 
HLA loci and are predisposed to develop T1D.8, 11, 12 During stage 1 of T1D progression 
 
 
 
2 
after exposure to an elusive environmental trigger, the immune tolerance to specific self-
antigens is lost and T1D-susceptible individuals express multiple anti-islet 
autoantibodies. At this particular phase, a portion of β cells has already begun to undergo 
irreversible functional loss and self-destruction.13, 14 However, it remains asymptomatic as 
there is no change physiologically to glucose tolerance. As the disease progress to stage 
2, abnormal glycemia starts to appear with a more significant loss in functional β -cell 
mass. However, full-blown T1D symptoms won’t appear until after reaching stage 3 of 
the disease when critical masses of β cells are being destroyed. At this stage of the 
disease, only up to 20% of β cells remaining, which leaves the individuals to rely on  
external insulin for their lifetime.15  
 
 
Figure 1. The Progression of T1D based on Time and The Beta-Cell Mass. 
 
 
Current Biomarkers In Prediction of T1D 
The progression of b-cell death is currently unpredictable, and the clinical 
symptoms of the disease are observed only when more than 80% of these cells are 
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3 
dysfunctional or destroyed.6, 7, 16  Hence, biomarkers that serve as predictive tools for the 
onset of clinical symptoms and indicators for the progression of the disease are in need. 
Biomarkers are “substance, structure or process that can be measured in the body 
such as itself or its products can be used to predict the incidence of outcome or to monitor 
stages of a disease”.17 In addition to accurately diagnosis of T1D at its onset, good 
biomarkers of T1D should be able to quantify the risks of an individual during the 
different developmental stages of this disorder. Currently, autoantibody assays are 
clinically used as the diagnostic tool for those who have a family history of T1D. These 
assays can predict a 5-10 years window gap before the clinical onset of T1D.12, 15 
However, these biomarkers cannot predict when the clinical symptoms will present; nor 
tell what initiated the autoimmune attack on pancreatic β cells. 18, 19 Whilst the 
seroconversion of islet autoantibody can diverge from months to years before disease 
onset, the time point at which seroconversion occurs, may already be too late for 
preventing autoimmune-mediated β cell destruction or applying any therapeutic strategies 
to revert diabetes. As a result, there are insatiable interests and immediate needs in 
identifying biomarkers that can accurately indicate the initial process of β cell destruction 
process, and can be used for more accurate early diagnosis of T1D. 
Lipids As Potential Biomarkers For T1D 
In addition to being the main component of the cell membrane, lipids also play 
roles in signal transduction, and they are generally secreted into the bloodstream carrying 
information of tissues or cells’ health status. Dysregulated lipid profiles are observed in 
different diseases,20, 21 including T1D.22-25 For example, studies conducted in Finland and 
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the United States showed that lipidomic profiles in the cord blood and blood 
serum/plasma of infants could differentiate T1D from healthy individuals.23, 26 Oresic et 
al. showed that children who later developed T1D have lower levels of choline-
containing phospholipids in their cord blood when compared to healthy children.22, 27 
Interestingly, they observed changes in lyso- and plasmalogen-phosphotidylcholine (PC) 
species prior to the appearance of islet autoantibodies in T1D patient.27  Later, a follow-
up study by the same authors focusing on children with HLA-conferred risk of T1D, 
investigated dysregulated lipidomic profiles at birth and during the development of b-cell 
autoimmunity and the progression of the disease. Agreeing with their previous results, 
they concluded that children who developed T1D had unique cord blood lipidomic 
profile, including a lower level of choline-phospholipids. Moreover, this newer study 
suggested that a panel of seven lipids could be used to predict the progression of T1D.23 
In addition to lacking the detailed molecular structure of the identified lipid species, most 
of the studies listed above used cross-sectional cohorts and samples collected from 
individuals with T1D clinical onset, it would be more informative if the lipidome during 
the different stages of T1D progression can be profiled longitudinally, so that the 
pathologically changes, even during the asymptomic period can be accurately captured to 
identify biomarkers indicating the early stages of T1D.   
It is desirable to longitudinally profile lipid dysregulation during an individual’s 
progression to T1D. As demonstrated in a very recent study, sera from 120 children from 
three groups (T1D progressor, non-progressor, and healthy control) were profiled for the 
changes in lipidome across 3 time points collected from <3 months up to 3 years of age.25 
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Comparison between time points showed that most of the changes in the lipidome were 
observed in a much younger age. Lower levels of sphingomyelins (SM) were observed in 
T1D patients when compared to healthy control and patients who developed 
autoantibodies but yet had a clinical onset T1D (non-progressor). The appearance of 
autoantibodies was associated with down-regulation of SMs and LPCs and up-regulation 
of cholesterol esters (CEs). Although validations are needed to further confirm the 
authenticity and utilities of these potential lipid markers, this study suggests that the 
concept that dysregulated lipidome exists at the early, asymptomic phases of T1D is 
valid, and it is feasible to identify novel lipid biomarkers predate the appearance of islet 
autoantibody for a very early prediction of T1D.  
Conclusions 
Biomarkers released from the pathological site or as systemic response to chronic 
diseases are at low level, which always pose a challenge to accurately determine the 
changes, especially considering many confounding factors such as age, gender, body 
mass index (BMI) are in play with the underlying disease biology. T1D is a polygenic 
autoimmune disease with an unknown etiology. Because of late intervention of the 
disease often leads to life-threatening complications, novel biomarkers are needed to 
monitor the disease progression and earlier disease intervention.  Compared to cross-
sectional studies, longitudinal studies can track the temporal changes of biomarkers on an 
individual basis by eliminating the large individual variations of human cohort. This 
requires high quality samples collected longitudinally from well characterized clinical 
cohorts. The samples of our study design were collected longitudinally from 5 months old 
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to 20 years old, which covers the span of T1D development and they were from age-
matched individually from healthy controls, T1D progressors and autoantibody positive, 
non-progressors. By applying advanced technologies to profile the lipidomic changes in 
these samples, we are aiming to uncover the dysregulated lipids correlated well to the 
natural progression of T1D.  
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CHAPTER II 
REVIEW OF LIPIDOMICS WORKFLOW: SAMPLE PREPARATION, SEPARATION  
AND MASS SPECTROMETRIC ANALYSIS 
Introduction 
Lipids are known to be ubiquitous molecules with a diversity of structures and are 
distributed throughout a wide range of organisms.28 They are the primary component of 
membranes acting as the outer barrier for cells and organelles.29 Moreover, lipids provide 
an appropriate hydrophobic environment for the interactions with membrane proteins.30 
Recently, evidence show that lipids play a vital role in many biological pathways, 
including transcription of genetic code to the regulation of pathway and physiological 
responses.31 In the last decade,  aberrant lipid metabolisms were observed in several 
human diseases such as diabetes, obesity, cancers and Alzheimer’s disease.32-35 The 
dysregulated profile of lipids provides a better insight into the biological pathways 
underlying the pathologies of these diseases and offers new directions for biomedical 
research.36 Hence, lipidomics has attracted increasing attention from clinical studies. 
Taken all together, a systematic study of lipids has become the focal point in advancing 
the momentum of biosciences.20  
The complexity in lipid structures, due to the number of different biochemical 
transformation happened during biosynthesis, has made lipids one of the most diverse 
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biomolecules. In 2005, LIPID MAPS consortium developed a comprehensive 
classification system and categorized lipids into eight categories based on their chemical 
structure and biochemical principles (Table 1).37-39 Each category is further divided into 
classes and subclasses, based on the common functional groups or chemical “building 
blocks”.39 In this dissertation, we will focus on lipid categories and classes that are 
abundant and biologically significant in the mammalian systems. They are 
glycerophospholipids (GP) and glycerolipids (GL). GL are lipids including acylglycerols, 
in combination with alkyl and 1Z-alkenyl variants, and GP are lipids contains a phosphate  
group esterified to one of the glycerol hydroxyl groups. 
Table 1. Lipid Categories and The Number of Structures Listed from the LIPID MAPS Database 
 
 
 
In general, the biological function and activity of a molecule are based on its 
chemical structure. Thus, even a minor change in the structure can affect its physical and 
biochemical properties, as a consequence, influence the metabolism within a living 
organism.40 The diversity in lipid function is reflected by an enormous variation in the 
structure of lipid molecules.39, 41, 42 To better understand the roles lipids play in a 
Category Abbreviation Structure in Database 
Fatty acyls FA 2678 
Glycerolipids GL 3009 
Glycerophospholipids GP 1970 
Sphingolipids SP 620 
Steol Lipids ST 1744 
Prenol Lipids PR 610 
Saccharolipids SL 11 
Polyketides PK 132 
 
 
 
9 
biological system, it is essential to characterize the accurate structure of individual lipid 
species, and on top of that, to determine changes of lipid metabolites associated with 
various pathophysiological conditions. Lipidomics, as the science for large scale study of 
lipid molecular species in biological systems, offers new opportunities for precision 
medicine by providing specific lipid molecular targets for disease diagnosis and 
prognosis.43-45 
Overview Of Lipidomic Analysis 
 
 
Figure 2. Standard Lipidomic Workflow including The Components  of Sample Collection, Sample 
Preparation, Data Acquisition, and Data Processing. 
 
 
The general lipidomic workflow includes lipid extraction, separation, structural 
characterization, feature identification, and statistical analysis (Fig.2). The type of 
samples and the purpose of the study should be taken into consideration for the 
experimental design. Hence, the lipidomic sample preparation should be tailored to the 
sample type, which is usually collected from a cell line, laboratory animals, or clinical  
hospitals and routinely stored at -80°C prior to analysis.  
Sample 
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Data 
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• Lipid Extractions (Folch’s, Bling 
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• Compound Identification
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Total Lipid Extraction Methods 
In biomedical research, the challenge has always been on how to efficiently 
collect the desired group or class of chemical compounds for the study. A critical step in 
lipidomic analysis is to effectively extract the majority of lipids representative in the 
sample without being biased, inducing, or promoting the degradation of lipids or 
contaminated with unwanted substances. The fidelity of the underlying biological study 
depends on the efficiency of the extraction method if one has a reliable analytical 
platform in the downstream sample analysis.  
 The main difference between lipids and other components of the biological 
sample (carbohydrates, proteins, and nucleic acid) is their hydrophobicity and solubility 
in an organic solvent.46 The performance of the lipid extraction with a solvent system 
depends on the partitioning of different lipid classes into the organic solvent used. In 
most cases, the lipidomic extraction procedure involves a phase separation, where 
hydrophobic lipids partition into the hydrophobic phase, while the hydrophilic molecules 
remain in the aqueous phase.47, 48 A good extraction process aims to recovery as many 
lipids as possible or to target the selected lipid classes with high specificity.  
Folch Method And Bligh And Dyer Method 
Folch and Bligh and Dyer methods were developed in the 1950s and have shown 
to be the most reliable and popular method used for lipid extraction for a variety of 
samples.49, 50 In general, both methods share a similar workflow, as shown in Figure 3. 
Briefly, all samples, except biological fluids, are homologized and introduced to a 
monophasic chloroform/methanol (2:1,v/v) for Folch and (1:2,v/v) for Bligh and Dyer 
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method. The use of methanol results in disruption of hydrogen bonding networks or 
electrostatic forces between lipids and biopolymers, releasing the lipids into the organic 
layer. The introduction of chloroform formed the two-phase system, with lipids migrating 
into the chloroform layer at the bottom, and the polar biomolecules in the top layer. The 
simplicity and efficiency of the liquid-liquid extraction in these two methods were 
implemented in a variety of samples to extract a broad range of lipid classes.47, 50, 51 Over 
the years, different modifications were done to these two methods, to make it more 
applicable for high throughput analysis. Overall, similar results were reported.48 In terms 
of polar lipids, both methods have shown a similar recovery rate; however, Folch method 
indicates a better recovery for non-polar lipids, while Bligh and Dyer method is more 
popular in sphingolipidomic studies.51 Thus, Folch method is the most popular procedure 
for total lipid extraction due to its recovery efficiency and the compatibility with a wide  
range of polarities of lipids. 
 
 
Figure 3. A Mixture of Organic Solvent (chloroform/methanol) was Added into The Sample, 
Vortexed, Incubated, and Centrifuged before Partition into Different Phases, Resulting Lipids 
Dissolved in The Bottom Layer, while The Middle Layer is The Protein and Top Layer is Water-
Soluble Substances. 
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MTBE And BUME 
One of the major drawbacks from the previous two extraction methods is the use 
of chloroform, which is a carcinogen and can be a health risk for lab personnel. In the last 
decade, different extraction protocols were proposed with the main objective of 
eliminating chloroform as the extraction solvent and having lipids dissolved in the upper 
organic layer to make it more amenable for automated liquid transfer. The most recent 
methods are methyl-tert-butyl ether (MTBE) and butanol and methanol (BUME) 
method.52, 53  
MTBE was first introduced by Matyash et al. with the total lipids collected in the 
lipid-enriched upper phase using MTBE solvent in combination with methanol and 
water.53 MTBE can offer a similar recovery when compared with the gold standard Folch 
method.54 Hence, MTBE method showed its potential with automation and being 
considered for automated lipidomic extraction.53 However, when taken with a high 
solvent/sample ratio, it is not compatible with the 96-well format. On the other hand, 
aiming for high throughput automated extraction of lipids, BUME method was proposed 
by Lofgren and coworkers to execute in 96-well format. 52, 55 The series of steps for 
sample preparation (sample collection, storage, homogenization, and extraction) were all 
performed in one single 2 mL polypropylene tube, hence the concept of “all-in-one-tube” 
concept. In terms of extraction efficiency, when compared with the gold standard Folch 
method, BUME obtained similar extraction efficiency for neutral lipids, sphingolipids 
and nonacidic phospholipids. 55 More evaluations between the three methods of MTBE, 
BUME and Folch could have been done to draw a more definitive conclusion. 
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Nevertheless, the Folch method remains the gold standard method in global lipidomics 
due to its unbiased recovery of all major lipid classes. 
Major Separation Techniques Used In Lipidomics 
Lipids are very heterogenous molecules, their diverse structures result into a wide 
range of chemical properties, from highly non-polar triacylglycerols to polar 
glycosphingolipids. As such, it is recommended to use a separation technique to increase 
the resolving power of analysis. In the past, thin-layer chromatography (TLC) or solid-
phase extraction (SPE) was used to pre-fractionate lipids into classes prior to any 
measurement of lipids.56 Since TLC and SPE are not as selective as liquid 
chromatography (LC), LC has been implemented to separate lipids based on their classes 
and/or molecular properties. Over the years, more researchers have adopted LC and 
developed different solvent systems to enhance the optimal separation of various lipids  
classes.  
 
 
Figure 4. General Structure and "building blocks" of Lipids. Fatty Acyl Chains are Attached to sn-1 
and 2 positions on the Glycerol Backbone of lipids, While the Head Group is Attached to The 
Backbone via Ester Linkage. 
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Liquid Chromatography 
Liquid chromatography utilizes the competitive adsorption between the analyte, 
stationary phase, and liquid mobile phase for separation. Compared to other techniques, 
LC offers speed, resolution, sensitivity and specificity. There are three approaches of LC 
for lipidomic analysis. They are normal phase-LC (NPLC), hydrophilic interaction LC 
(HILIC), and reversed phase LC (RPLC).57-60  These approaches separate lipids based on 
different mechanisms and can be tailored to separate the targeted analyte from a complex 
biological matrix.  
Normal Phase Liquid Chromatography 
NPLC separates lipids based on the polarity of the head groups (Figure 4),61 and 
has the capability to resolve a wide range of lipid classes. In the 1980s, Christie was the 
pioneer in utilizing the polarity interaction of NPLC to separate class-based lipids in real 
samples.59, 62 Throughout the years, modifications, including the introduction of aqueous 
and additives, improved the reproducibility and the peak shape of acidic phospholipids. 
Most importantly, the current approach in NPLC-based lipidomics uses a long, microbore 
silica column at a flow rate from 0.1-1 mL/min, and a higher flow rate for the desired 
study if there is a splitter. Typically, NPLC consists of a quaternary solvent system and 
uses highly non-polar solvents. The separation starts with a weak mobile phase such as 
heptane, isooctane, chloroform or a mixture of these solvents, and gradually introduces 
the stronger mobile phase for the elution of polar lipids. The stronger mobile phase 
comprises of methanol, IPA/MTBE, isooctane/IPA, acetone, IPA/MeOH, etc.61 
Triethylamine has been used to minimize the influence of fatty acyl chains in the 
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retention of the column particles.61, 63 Depending on the type of detector, different 
additives may be needed. Additives can be salts such as ammonium acetate, ammonium 
formate, diethylamine, formic acids. In NPLC, the analysis time is typically longer (30-
60 mins) than other techniques, primarily due to the choice of a longer column and the 
large particle-size sorbents and the time it takes for column re-equlibration. With the 
continuous development of NPLC, the number of lipid classes separated in a single run, 
increased from <10 lipid classes to more than 20 lipid classes and sub-classes, covering 
from non-polar to polar GL lipids in biological samples.59, 63-65  
Hydrophilic Interaction Liquid Chromatography 
Another approach that applies similar principle as NPLC to separate lipids is 
HILIC. Different from NPLC, HILIC uses non-polar solvents with the addition of water 
in the mobile phase to maintain a stagnant enriched water layer on the surface, which 
may attract the analyte.66 Moreover, a stronger solvent system is used, which improves 
the separation of more polar lipids such as GP subclasses. HILIC uses a shorter column 
with a smaller ID, operated at a similar flow rate of NPLC, resulting in a shorter analysis 
time (15-60 mins). Usually, with HILIC, ACN or the mixture of ACN are used in the 
system to resolve the non-polar lipids, while the more polar solvent presented at the end 
disrupts the bonding between polar lipids and particles inside the silica or the BEH 
column. The additive used for HILIC is the same as NPLC. HILIC has been implemented 
on the separation of polar lipids,67 and becomes a fundamental technique in the separation 
of sphingolipids while NPLC has more applications on a broader range of lipid classes 
and sub-classes in biological samples. 
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Reversed-Phase Liquid Chromatography 
RPLC is the most popular LC technique and has been most widely used for 
analysis at molecular level-based separation because of the high demand in studying 
lipids at the molecular level.63, 68, 69 The mechanism of RPLC separation of lipids is based 
on the interaction between the lipophilicity of the fatty acyl chains and the hydrophobic 
stationary phase (Figure 4).70, 71 Lipophilicity is primarily determined by the length and 
the number of double bonds in the acyl chains. Thus, a lipid species contains a longer 
fatty acyl chain will stay in the column longer than the one with a shorter chain, and the 
saturated lipids will elute later when compared to lipids with mon- or poly-unsaturated 
analogs. Previous studies showed the use of long, narrow column with 2-5 µm particle 
size, operating at high UHPLC back pressure range while maintaining the high 
resolution. Lately, the new technology of using porous shell fused to a solid core 
decreases the diffusional mass transfer path at high speed, resulting in a high-resolution 
chromatogram at shorter time of separation. The standard RPLC columns used in 
lipidomics are Acquity UPLC BEH C18, HSST3, BEH C8, Kinetex C18, and Accucore 
C30. These columns can endure a high-pressure flow rate while maintaining the well-
separated chromatogram. In RPLC, a weak mobile phase is applied at the beginning of 
the gradient which is made of water mixed with organic solvents such as 
water/acetonitrile (ACN), water/iso-propanol (IPA), or water/methanol/tetrahydrofuran, 
and gradually the gradient transits to a stronger mobile phase consists of high percentage 
of IPA. Based on its capability of separating lipids at the molecular level, RPLC is the 
primary tool for high-throughput separation and analysis of lipidome in biomedical 
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research.57 Over the years, deciphering the complexity of molecular lipids has highlighted 
the need to resolve isomers and isobars within a lipid class or from different lipid classes, 
especially the isomeric lipids that have different biological functions. With the most 
recent developments in column chemistry and solvent system optimization, RPLC is 
capable of separating lipids with varying compositions of fatty acyls, sn-positional 
isomers, and some isobaric species.72, 73 For example, application of RPLC in human 
plasma samples resulted in 300-400 lipid molecules identified, yet there are a high 
number of co-eluting peaks that can’t be determined to their molecular levels.26, 74, 75  
Two-Dimensional Liquid Chromatography 
While each LC approach has its advantages, there are inherent limitations in each 
approach if using alone, which can be overcome by integrating with other approaches. 
For example, NPLC and HILIC are good at separating lipids based on their classes, while 
lacking the separation power of individual lipid species; on the contrary, RPLC can 
provide molecular level separation, but lipid species with the same or similar fatty acyl 
chains but belonging to different lipid classes can co-elute. Therefore, pairing LC 
techniques together can leverage more separation principles and results in a better 
separation.60, 63, 76-78 This so called 2D-LC can be performed on-line (such as HILIC-
RPLC) or off-line (such as NPLC-RPLC). The off-line mode offers a full optimization of 
separation in each of the dimension, even though it might be labor-intensive. The on-line 
approach, on the other hand, can be automated, but the separation is not as 
comprehensive as what off-line mode can deliver, due to the restrictions in sampling time 
and solvent compatibility. For a comprehensive identification of lipid species in the 
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lipidome of a complex biological sample, 2D-LC is frequently recommended.63, 77, 79-81 
This not only can uncover the low abundant lipid species that typically would be masked 
by the high abundant lipids, doing so would also enhance the confidence in assignment of  
the molecular structure of lipids. 
 
 
Figure 5. Mechanism of Electrospray Ionization. 
 
 
Mass Spectrometric Analysis Of Lipids 
Ionization Of Lipids 
Concurrent with the development of mass spectrometric technologies, various 
methods have been applied to ionize lipids. In the 1980s, the popular method for 
ionization of biomolecule is fast atom bombardment (FAB), as such FAB was used in 
generating lipid ions for mass spectrometric analysis, but it has low sensitivity and is 
contaminated with ions from the insource fragmentation and matrix ions.82 The need for a 
soft ionization technique resulted in the development of electrospray ionization (ESI) in 
the 1990s.83 Compared to FAB, ESI offered up to 1000 times more sensitivity, enabled a 
rapid growth in the number of lipids identified in biological samples.83  
Fenn and colleagues first developed ESI.84 To analyze polar compounds, ESI uses 
a strong electric field under the atmospheric pressure to assist the transfer of ions from 
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solution into the gaseous phase prior to the mass spectrometric analysis. Compounds 
analyzed by ESI are converted to ionic form by protonation/deprotonation or ion 
adductation. To do so, a solution of compounds is dispersed to a fine spray of charged 
droplets, followed by solvent evaporation using nebulizing gas, and finally ejection from 
the highly charged droplets and desolvation into ions (Figure 5). 
 ESI-MS is a highly sensitive and efficient method, as long as a sufficient dipole 
potential is presented in a molecule to interact with the charge, ions can be formed and 
analyzed. ESI-MS-based shotgun lipidomics was first proposed by Han and Gross in 
2003,85 to directly analyze lipids from biological samples without any LC separations. In 
shotgun lipidomics, additives were added into the solution of lipid extract to assist the 
ionization of lipids. Positive ESI-MS yields abundant [M+H]+ and [M+X]+ (X= metal 
adducts such as Na, K, Li, etc.), while negative ESI-MS yields [M-H]- and other adducts. 
The results obtained by Han and coworkers were impressive and high throughput; 
however, there were challenges in working with a biological sample without any 
separation techniques. With the separation power provided by LC, ESI was also used to 
couple LC separation and MS analysis as it is a natural interface between these two 
techniques. For enhanced performance, the LC mobile phase needs to be a volatile 
solvent to preserve the ionization efficiency of ESI. NPLC uses apolar solvents; hence, 
the low conductivity of these solvents are not suitable with ESI-MS. In contrast, HILIC 
and RPLC are more compatible with ESI due to the organic-rich aqueous mobile phase 
can readily induce the ionization and desorption in the source.  
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Another well-known ionization technique is matrix-assisted laser desorption 
ionization (MALDI), which has been used for direct lipid analysis of a vast array of 
biological samples such as tissues.86-88 MALDI has been applied in studying a variety of 
lipid classes, from non-polar lipids such as triacylglycerols to highly polar lipids of 
glycosphingolipids.89-91 There are many applications of MALDI in biomedical research 
of lipidomics, especially when it comes to imaging lipid species in brain-related 
diseases.92-94 The advantages of MALDI lie in its tolerance of impurities and less labor-
intensive in terms of sample preparation. Moreover, it was observed that MALDI is more 
sensitive to phospholipids in the positive mode compared to ESI, resulting in multiple 
adducts for one lipid species in a single spectrum.95 This can be an advantage but also a 
disadvantage because of the complexity of the spectrum and the competition for 
ionization between phospholipids and other lipids, making it difficult for identification as 
well as quantification.96 Besides, MALDI is not compatible with LC technique. These 
shortcomings limit the application of MALDI in non-imaging-based lipidomics studies, 
where ESI is still dominated.  
Tandem Mass Spectrometry For Structure Characterization Of Lipids 
Confident identification of a lipid species requires accurate measurement of the 
molecular weight, isotopic pattern and very informative sub-structural information, with 
the former ones provided by high resolution MS and the latter one tandem mass 
spectrometric techniques. Tandem mass spectrometry or MS/MS is the basis for 
structural characterization of lipids, different scanning approaches such as product ion 
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scans, precursor ion scans, neutral loss scans, and multiple reaction monitoring scans are 
routinely used in shotgun and targeted lipidomics studies.97-103  
Collisional induced dissociation (CID) is the default technique in commercial 
mass spectrometers for performing tandem mass spectrometry and the most commonly 
used fragmentation technique for structural analysis of lipids. To perform CID, mass 
selected ions are collided with inert gas molecules through either potential-driven ion 
acceleration or excitation at resonant frequency of ion motion, which leads to increased 
ion internal energy and bond cleavage. Lipid species within the same class often follow 
the same fragmentation pattern under CID, whilst different lipid classes having different 
headgroups present unique class-characteristic fragment ions. In positive ionization 
mode, GPs form protonated or ammonium adduct [M+H]+ or [M+NH4]+, or a wide range 
of metal adducts including [M+Na]+, [M+K]+ and [M+Li]+, etc. Although the protonated 
adducts can form product ions resulting from neutral loss of fatty acyls, their relative 
abundance is very low, which makes it difficult for assignment of the structures. 
Alternatively, fragmentation of metal adducts showed more information-rich fragments 
that can indicate the sn-position on the glycerol backbone. However, their applications 
are not popular in the biomedical research due to the overcomplicated spectra.104-107  
For acidic GPs that favor negative ionization, they generally form deprotonated 
ions [M-H]-. For example, CID fragmentation of PS (16:0_18:1) produces the 
carboxylate anions [RCO2]-  at m/z 255 and 281, known as fatty acyl substituents. These 
two product ions also present concomitantly with anions of the fatty acids RCO2H or 
ketene derivatives R’CHCO. Moreover, the precursor ions of PS easily lose the serine 
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moiety (-87 Da) under the influence of CID. From these fragments in a spectrum, one can 
conclude the lipid class, as well as the composition of the acyl chains (number of carbon 
and double bonds). Meanwhile, PCs and SMs cannot be easily deprotonated, instead, they 
form acetate [M+CH3CO2]-, formate [M+HCO2]-, or chloride adduct [M+Cl]-. CID of 
these adducts generates neutral loss of the methyl group [M-CH3]-, and further 
disassociates to [RCO2H]- or [R’CHCO]- to reveal the structure of the fatty acyls. 
Moreover, the relative abundances/ratio between two fatty acid ions [R1CO2] -and 
[R2CO2]- in GPs can be used for sn-assignment. For instance, the PC (16:0_18:0) yielding 
two fatty acid ions at m/z 255 (FA (16:0)), and the more abundant at m/z 281 (FA 
(18:1)). This result indicated the FA (16:0) belongs to sn-1 position while FA (18:1) 
attached to sn-2 position, so this lipid is reported as PC (16:0/18:1) with clear sn-
annotation. Hence, the ratio of [R1CO2]- / [R2CO2]- <1 has been used to characterize the 
sn-assignment of lipids. The combined use of CID-MS/MS in both ionization modes can 
provide both the head group and fatty acyl information and to a certain degree, the stereo-
specificity of sn-position; therefore, it has been increasingly applied to lipidomic studies.  
It is of note that a different version of CID is implemented in the high resolution orbitrap 
instruments; this higher energy collisional dissociation (HCD) performs similarly to the 
CID in other mass spectrometers. Both techniques produce very similar fragments, with a 
slightly different relative ratio. 
Although CID/HCD has been the main tool for structural elucidation of lipids, the 
fragmentation can only provide the head group (lipid class), the composition of fatty 
acyls (total number of carbons and double bonds), and sn-assignment in some cases. 
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Direct CID/HCD of lipid ions has not been able to form fragments that can indicate the 
unsaturation site on acyl chains, or the C=C stereochemistry, which are level 4 and 5 of 
lipid structural identification as illustrated in Fig. 6. This has remained as the major 
challenge in the structural elucidation of lipids. Nonetheless, various approaches have  
been developed to overcome this challenge.  
 
 
Figure 6. Summary of The Levels of Structural Identification in Lipids using PC 38:1 as an Example. 
Level 1 contains Information of Total Number of Carbon and Double Bond; Level 2 presents 
Compositional Isomers with The Composition of Fatty Acyl Chains; Level 3 contains sn-assignment 
of Fatty Acyls; Level 4 represents Lipids with information of Double Bond Positions; and Level 5 
contains cis/tran information. 
 
 
One of the approach is to derivatize unsaturated lipids using olefin-specific 
photochemistry or chemistry, such as using Paterno-Buchi,108 and most recently, m-
CPBA epoxidation109 to enable a selective reaction to the C=C, which is carried out either 
in solution or during ionization process, then using CID-MS/MS of the derivatized ions to 
generate fragment ions specific to C=C position. In Paterno-Buchi reaction, a carbonyl 
PC(38:1)
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and an olefin produce a four-membered oxetane ring via UV irradiation during ESI, and 
CID-MS/MS of the oxetane ring-containing derivative subsequently yields diagnostic ion 
pairs with 16 Da different. Although this reaction is implemented explicitly for 
pinpointing the double bond position, its reaction efficiency is rather low, resulting in a 
mixture of reacted and non-reacted lipids, which overcomplicates the interpretation of 
mass spectra. m-CPBA, on the  other hand, utilizes the highly reactive epoxidation 
reaction of C=C to form an epoxide product in solution, which subsequently is being 
ionized and fragmented under CID-MS/MS to form aldehyde and olefin diagnostic ions 
(16 Da mass different). While the reaction is reported to have a complete conversion after 
10 min and the diagnostic fragments are easy to generate and interpret in any commercial 
mass spectrometers, the epoxide intermediate is induced prior to the ESI, and can be an 
isobar to other lipids if studied in a complex mixture. In addition, this technique is still 
under development to be compatible with polyunsaturated lipids. Overall, both 
techniques can pinpoint the position of unsaturation in lipids and use routine CID-
MS/MS for dissociation of derivatized ions, their application to complex biological 
sample may be limited as the low reaction efficiency, or the newly formed products can 
introduce additional species, sometimes isomeric or isobaric to the species in the already 
complicated lipidome. 
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Figure 7. Mechanism of The Ozonolysis Reaction. 1,3-Dipolar Cycloaddition of Ozone to The Alkene 
Leading to The Primary Ozonide, Which Decomposes to give a Carbonyl Oxide and a Carbonyl 
Compound.  
 
 
Gas Phase Ion Chemistry 
The reaction between ozone and olefin is also very specific and ozonolysis has 
been used in organic chemistry for many decades to oxidize alkenes in solution. This 
reaction was first used in solution for lipid unsaturation analysis using a mass 
spectrometer by Murphy and coworkers in 1996.110 Ten years later, Blanksby and 
coworkers revisited the same subject and initiated ozonolysis in the gas phase, by 
generating ozone using the high voltage corona discharge in the ESI source.111, 112 Once 
ozone attacks the alkene double bond, it follows the Criegee mechanism (Fig. 7),113  and 
dissociates the ozonide into a carbonyl oxide diradical and an aldehyde. The ions 
observed in the spectra are the ones that carry the charge and form the paired products. 
They are the charge-bearing Criegee intermediate and aldehyde, with 16 Da mass 
difference (Fig. 8). While OzESI-MS offers high selectivity to the C=C double bonds, 
their applications are limited to individual lipids or simple lipid mixtures because the 
reaction happens with every unsaturated lipids at the source and therefore lacks 
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selectivity with targeted lipids, in addition to the low reaction efficiency.112 Moreover, 
the OzESI products are isobaric with other oxidized lipid ions directly from the lipid 
extract, and the assignment of fragment ions to their respective precursor ions becomes 
ambiguous as the complexity of the mixture increases. To further improve gas phase 
ozonolysis in mass spectrometry, Blanksby and his team brought ozone gas into an ion 
trap of a mass spectrometer and utilized the ion trap as a gas chamber/reaction cell.114 
This approach kept the selectivity of ozonolysis to only the C=C of mass-selected lipid 
ions. This technique was first introduced in 2008, and termed ozone- induced dissociation 
(OzID).114 In the last ten years, OzID-MS was implemented on a few different instrument 
platforms, from low resolution ion trap instruments to high resolution Q-TOF based mass 
spectrometers, and from studying only lipid standards to application of biological 
samples  (Fig. 9).115-119 Moreover, OzID can be hyphenated with CID in tandem 
dissociation to get more informative structural information of lipids. The improvement in 
its efficiency has also moved from being only applicable with direct infusion to 
compatible with LC-based separation.115-117, 120-125 OzID-MS also is promising in 
distinguishing between the cis/trans-isomers;119, 126 however, reference lipid standards are 
suggested to be compared with before a definitive assignment of the structure can be 
reached.  
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Figure 8. OzID-MS Spectra of PC (16:0/18:1). Ozone Attacked the C=C Double bond on The FA 
(18:1) of the Lipid, to Form Primary Ozonide, and Subsequently Cleaved to Form Aldehyde Product 
(m/z 650) and the Criegee Product (m/z 666). These Two Product Ions are 16 Da apart.  
 
 
 
 
Figure 9. The Revolution of OzID-MS over the last 10 years. 
 
 
Conclusion And Future Directions 
Biological samples are complex. Lipids are immersed in and also bound to other 
biological molecules, such as proteins. High structural diversity of lipids itself already 
poses a significant challenge as many isomeric lipid species exist in a biological sample. 
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In addition, high abundant lipid species can mask the detection of low abundant ones. 
Similarly, lipid classes with high ionization efficiency can mask the detection of the 
classes with lower ionization efficiency. As such, comprehensively profiling the lipidome 
and establishing the structure-function relationship of lipids require optimal extraction of 
lipids from the biological matrix, integrated use of separation methods to reduce the 
complexity of lipids prior to structural analysis, and combined use of positive and 
negative ionization modes and tandem mass spectrometric techniques, including both 
CID/HCD and OzID to thoroughly and confidently characterize the structure of lipid 
species.  This is the strategy that we have adopted in this dissertation to identify lipid 
biomarkers for T1D, and will be presented in detail in the following chapters.  
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CHAPTER III 
ACCURATE MASS AND RETENTION TIME LIBRARY OF SERUM LIPIDS FOR  
TYPE 1 DIABETES RESEARCH 
This chapter is published at journal Analytical and Bioanalytical Chemistry and is 
presented in this style. 
 
 
Introduction 
Besides of being essential structural components of cell membrane, lipids have 
other distinctive biochemical roles in providing a hydrophobic environment for 
membrane proteins, assisting cell signaling process, regulating action of hormones, and 
storing biochemical energy.31, 127 Dysregulation of lipid metabolism has offered critical 
insights into the pathogenesis of complex diseases, and lipids are identified as biomarkers 
to cancers, diabetes, Alzheimer’s and other inflammatory diseases.128, 129 While clinical 
type 1 diabetes (T1D) features metabolic dysregulation of some serum lipid species, 
interestingly, changes in lipidome appear to precede hyperglycemia or even the 
appearance of islet autoimmunity.25, 26, 130  
Biomarkers can be either secreted or leaked from pathologic tissues to 
bloodstream. Although cell, tissue and biofluid samples are routinely used to study 
diseases, blood plasma and serum are the most commonly used specimen for clinical 
diagnostics because of their availability.131 However, significant analytical challenges are 
associated with this type of complex specimen, namely the identification of the low 
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abundant lipids and the differentiation of isobaric and isomeric species commonly exist in 
glycerophospholipids and glycerolipids classes. Because of these, most of the lipids 
reported in the literature were characterized to the level of summed composition, i.e. total 
number of carbon and double bonds in the fatty acyls, which results in ambiguity in 
characterizing the exact molecular structure and, in turn, hinders further investigation into 
the roles of these lipids in biological processes.28  
Liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS) is 
increasing used for untargeted lipidomic analysis owing to the increases in LC resolving 
power, decreasing particle size, novel column chemistry and new separation 
mechanisms.58, 63, 73, 80, 132, 133 The popularity of RPLC-MS based method can be further 
explained by several advantages such as more reliable identifications of individual lipid 
species exist at trace level and the separation of isomeric and isobaric lipids with reduced 
ion suppression.63, 132  Software, such as LipidBlast, LipidSearch, LipidMiner, and 
MzMine2 were developed to process LC-MS/MS based untargeted lipidomics data and to 
handle the need of automated data processing.134-137 These software use in-silico 
generated mass fragment libraries - many based on LIPID MAPS 
(https://www.lipidmaps.org/) - for lipid spectrum annotation. The drawback of providing 
a large database for lipidomic profiling in compound identification is the prevalence of 
false positive identifications. Incorporating LC retention time information into the 
database search could greatly reduce the search space and improve the search accuracy. 
In this respect, accurate mass and time tag approach has been developed for 
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proteomics,138, 139 and more recently applied to metabolomics,140 but rarely this approach 
has been used in lipidomics.141  
Previously, we developed an offline two-dimensional LC-MS/MS method for 
untargeted lipidomic profiling.63 In this approach, a mixed-mode LC and RPLC coupled 
to a high resolution mass spectrometer was demonstrated to double the lipidomic 
coverage for complex tissue and plasma samples in comparison to RPLC-MS/MS alone. 
More importantly, very reproducible retention time and high mass measurement accuracy 
was achieved for each lipid molecular species. In current work, we apply this approach 
for a comprehensive identification of lipids in T1D patient sera. Total lipids extracted 
from pooled sera were fractionated using mixed-mode LC based on the head group of 
each lipid class, collected fractions were further separated on a RPLC-MS/MS platform k   
cohort. The DAISY study protocol was approved by the Institutional Review Board of 
the University of Colorado and detailed study design and methods have been previously 
published.142, 143 Written informed consent were obtained for all study participants from a 
parent or legal guardian. Samples were stored at -80º C prior to analysis. Analysis of 
these samples was also approved by the Institutional Review Board of the University of 
North Carolina at Greensboro. All research was performed in accordance with relevant 
guidelines/regulations. 
In total, serum samples from 50 subjects were selected from two groups: Type 1 
Diabetes (T1D) group comprised of children who developed islet autoimmunity and 
progressed to T1D and the control group from children who remained negative islet 
autoimmunity at all times. Four time points (0.7 to 14.7 years of age) during the disease 
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progression in the T1D group were selected for this study, which include the earliest time 
point possible in the longitudinal study, the time point prior to and after appearance of 
persistent islet autoimmunity, and the time point of clinical diagnosis. Sample selection 
of the control group was age and sex matched to the T1D group. 
Pooled samples were created to represent different stages of disease development 
and also reflect the nature of each group. Aliquot of 5 µL from each sample within the 
first two time points of each group were pooled, so were the last two time points. 
Extraction of serum lipids was carried out following a modified Folch method.63 Briefly, 
pooled samples were diluted with cold (-20º C) chloroform/methanol (2:1, v/v) at ratio of 
5:1 (solvent/sample ratio). The mixture was vortexed for 10 s, then set at room 
temperature for 10 min and vortexed again before centrifuging for 10 min at rate 10,000 
RPM. The chloroform phase was collected to a glass vial, followed by evaporation of the 
extracted lipids to dryness under vacuum, and stored at -80° C in nitrogen gas prior to 
further analysis. 
Materials and Methods 
Chemical Reagents And Standards 
Ammonium formate, n-heptane, acetone, methanol, isopropanol (IPA) and water 
(Optima® LC-MS grade) were provided by Fisher Scientific (Fair Lawn, NJ). Acetonitrile 
(ACN) and formic acid were of LC/MS quality and acquired from Fluka (Germany). 
Chloroform (HPLC grade) and ammonia solution were purchased from Merck 
(Germany).  
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Lipid standards were purchased from Avanti Polar Lipids (Alabaster, AL), which 
include Cer d18:0/24:1, PC 18:0/18:1, PE 16:0/18:1, PG 16:0/18:1, PS 16:0/18:1, PI 
21:0/22:6, PC P-18:0/20:4, PC O-18:0/20:0, PE P-18:0/22:6, PE O-18:0/18:0, SM 
d18:1/12:0, and d5-TG ISTD Mix I. The acylglycerols, fatty acids, cholesterol and 
cholesterol esters were obtained from Nu-Chek Prep, Inc. (Elysian, MN).  
Mixed-Mode LC Fractionation Of Lipid Classes 
The mixed-mode LC separation was performed according to our previous 
published method using an Agilent HPLC equipped with a quaternary pump, and an 
Agilent 1260 Infinity evaporative light scattering detector (ELSD) (Palo Alto, CA, 
USA).63 The method was run on a Chromolith Performance Si column (100mm×4.6mm, 
macropores size 2.1μm and mesopores size 13nm, Merck, Darmstadt, Germany). The 
autosampler was set up at 23º C and the injection volume was 10 µL, equivalent to 100 
µL of serum. 
Overall, all lipid classes were collected into these fractions with the following 
order: CE and TG from 1- 3.2 min; Chol and 1,3-DG from 3.21-4.1; 1,2-DG from 4.11-
5.5 min; MG from 11-13.6 min; Cer from 13.61- 15 min; FAs from 15.01- 17 min; PG 
from 20.51- 22 min; PE from 26.01- 28 min; PI and PS from 28.01-30.5 min; PC from 
30.51- 35 min; SM from 35.01- 39 min; sn-1 LPCs from 39.6-41 min; sn-2 LPCs from 
41.5-42.4 min. 
RPLC- MS/MS Analysis  
The RPLC-MS/MS analysis was performed as we reported previously,73 using a 
Vanquish UHPLC system coupled to a high resolution hybrid Quadrupole-Orbitrap mass 
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spectrometer (QExactive HF, ThermoFisher Scientific, USA). The separation was 
achieved using an Accucore C30 column (ThermoFisher Scientific) maintained at 40º C 
and the gradient was delivered at a flow rate of 350 µL/min. The mobile phases A and B 
were ACN:H2O (60:40, v/v) and IPA:ACN (90:10, v/v), respectively, both containing 10 
mM NH4HCO3 and 0.1% HCOOH.63, 73 The sample tray was set at 15°C with the 
injection volume of 5 µL.  
The following parameters were used in electrospray ionization: the spray voltage, 
the capillary temperature and the heater temperature were at 3 kV, 350 °C and 400 °C, 
respectively, for both ionization modes; the S-Lens RF level was set at 50. The Orbitrap 
mass analyzer was operated at a resolving power of 120,000 in full-scan mode (scan 
range: 114 – 1700 m/z; automatic gain control target: 1e6) and of 30,000 in the Top20 
data-dependent MS2 mode (HCD fragmentation with stepped normalized collision 
energy: 25 and 30 in positive ion mode, and 20, 24 and 28 in negative ion mode; 
maximum ion injection time: 100 ms; isolation window: 1 m/z; automatic gain control 
target: 1e5 with dynamic exclusion setting of 15 s). 
Fatty Acid Analysis 
The method for total fatty acid analysis was described in our previous work.63 
Briefly, total lipids were extracted from human serum and dried prior to hydrolysis and 
derivatization with 2M KOH/CH3OH. The resulted fatty acid methyl esters (FAMEs) 
were extracted and profiled using an Agilent 7890 GC system (Agilent Technologies, 
Santa Clara, CA) coupled to a Leco Pegasus HT time-of flight MS (Leco, St. Joseph, 
MI). A HP-88 column (100 mx 0.25 mm) with a film thickness of 0.2 µm (Agilent 
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Technologies) was utilized for separation of FAMEs. Commercial FAMEs standard 
mixture (Agilent) was used as reference standards.  
Data Processing  
All LC-MS/MS data files were processed using LipidSearch software (version 
4.1) (ThermoFisher Scientific) to identify lipid molecular species within each lipid 
fraction. Settings of LipidSearch were as follow: precursor tolerance: 5 ppm; product 
tolerance: 5 ppm; product ion threshold: 5%; m-score threshold: 1; Quan m/z tolerance: ± 
5 ppm; Quan RT (retention time) range: ± 0.5 min; use of main isomer filter and ID 
quality filters A, B, C and D; Adduct ions: +H and +NH4 for positive ion mode, and -H, 
+HCOO and -2H for negative ion mode. The lipid classes selected for the search were: 
LPC, PC, LPE, PE, LPS, PS, LPG, PG, LPI, PI, LPA, PA, SM, MG, DG, TG, CL, So, 
Cer, CE. The same lipid annotations identified within ± 0.1 min were merged into the 
aligned results. LipidSearch results were manually inspected for sn-positional assignment 
of fatty acyls according to corresponding fragment ion intensities in tandem mass 
spectrometry. Identification results were further filtered using the retention time -total 
fatty acyl chain length correlation and, confident identification was also restricted to fatty 
acyl compositions provided by GC-MS-based total fatty acid analysis.  
The resultant raw data files of the pre-T1D sample were processed using 
Progenesis QI (Nonlinear Dynamics, UK) for peak detection with the following 
parameters: peak percentage 0.04%, retention time windows from 1 min to 25 min. All 
detected features were searched against our human serum lipid AMT library with 
matching tolerances of 0.2 min in retention time and 10 ppm in mass accuracy.  
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Results 
Isomeric and isobaric lipid species are dominant in highly complex blood serum 
samples, in addition, highly abundant lipid species can mask the low abundant lipid 
species, similarly the high ionization efficiency species can interfere the detection of 
species with low ionization efficiency. Therefore, to broaden the coverage of serum 
lipidome and to provide highly confident lipid identification, a mixed-mode-LC coupled 
with an ELSD detector was used to fractionate the total lipid extract into different lipid 
classes according to the polarity of lipid head group, which is followed by further 
separation of the collected fractions into individual molecular species and structural 
characterization using RPLC-MS/MS analysis (Fig. 10).  
 
 
Figure 10. Workflow to Create The Accurate Mass and Time Tag Library for Serum Lipids. Total 
Lipids were Extracted From Pooled Samples. In the First Dimension of LC Separation, Fractions 
Containing Lipid Classes from Total Lipid Extraction were Separated and Collected using Mixed-
Mode LC-ELSD, and further Analyzed at the Molecular Level in The Second LC Dimension using 
RPLC-MS/MS. Putative Identifications Obtained from Automated Data Processing Software 
LipidSearch were Manually Validated using Multiple Data Filtering Criteria (total fatty acid 
analysis by GC-MS, MS/MS profile and LC Elution Order), Only The Verified Lipid Identifications 
were Curated into The Final Lipid Library with Each Species Annotated With Accurate Mass and 
RPLC Retention Time.  
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Fractionation Of Total Lipid Extracts Using Mixed-Mode LC To Simplify The 
Sample Complexity Of Downstream RPLC-MS/MS 
We applied a previously optimized mixed-mode LC-ELSD method for class-level 
separation of lipids from total lipid extract of serum.63 In total, 18 lipid classes and 
subclasses were detected and eluted in the order of increasing polarity (Fig. 11), namely: 
cholesterol ester (CE), triacylglycerol (TG), cholesterol (Chol),  phosphatidylglycerol 
(PG), phosphatidylethanolamine (PE), phosphatidylethanolamine plasmalogen (p-PE), 
lysophosphatidylglycerol (LPG),  phosphatidylinositol (PI), phosphatidylserine (PS), 
lysophosphatidylethanolamine (LPE), phosphatidylcholine (PC), phosphatidylcholine 
plasmalogen (p-PC), sphingomyelin (SM), sn2-lysophosphatidylcholine (sn2-LPC) and 
sn1-lysophosphatidylcholine (sn1-LPC); ceramide (Cer), 1,3-diacylglycerol (1,3-DG) and 
1,2-diacylglycerol (1,2-DG) existed only in low level in serum, therefore they were not 
labeled on the chromatogram. Because of the low level of LPG, LPE and LPI in serum, 
they co-eluted with other glycerophospholipids, but this did not pose a challenge in 
downstream RPLC-MS/MS analysis as the co-eluting classes do not share isobaric 
species (Fig. 11).  Although mixed-mode LC-ELSD analysis can distinguish disease-
associated dysregulation of metabolism at the lipid class level, overall, there were no 
noticeable class-level changes between the disease groups or between the early and late 
time points of each group.  
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Figure 11. Mixed-Mode LC-ELSD Chromatograms Obtained from Total Lipid Extract of Human 
Sera. a) Pre-T1D Samples and b) Healthy Control Sample. Both Chromatograms Showed Similar 
Lipid Profiles at Lipid Class Level. 1: CE, 2: TG, 3: Chol, 4: FA, 5: PG, 6: LPG, PE, p-PE, 7: PI, PS, 
LPE, 8:PC, p-PC, LPI, 9:SM, 10: sn2-LPC, sn1-LPC. 
 
 
RPLC-MS/MS Analysis Of Lipid-Class Fractions Improved Confidence In 
Structural Identification Of Lipid Molecular Species 
With mixed-mode LC separation, the cross-class, isobaric species used to co-elute 
were separated into different fractions for further downstream RPLC-MS/MS-based 
molecular level separation and identification. This greatly improved the confidence of 
structural assignment. For instance, a full scan MS of PC fraction showed a lipid species 
with a neutral mass of 755.5465 Da. According to Human Metabolome Data Base 
(www.hmdb.ca) and LIPID MAPS (www.lipidmaps.org), 32 and 28 isomeric lipid 
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species from different lipid classes are associated with this mass, respectively, each with 
a unique composition. However, because this species was from the PC fraction, we 
limited the database search space of LipidSearch to PC when processing the RPLC-
MS/MS raw data of this fraction. Specifically, the precursor ion at m/z 756.5529 
([M+H]+) was selected for MS/MS fragmentation in positive ionization mode. As shown 
in Fig. 12a, the base peak at m/z 184.0733 - a signature ion of phosphocholine head 
group confirmed the identity of the fraction collected in the mixed-mode LC separation 
as PC. Similarly, m/z 800.5445 ([M+HCOO]-) was selected in the negative ionization 
mode for MS/MS, and it aligned well in retention time (<0.1 min) with the positive mode 
data. As shown in Fig. 12b, prominent ions at m/z 253.2172 and 279.2329, corresponding 
to the ions of [FA(16:1)-H]- and [FA(18:2)-H]-, respectively, demonstrated that the fatty 
acyl composition of this species is 16:1 and 18:2. The m/z 279.2329 as the base peak 
indicated that FA 18:2 located at sn-2 position on the glycerol backbone, as it is known 
that fragment ion ratio of [FA1-H]-/[FA2-H]- is less than 1.72, 73, 144 Hence, we concluded 
the identification for the species with neutral mass of 755.5465 Da with the retention time 
of 9.61 min to be PC 16:1/18:2.   
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Although fragment ion ratio of [FA1-H]-/[FA2-H]- <1 has been commonly used to 
assign the sn-positions, there are reported exceptions to this rule and it casts doubt on 
solely relying on this ratio to assign the sn- position when using different collision 
energies.98, 145-147 Therefore, we performed MS/MS for glycerolphospholipids and 
triacylglycerols standards containing different compositions of fatty acyl chains. These 
standards were studied with the stepped collision energy listed in the method section, 
Figure 12. MS/MS Spectra of  PC 16:1/18:2 in a), Positive ion Mode and b), Negative 
ion Mode. m/z 184.0733 in a) Shows the Signature ion of PC , Which also Confirmed 
The Accuracy of Mixed-Mode LC Fractionation, While m/z 253.2172 and 279.2329 in 
b) Reflect the Composition of the Two Fatty Acyl Chains and The sn-position 
assignment. 
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under both direct infusion and LC-MS conditions. In agreement with the literature,73, 104, 
106, 107, 146, 148 our data suggested that for most of the phospholipids, generation of [FA2-
H]- is more favorable than [FA1-H]- and the ratio of [FA1-H]-/[FA2-H]- is consistently 
smaller than 1 at different normalized collision energy. As a result, majority of the lipid 
species identified in this work have clear annotation of sn-positions using the “/”; for 
lipids with uncertainty in assigning the sn-position, we annotated it with “_”.149, 150 
Elution Order Of Lipids On RPLC Column Depends On The Total Carbon Number 
And Degree Of Unsaturation Of The Fatty Acyls 
Relative retention on RPLC column depends on the hydrophobicity of analyte, the 
more hydrophobic, the later it elutes. In the case of lipids, this is determined primarily by 
the length and saturation of fatty acyls. This rule is especially true for the molecular 
species within the same class of lipids, where all species share the same head group.71, 151 
We plotted the retention time versus the total carbon number of fatty acyls and observed, 
as shown in Fig. 13, a relationship of second degree polynomial regression for the fully 
saturated species of the abundant serum lipid classes: TG, SM, PC, LPC and Cer, with 
each class having a different slope reflecting the actual gradient conditions experienced 
by species in each class. In these plots, we observed species with the same number of 
total carbon but different retention time. By studying their MS/MS profile in both 
positive and negative mode, we confirmed they are sn-position isomers. Nevertheless, the 
correlation coefficients R2 are greater than 0.99 in all plots. To our knowledge, this is the 
most comprehensive determination of the dependence between elution order and total  
carbon number of various species of different lipid classes.  
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A similar correlation was observed for the fatty acyls containing one, two and 
multiple double bonds (Fig. 14). Compared with lipids containing fully saturated fatty 
acyls, more lipid molecules with the same total number of carbon and double bond 
exhibited different retention time (vertically lined dots). These species are isomers with 
different compositions of fatty acyl chains, in particular the C=C positional isomers, as 
the interactions are slightly different between different locations of C=C double bond and 
the C30 RPLC column. As a result of the presence of these isomeric lipid species, the 
correlation R2 are slightly lower than the values of the fully saturated lipids in Fig. 13, 
but still are greater than 0.97 with the species having less than 3 double bonds. When the 
lipid species have at least 3 double bonds, the correlation R2 were generally reduced, with 
the SM and TG lipids significantly reduced to >0.80.  Overall, PC had the highest 
correlation between retention time and total carbon number, even when the degree of 
unsaturation increased; while TG and SM had a lower correlation coefficient due to the 
complexity of the structures and a higher number of isomers (more vertical dots) for each 
species. 
In addition, higher degree of unsaturation resulted in the lipid species eluting 
earlier when comparing the lipid species with the same total number of carbon and 
different number of double bonds, i.e. for the same lipid class, the X:2 lipid species 
eluted earlier than X:1 when X is identical (Fig. 14), which is in agreement with previous 
report.71 It is of note that the excellent correlation observed between the retention time on 
RPLC and the length and degree of unsaturation of fatty acyls provide a way to filter the 
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output of LipidSearch software. As a result, those putative lipid identifications that 
deviated from the established regression curves were further filtered out and not counted  
as valid.  
 
 
Figure 13. Plots Showing Dependences of RPLC Retention Times of Saturated Lipids to The Total 
Number of Carbon, each Panel is a Different Lipid Class (TG, SM, PC, Cer, and LPC). Lipid 
Molecules with longer fatty acyl chain (larger number of total carbon) are less polar and elute later 
from column.  
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GC-MS Based Fatty Acyl Analysis Improved Confidence In Identification Of Fatty 
Acyl Composition Of Lipids 
Lipidomics research requires automated data annotation software, particularly at 
the initial identification stage. LipidSearch software is highly sensitive in peak detection, 
hence, often times, species in the noise were considered as identifications. Another 
observation from using LipidSearch as well as other automated software is the ability to 
identify “biological impossible” lipids due to the input of the in-silico library. The large 
number of putative identifications resulting from combinatorial enumeration inevitably 
generates large number of false positive identifications. To this end, we performed fatty 
acyl methyl ester analysis using GC-MS by derivatizing the fatty acyls hydrolyzed from 
lipid backbone under alkaline methanol condition. Using methyl ester derivatives of fatty 
acid standards as reference, fatty acyl chains of serum lipids were analyzed. Results 
showed that the fatty acyl chain lengths varied from 8 to 24 carbons, including the odd 
numbered chains, and the degree of unsaturation varied from 0 to 6. While it is possible 
that serum lipids contain unique fatty acyls of odd numbered carbon (>21 carbons) or 
more than 6 double bonds, their low abundance in these serum samples did not provide 
strong enough justification for the inclusion of these fatty acyls as valid lipid 
identifications. Based on the results of fatty acyl analysis, we filtered out the putative 
lipid identifications to limit the valid identifications only to those ones containing the  
detected fatty acyls.  
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Figure 14. Plots Showing Dependences of RPLC Retention Times of Unsaturated Lipids to The Total 
Numbers of Carbon, with each Panel Showing a Different Lipid Class (TG, SM, and PC)  or Degree 
of Unsaturation (1 to 4).  Within each class, slightly different retention times were observed between 
different C=C positional isomers and sn-position isomers (vertically lined dots).    
 
 
Contents And Characteristics Of The Human Serum Lipid Library 
Using the offline 2D-LC-MS/MS approach and the data filtering and validating 
approaches mentioned above, we confidently identified 753 lipid molecular species in 
healthy control and pre-T1D human sera. The curated library, as provided in Table S1, 
contains information of accurate mass, RPLC retention time for each identified species. 
Overall, these 753 lipid molecules belong to 13 major lipid classes: Cer, DG, LPC, LPE, 
LPI, LPG, TG, PC, PI, PE, PS, PG and SM (Fig. 15). The sub-classes including 
plasmalogen and sn-position (1,3- and 1,2-DG and sn-1/sn-2 LPC) were combined and 
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reported under their corresponding representative classes such as DG, PC, PE, LPE and 
LPC. Every lipid class was detected in both positive and negative ionization mode, 
except TG and Cer, which were solely in positive mode. [M+H]+ and [M+NH4]+ are the 
dominant ions in positive ionization mode,  whilst [M-H]- and [M+HCOO]-in the 
negative mode.  In total, 88% of the lipids within our human serum lipid library are 
unsaturated lipid species, with 83% of them being polyunsaturated (degree of 
unsaturation >2). Majority of the species observed belong to TG, SM, PC and PE classes. 
Cer species are composed of fatty acids of 16 to 24 carbons, with the majority having one 
to two double bonds and an appearance of the odd long chain base d17:1. Both 1,2-DG 
and 1,3-DG were detected, with a predominance of polyunsaturated 1,2-DG species. 
Lyso-glycerophospholipids (LPLs) including LPC, LPI, LPG, LPE were also found in the 
serum sample with a diverse fatty acyl chain length of 12-22 carbon. LPC is the most 
dominant LPLs with the strong preference of sn-1 over sn-2 isomers. Moreover, we were 
able to clearly identify plasmanyl and plasmenyl PLs using their distinct MS/MS 
fragments. 
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Figure 15. Relative Distribution of Lipid Species contained in The Serum Lipid Library. 
 
 
We further plotted the spatial distribution of all lipids included in the library in the 
two dimensional spaces of RPLC-retention time and m/z.  As shown in Fig. 16, clusters 
of lipids with mass ranges from 400-600 Da, 500-900 Da and >900 Da eluted in the 
following order: earlier than 5 min, 5.5-17 min, and after 17 to 25 min, respectively. 
Clearly, many isobaric and isomers species overlapped and it would be challenging to 
identify them if only using RPLC-MS/MS. The only lipid class that was separated well 
from others on RPLC is the highly non-polar TG. Lipid species belonging to LPLs eluted 
together, and GPLs (PC, PE, PI, PS) co-eluted with the DG, SM and Cer species. 
However, DG and Cer species have a different mass range from phospholipids. 
Conversely, with mixed-mode LC, we increased the level of confidence in lipid 
identification because a correct identification needs to come from the right fraction (lipid  
class), and match with the accurate mass and the elution order.  
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Figure 16. Individual Lipid Molecular Species Identified in Human Sera, Plotted with Their Respective 
m/z and Retention Time (min) on the RPLC. Identification of These Lipid Molecular Species was 
Facilitated by Lipid Class Level Fractionation using Mixed-Mode LC-ELSD, and Molecular Species 
Level Separation using RPLC-MS/MS.  
 
 
Application Of The Lipid Library To Identify Lipids From Serum Sample  
As a demonstration of the utility of the curated library in identification of lipids 
from biological sample, total lipids extracted from one individual pre-T1D serum sample 
were directly analyzed by RPLC-MS/MS without fractionation at lipid class level and 
raw data files were processed using two approaches - without and with our AMT serum 
lipids database. In the first approach, the raw data were processed directly using 
LipidSearch software resulting into 217 lipid species identified with assignment of sn-
positions. In the second approach, the resultant raw data were processed using Progenesis 
QI software. Detected features from Progenesis QI were searched against the curated 
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human serum lipid library based on the accurate mass and RPLC retention time of each 
lipid molecular species. In total, we identified 412 molecular lipids in one individual pre-
T1D serum sample, as summarized in Fig. 17. Majority of the species identified are in the 
class of TG, PC, SM, PE and LPC, which is proportional to the composition of lipid 
library. The profile of carbon length and degree of unsaturation for each fatty acyl in T1D 
lipidome varied from 10-22 carbons, including some odd chains (15 and 17 carbons), and 
0-6 double bonds C=C. Hence, with the use of our AMT lipid serum database, we are 
able to increase the number of identification significantly, mostly from the low abundant  
species.  
 
 
Figure 17. Number of Lipid Species identified from a T1D Serum Sample. Progenesis QI was Used to 
Match the LC-MS Profiles of The T1D Serum Sample to the Serum Lipid AMT Library. 
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Discussion 
There has been an increased interest in comprehensively characterizing the human 
serum lipidome for its use in disease diagnosis. However, due to the complexity of blood 
serum samples, it is commonly recognized that many lipid species are unlikely to be 
detected due to their low abundance in serum, which is further hindered by the limited 
resolving power of one-dimensional LC separation and the under-sampling issue of data-
dependent MS/MS. The accurate mass and time (AMT) tag approach was initially 
developed for high throughput proteomics to provide extensive coverage of complex 
peptide mixtures by taking advantage of the high resolution and wide dynamic range of 
the MS scans, which largely overcame the under-sampling issue in MS/MS-based peptide 
identification.139 The concept employed in AMT tag based-proteomics studies could be 
applied to study other biomolecules, such as lipids.141 Specifically, if an AMT tag library 
can be generated for various lipid species using a reproducible and robust LC-MS 
platform, then lipids from different samples of the same type of specimen could be 
analyzed in high throughput using the identical platform, where the AMT tag library 
would serve as a look-up table for lipid identification using LC retention time and 
accurate mass instead of relying on the MS/MS spectrum.  
To achieve this, we employed offline two-dimensional LC separation,63 which 
used mixed-mode LC in the first dimension to fractionate the total lipid extract into lipid 
classes, followed by reversed phase LC separation to further separate lipids in the same 
class into molecular species. The chromatographic separation and mass spectrometric 
detection conditions have previously been optimized in our laboratory, which doubled the 
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coverage of rat serum and liver lipidome compared to using RPLC-MS/MS alone. 
Fractionating total lipid extract into different lipid classes prior to the 2nd dimensional 
RPLC-MS/MS analysis is critical for building the library, as it greatly increased the 
confidence in lipid identification process by limiting the cross contamination of co-
eluting isobaric/isomeric species between different lipid classes. For example, isobaric 
PC and SM can be challenging to differentiate when co-eluted on RPLC column because 
they share the common characteristic fragment ion (phosphocholine head group) in 
positive ionization mode.101 However, the ambiguities in identification can be eliminated 
with additional dimension of separation provided by mixed-mode LC on which SM is 
clearly separated from PC.  
Automated lipid identification programs, such as LipidSearch, are powerful in 
identification of lipid molecular species based on pre-configured fragmentation rules.135 
However, not all MS/MS spectra acquired from real biological samples are of high 
quality, which can be further complicated by lipids co-eluted and co-fragmented within 
the precursor ion selection window. This undoubtedly poses a challenge in structural 
elucidation when only head group-specific ions can be observed. As an effort to improve 
the confidence of identified lipids, we did total fatty acyl analysis using GC-MS to limit 
the composition of identified lipids only to those detected fatty acyls. We also observed a 
rigorous dependence between the RPLC retention time and the sum composition of total 
carbon number of all fatty acyls, which was used to further remove the putative lipid 
identifications not following the trend line.  
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 The ratio of [FA1-H]-/[FA2-H]- has been used for sn-positional assignments; 
however, relative intensities of the two carboxylate anions can vary depending on length 
and unsaturation, as well as the collision energy used in fragmentation.72, 147, 152, 153 In this 
respect, it has been reported that different fragmentation patterns originated from 
different cleavage sites could be formed as a result of very different collision energies,154 
or the ratio of [FA1-H]-/[FA2-H]- could be altered with the collision energy.146, 147 Hence, 
to confidently identify the sn-position assignment of fatty acyls, we studied the relative 
ratio of [FA1-H]-/[FA2-H]- using a list of representative lipid standards with different fatty 
acyl chains for each class, and concluded that [FA1-H]-/[FA2-H]- <1 can be used to assign 
the fatty acyl positions in  most of lipid classes under our experimental conditions, i.e. 
NCE 20–30 under HCD. Thus, within the stepped collision energies used in this work, 
we ruled out their effects on reversing the ratio of carboxylate anions.  
Results from mixed-mode LC separation showed that there were no noticeable 
lipid class-level changes between healthy and T1D group or between the early and late 
time points of each group. Considering the samples used in this study were collected 
from patients older than 8 months and pooled from 25 subjects and two time points, our 
observation is somewhat in agreement with the serum lipid profile changes reported for 
the Finnish Type 1 Diabetes Prediction and Prevention cohort (DIPP) study, where the 
lipidomic profile changes associated with the progression of T1D appear to be most 
pronounced in children at 3 months of age.25 Nevertheless, no change at the lipid class 
level further underline the importance of separating lipids at the molecular species level.  
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In agreement with the literature, our finding revealed that TG, PC, and SM are 
predominant lipids in human serum, with TG comprising over 50% of lipids having more 
than 52 fatty acyl carbon atoms.155, 156 Compared to the previous published human 
plasma/serum lipidome, our lipid library provided unambiguous identifications at the 
level of sn-assignment for most of the glycerolphospholipids.81, 156, 157 Although generally 
not native to mammalian cell lipidome, glycerolphospholipids containing odd chain fatty 
acyls and longer chain fatty acyls on the sn-1 position were also observed and passed our 
validation criteria. It is of note that, despite cholesterol and fatty acids being abundant 
classes observed in the mixed-mode LC (Fig. 11), we didn’t perform identification of 
these two classes at the molecular level. Cholesterols have been known to ionize poorly 
with electrospray ionization unless derivatized to cholesterol esters158 and therefore 
traditionally cholesterols are ionized with chemical or photo ionization techniques and 
not suitable for detection using our electrospray ionization-based platform. With respect 
to identification of free fatty acids, the main fragment ions resulted from CO2 loss 
requires NCE > 50,159 which greatly exceed the NCE used for other lipid classes.  
 In summary, using orthogonal and highly resolving separation methods of 
mixed-mode LC and RPLC in conjunction with high resolution tandem mass 
spectrometry and multiple levels of data filtering and validation, we have created a 
comprehensive human serum lipid library containing 753 lipid molecular species, with 
accurate mass and retention time annotated for each lipid molecule and with confident 
assignment of fatty acyl sn-positions for most of the species. This library not only 
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provides a comprehensive resource for studies of T1D, it will also be valuable for 
biomarker studies of other childhood diseases.  
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CHAPTER IV 
OZONE-INDUCED DISSOCIATION ON A TRAVELING WAVE HIGH  
RESOLUTION MASS SPECTROMETER FOR DETERMINATION   
OF DOUBLE BOND POSITION IN LIPIDS 
This chapter has been published in journal Rapid Communication in Mass 
Spectrometry and is presented in that style. Vu, N., Brown, J., Giles, K., Zhang, 
Q. RCMS. 2017, 30, 1415-1423 
 
 
Introduction 
Lipids are involved in a wide range of biological processes from being a major 
component of cell membranes to regulation of metabolic pathways. Changes in lipids are 
reflected in various pathological and physiological conditions.39, 160-163 Consequently, 
lipids have been implicated as biomarkers and major contributors to diverse diseases such 
as obesity, diabetes, cancers and Alzheimer’s.21, 36 
The function of a lipid depends on its molecular structure. Lipid isomers that 
differ only in their fatty acyl C=C position can have very distinctive roles functionally. 
For example,  free fatty acids (FFAs) that contain double bonds at w6 or w9 positions 
inhibit the activity of nicotinic acetylcholine receptor, while the w11 and w13 isomers 
have no such effect.164 Similarly, FA (18:1, w3) prevents cardiovascular disease whilst its 
w6 double bond positional isomer worsens this disease.165 Thus, detailed characterization 
of lipid structures would aid in understanding their biological functions. 
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Recent advancements in the field of mass spectrometry (MS) have greatly 
improved the field of lipidomics, as a result more lipids have been identified with better 
structural annotation.73, 166-169 However, the determination of carbon-carbon double bond 
locations within the unsaturated fatty acyl chains still remains a challenge. Different 
hyphenated mass spectrometry techniques have been used to localize lipid double bond 
positional isomers. In gas chromatography coupled with mass spectrometry (GC-MS), 
lipid molecules are derivatized to form methyl esters for volatilization, which is followed 
by fragmentation with high energy electron ionization. Although this GC-MS analysis 
can pinpoint the location of a double bond that is closest to the methyl end of the fatty 
acyl chain,  it only allows confident identification of the location of double bonds in 
monounsaturated lipid species.170  In addition, the sn- substituent information is lost 
during the hydrolysis process and therefore GC-MS is incapable of determining C=C 
positions from intact lipids. On the other hand, the commonly used low energy collision 
induced dissociation (CID)-MS, is able to assign the sn- positions and identify the total 
number of carbon on each fatty acyl chain along with their total degree of unsaturation 
from intact lipids, but struggles to characterize the locations of double bonds without 
using multistage ion activation techniques on lipid-metal adduct ions.171-175 Alternatively, 
high energy CID-MS has been applied to study the structural variation of the fatty acyl 
chains, yielding a highly complicated fragmentation spectrum embedded with structurally 
diagnostic product ions.176-178  
 C=C selective ion-molecule reactions are promising techniques that largely 
overcome the above mentioned limitations. They also offer increased sensitivity and the 
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ability to provide detailed structural information of a given lipid molecule when coupled 
with mass spectrometry. Xia and co-workers coupled a photochemical reaction online 
with tandem mass spectrometry. 179-182 When the Paternò-Büchi (PB) reaction product 
between a lipid ion and acetone is activated using CID, it generates a pair of diagnostic 
ions originating from the C=C location. Using 193 nm laser, Brodbelt and co-workers 
implemented ultraviolet photodissociation on an Orbirap mass spectrometer to localize 
C=C in lipids.183 Another well-known ion-molecule reaction is the Ozone-induced 
dissociation (OzID) pioneered by Blanksby and co-workers, which uses the ozonolysis 
reaction of C=C to pinpoint the location of double bonds based on the neutral loss of 
diagnostic fragment ions (aldehyde and Criegee ions).114, 116, 121, 126, 170, 184 OzID has been 
implemented in both shotgun and LC-MS based lipid analyses, mainly using ion trap MS 
platforms (Thermo LTQ and AB QTRAP) to characterize the lipid double bond 
positional isomers; however, the presence of ozone/oxygen results in decreased 
resolution for helium filled ion traps when ozone/oxygen concentration exceeds a certain 
percentage in helium.114 In addition, most of the OzID-MS experiments carried out so far 
were focused on the sodiated adducts of lipids owing to their stability and predominant 
presence in shot-gun based lipidomics workflow;[31, 32] fragmentation of the most 
commonly observed protonated ions generated in LC-MS based lipidomics workflow has 
been less explored.  
 In this work, we demonstrate the ozonolysis of protonated lipid ions in a high 
resolution MS instrument platform to elucidate the locations of double bonds on the lipid 
fatty acyl chains. The experimental arrangement was based on a Synapt G2 HDMS 
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instrument (Waters Corp., Milford, MA), a MS with high resolution and accurate mass 
capability that employs Traveling Wave-based stacked ring ion guides (SRIGs) for ion 
transfer.185 By modifying the default potential settings, we improved the OzID efficiency 
by increasing the reaction time between lipid ions and ozone gas in the TriWave region 
whilst maintaining the duty cycle of the scan. This approach is promising in both shotgun 
and LC-MS based lipid analysis to fully characterize the structure of unsaturated, intact 
lipids.  
Experimental 
Chemicals 
C18:2 (10E,12Z) methyl ester was purchased from Nu-Chek Prep, Inc (Elysian, 
MN). All phospholipid standards were obtained from Avanti Polar lipids, Inc (Alabaster, 
AL). HPLC grade methanol, acetonitrile (ACN), and isopropanol (IPA) were purchased 
from Sigma-Aldrich (St. Louis, MO). LC-MS grade ammonium formate and formic acid 
were provided by Fisher Scientific (Pittsburgh, PA). 
Sample Preparations 
C18:2 (10E,12Z) methyl ester standard solution was prepared in methanol at a 
concentration of 12.5 µM. Phospholipid standard solutions were prepared in the solvent 
of ACN/IPA/H2O (65/30/5, v/v/v) at a concentration of 25 µM. To aid the formation of 
protonated, 10 mM of ammonium formate and 0.1% formic acid were added into each 
standard solution. All standards were stored at -20°C. A solution of 2 ng/µL leucine 
encephalin (Waters, UK) in ACN/H2O (50/50, v/v) with 0.1% formic acid was used as 
the lock mass for instrument calibrations. 
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In-line Ozone Generation 
An O3MEGA Integrated Ozone Delivery System (MKS Inc, Andover, MA) was 
used for in-situ production of ozone from high purity oxygen. The oxygen pressure was 
set to 15 psi and the ozone system was set to output up to 18 wt% of ozone at a flow rate 
of 0.5 slm. The generated ozone/oxygen mixture was connected to the mass spectrometer 
Trap/Transfer gas supply, with the excess guided to an Ozone Destruct Module (MKS 
Inc.) to convert ozone back to oxygen before venting to the laboratory exhaust system 
(Fig. 1). To ensure safe operation of the ozone delivery system, an Ozone Leak 
Detector/Monitor (Ozone Engineering Inc., El Sobrante, CA) was installed to alarm and 
shut down ozone production if room ozone concentration exceeded safe levels.  
Mass Spectrometry 
OzID-MS experiments were performed on a Waters Synapt G2 HDMS (Milford, 
MA) with MassLynx v4.1 instrument control and data acquisition software. The Synapt 
G2 HDMS has a TriWave region positioned between a quadrupole mass analyzer and an 
orthogonal time-of-flight (oa-ToF) mass detector (Fig. 18). The TriWave region is 
comprised of traveling wave-based SRIGs which have confining radio frequency and 
superimposed transient DC voltages for ion propulsion. These serve as: collision cell 
(Trap); ion mobility separator (IMS) and ion transport device (Transfer) delivering 
sophisticated ion manipulation functions, including ion accumulation, collision induced 
dissociation, ion mobility based separation and high speed ion transfer for TOF based 
detection. In the trap and transfer regions, ions can be manipulated to accumulate or 
fragment using CID prior or after the IMS region.186, 187  
 
 
 
60 
The Argon collision gas inlet of the mass spectrometer was connected to a 
stainless-steel T union to accept both Argon and Ozone, with each line having its own 
shutoff valve. This inlet supplies collision gas to both Trap and Transfer cells as 
configured by the manufacturer (Fig. 18). The trap and transfer gas flow was maintained 
at 2.0 mL/min using a flow controller (Bronkhorst, Suffolk, UK) operated via MassLynx. 
At this gas flow rate, pressures at the trap and transfer regions were at ~1.0 e-2 and 1.0 e-
4 mbar, respectively. The effective ozone concentration during OzID was at 6.0 %, which 
can be achieved by either diluting the in line generated high concentration Ozone with 
Argon or by directly generating Ozone at this concentration.  
Sample was directly infused using a syringe pump at a flow rate of 5 µL/min, and 
ionized using the electrospray ionization source. The parameter settings for ionization 
were: source capillary voltage 2.70 kV; sample cone voltage 30V and extraction cone 
voltage 6.0V; source and desolvation temperature at 40°C and 80°C, respectively; the 
cone gas and desolvation gas flow rate at 50 L/h and 500 L/h of nitrogen respectively. 
Precursor ions were mass selected in the quadrupole and reacted with ozone gas in the 
trap and transfer regions before reaching the ToF detector. Full MS spectra were acquired 
for every sample. The scan rate was set at 0.2 s/scan. 
The default trap and transfer collision energy were at 4.0 and 2.0 V, respectively. 
The Wave height and velocity in the trap region were set at 0.5 V and 300 m/s; in the 
transfer region were  set at 0.2 V and 247 m/s. Additionally, the TriWave DC conditions 
were set as follows: for the trap region: trap DC entrance 2.0 V, trap DC -2.0 V, Trap DC 
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exit 0.0 V; for the transfer region: transfer DC entrance and exit at 5.0 V and 15.0 V, 
respectively. 
Results and Discussions 
Performance Of OzID At The Default Trap And Transfer Settings 
All OzID performances of lipid standards were first studied using default 
acquisition settings of the Synapt G2 HDMS. In our experimental design, ozone gas was 
supplied in the trap and transfer regions to perform ozonolysis (Fig. 18).  Ion residence 
time within the TriWave region can be estimated from the traveling wave velocity, which 
is derived from the distance between pairs of electrodes divided by the time the pulse 
remains on each pair. For example, the spacing between each electrode pair in the trap 
and transfer regions is 3 mm; therefore, a 10 µs pulse time gives rise to an average 
velocity of 300 m/s. Under these default settings, it takes 946 µs for an ion beam to 
transmit through the trap and transfer regions while interacting with neutral gas before  
reaching to the ToF detector.187  
The conjugated lipid standard FAME C18:2(10E,12Z), previously shown to 
readily undergo ozonolysis was initially used to study OzID efficiency under the 
instrument default settings.184 When oxygen was employed as the collision gas, the 
sodium adduct (m/z 317) alone was observed in MS/MS spectrum under default minimal 
collision energy used for ion transmission (Fig. 19A). In contrast, when ozone gas was 
introduced into the collision cells, OzID aldehyde product ions at m/z 223 and 249 were 
generated with low intensity (Fig. 19B). These ions are specific to the 10 and 12th 
position of the double bond location, respectively. Likewise, ozonolysis reaction of the 
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protonated ions of PC (16:0/18:1(9Z)) (m/z 760) resulted in the characteristic neutral loss 
of 110 Da and 94 Da at the position n-9, which yielded the aldehyde and Criegee 
products ions at m/z 650 and 666, respectively (Fig. 20A). Compared to conjugated C=C 
(Fig. 19B), the monounsaturated C=C has ~ 30 times lower OzID efficiency. This is in 
line with what reported previously on the reaction rate difference between conjugated and 
single C=C when taking into consideration of the double bond conformation.188 It should 
be noted that these product ions were very weak and could only be observed in the 
spectra under high magnification. Nevertheless, these results indicated that OzID-MS  
could be implemented in the Traveling Wave mass spectrometer.  
 
 
Figure 18. Schematic of The Traveling Wave Q-TOF Mass Spectrometer (Synapt G2) Modified to 
Allow OzID in The Trap and Transfer Cells. IMS was Off during Experiment. 
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Optimization Of Traveling Wave Height And Velocity In Trap Region To Improve 
OzID Efficiency 
Under the default instrument settings, the traveling wave is set at an elevated 
wave velocity and wave height in order to reduce ion transmission times whilst 
maintaining sensitivity.186  Although this default setting is very beneficial for normal 
applications, it depresses ozonolysis of unsaturated lipid ions due to the short reaction 
time with ozone. Thus, modifying the wave height and wave velocity would effectively 
allow control of the movement of ions across the trap and transfer regions and their  
reaction time with ozone. 
  
 
Figure 19. OzID-MS Spectra of FAME C18:2 (10E,12Z) under Different MS Settings: A, Oxygen, 
MS/MS at default settings; B, Ozone, MS/MS at Default Settings; C, Ozone, Trap wave height = 0.2 
V; D, Ozone, Trap Wave Height = 0.2 V, Trap Wave Velocity = 8 m/s, Transfer Wave Height = 0.4 V 
and Transfer Wave Velocity = 247 m/s. 
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Figure 20. OzID-MS Spectra of PC (16:0/18:1(9Z)) under Different MS Settings. A, Ozone, Default 
Settings. B, Ozone, Trap Wave Height = 0.2 V, Trap Wave Velocity = 8 m/s, Transfer Wave Height = 
0.4 V and Transfer Wave Velocity = 247 m/s 
 
 
Increasing the height of traveling wave reduces the chance of ions ‘rolling-over’ 
the waves and so reduces residence time in the collision cells. Based on this, a series of 
trap wave heights were applied from 0.0 V to 0.5 V (at fixed 300m/s wave velocity) to 
study the effect on ozonolysis of the sodiated ion of FAME C18:2 (10E,12Z). In Fig. 21A 
it can be seen that 0.2 V wave height produced the highest yield of the OzID products and 
the spectrum is shown in Fig. 19C, which showed a 10x increase in OzID product yield 
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compared to OzID spectrum under default settings (Fig. 19B). Additionally, when the 
wave height was < 0.2 V, ion impulses were not sufficient to allow the ions to keep up 
with the traveling wave through the SRIG, leading to significant loss of signal intensity. 
This is possibly due to the transit time being too long and ions not exiting the TriWave 
before the interscan period during which a sweep-out pulse is applied. Likewise, trap 
wave velocity could be decreased to enhance the OzID reaction (Fig. 21B). Results 
showed that trap wave velocity of 8 m/s (at fixed 0.2 V wave height) produced the 
highest relative intensity of the OzID product ions because lipid precursor ions remained 
in the trap and transfer regions together with ozone gas for 16.65 ms, which is 
significantly longer than the 946 µs of the default setting. A slight enhancement to the 
OzID efficiency was observed in the transfer region by altering the wave height to 0.4 V 
while keeping the defaulted transfer wave velocity at 247 m/s (Fig. 19C &D); however, 
unlike the trap region, overall there was no significant change in OzID efficiency when 
varying the wave height or wave velocity in the transfer region. This may be explained by 
1) the lower pressure (1.0 e-4 mbar) thus lower effective ozone concentration in the 
transfer region; and 2) ions having higher velocity (i.e. reduced residence time) in the 
transfer cell, likely as a result of the trap bias applied in TOF mode which effectively 
adds to the traveling wave velocity in the transfer region.  
Using FAME C18:2 (10E,12Z) as a conjugated C=C containing standard, the 
optimized traveling wave velocity and height in both trap and transfer regions increased 
OzID efficiency ~1000x when compared with the result obtained under the default 
settings (Fig. 19D vs Fig. 19B). Identical experiments were performed on PC 
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(16:0/18:1(9Z)) to ensure the improvement of ozonolysis also worked on lipids 
containing a single C=C (Fig. 20B). Results showed a ~600x improvement in OzID 
efficiency using optimized trap and transfer traveling wave height and velocity settings 
for a monounsaturated lipid (Fig. 20B vs Fig. 20A). The different OzID yield for 
conjugated and mono C=C is a result of their different reactivity with ozone, as it is  
known that the former has much faster reaction rate than the latter one.188  
 
 
Figure 21. Effects of Changing Traveling Wave Height and Wave Velocity on OzID Efficiency: A, 
Trap Wave Height Effect; B, Trap Wave Velocity Effect; C, Transfer Wave Height Effect; D, 
Transfer Wave Velocity Effect. Data obtained by direct infusion of FAME C18:2 (10E,12Z). 
 
 
It is of note that an ion with m/z 263.1630 appeared when FAME C18:2 (10E, 
12Z) reacted with ozone under optimized trap and transfer wave height and velocity 
settings (Fig. 19D). A radical cation of m/z 262 was reported previously from OzID of 
this compound,188 however, the accurate mass that we measured for this ion preclude its 
identity as this radical cation. The exact identify of this ion remains to be determined; it is 
likely a result of hydrogen abstraction by the radical cation from other gas molecules in  
the vacuum environment (mass measurement error ppm).  
 
 
 
67 
 
 
Figure 22. Diagrams Illustrate The Transmission of Ions Through The Trap Cell in The TriWave 
Region and The Effect to Gas Phase Ozonolysis by Changing Trap Entrance Voltage and Trap DC 
Voltage. Potential Hills are Based on Trap Wave Height at 0.2 V. Trap Entrance DC and Trap DC 
are The Voltage Applied at The Entrance, and The End of Trap Cells (before Ions entering the IMS), 
respectively. Under the default setting (A) of trap entrance (2V) and trap DC (-2V), ions can easily 
transmit through trap cell. Upon the increase of trap entrance and trap DC voltage (B), an artificial 
“ion dam” is created in the trap region to hold ions in this region to react with ozone. 
 
 
Optimization Of Trapping DC Bias And Entrance Potential To Further Improve 
OzID Efficiency 
An alternate strategy that could prolong ion transit time is to increase the trap 
entrance voltage and trap DC. The trap entrance voltage is the voltage applied to the 
differential aperture at the entrance to the trap region, immediately after precursor ion 
selection in the quadrupole section. Trap DC is the potential of the post gate transport 
region of the trap cell. In the default setting, the trap entrance voltage and trap DC are set 
at 2V and -2 V, respectively relative to the main trap SRIG, to facilitate transmission of 
accumulated ions to the IMS cell (Fig. 22). However, these settings adversely decrease 
reaction time between ozone and lipid precursor ions, reducing efficiency. Alternatively, 
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these settings can be modified to analogously create a “water dam” for the incoming ions, 
in order to increase residence time and boost the ozonolysis efficiency while maintaining 
the signal intensity of the spectrum (Fig. 22). Trap entrance and trap DC were optimized 
at 7V and 0.2V (Fig. 23), respectively, for maximum ozonolysis yield. The high trap 
entrance voltage would slow/hold the stream of ions at the entrance to the trap region, 
therefore, lengthen the reaction time of precursor ions with ozone gas exiting the trap. 
Once the number of ions built up at the trap entrance space charge effects would 
overwhelm the “dam”, precursor ions and OzID product ions would travel through trap 
and transfer cells to reach to TOF detector, while OzID was further performed during 
their transit. It is of note that these optimal ion dam settings are at the expense of reduced 
overall ion transmission and signal intensity, therefore, we used trap DC of 0.2 V instead 
of 0.4 V because higher OzID yield but significantly lower ion transmission was present 
in the latter (Fig. 23A). 
The OzID-MS spectrum of protonated PC (16:0/18:1(9Z)) generated using these 
settings had sufficiently high intensity and signal-to-noise ratios to make OzID product 
ions  the base peak in spectrum (Fig. 24A). To our knowledge, this is the first time that 
ozonolysis of a protonated monounsaturated lipid ion has been demonstrated with such 
high reaction efficiency, by simply passing the ions through the ozone gas at a slower 
rate. Compared to the spectrum acquired under the default acquisition setting (Fig. 20A), 
the aldehyde product ion (m/z 650) represents >40,000x improvement in OzID efficiency 
(A650/A760). Even considering all the ion transmission losses with ion dam settings, the 
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absolute intensity of the aldehyde ion under ion dam settings still has~300x increase to 
that of the default settings. 
In addition to the commonly observed OzID products – the aldehyde and Criegee 
ions, we observed another abundant product ion at m/z 636.4240 (Fig. 24A). This ion is 
likely to be the further oxidation product of the vinyl peroxide structure of the Criegee 
ion as illustrated previously.126 Under  the environment of high concentration ozone, the 
vinyl peroxide ion lost a formaldehyde (H2CO) to form the unique product observed , 
which has similar mass to the direct C=C cleavage product (m/z 636.4599) generated 
using a high energy collision (~10 keV) either on magnetic sector or TOF/TOF 
instruments.176 Because the default collision energy in our OzID settings was at 4 eV and 
the high mass measurement accuracy of the Synapt G2, we were able to assign the 
product ions correctly as further oxidation product of vinyl peroxide (theoretical mass  
636.4240) , not of C=C bond direct cleavage.  
 
 
Figure 23. Effects on Changing Trap Entrance and Trap DC on OzID Efficiency: A, Trap DC Effect; 
B, Trap Entrance Effect. Data Obtained by Direct Infusion of PC (16:0/18:1(9Z)). 
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Overall, the enhancement in efficiency and sensitivity of OzID on the traveling 
wave mass spectrometry system illustrates the benefit of prolonged reaction time with 
ozone, and suggests the potential for its integration with a shotgun-based high throughput 
lipidomics workflow. Application of these settings to differentiate lipid regioisomers was 
performed below.  
Difference In The Yields Of OzID Products Can Distinguish Isomeric Lipids 
It has been reported that lipid isomers can be distinguished using OzID fragment 
ions of sodiated adducts.114, 116, 121, 126, 184 To see if similar patterns can be observed using 
protonated lipid ions on this traveling wave-based  OzID-MS, we selected four 
monounsaturated lipid standards: PC (16:0/18:1(9Z)), PC (18:1(9Z)/16:0), PC 
(18:1(9E)/18:1(9E)) and PC (18:1(9Z)/18:1(9Z)), with the former two representing sn-
positional isomers and the latter two as cis-trans configurational isomers. Due to the 
solvents used, protonated ions were the most abundant ions for these lipids and the 
experiments were performed on them. 
sn-positional Isomers 
The OzID-MS spectra of the [M+H]+ ions of the two sn-positional isomers: PC 
(16:0/18:1(9Z)) and PC (18:1(9Z)/16:0) were acquired under identical ozone 
concentration and MS instrumental parameter settings (Fig 24A & 24B). The pairs of 
aldehyde (m/z 650) and Criegee product ions (m/z 666, very weak) observed in each of 
these spectra are characteristic of the expected neutral loss of 110 Da and 94 Da, resulting 
from the cleavage at double bond position n-9. Given the same OzID-MS settings, it is 
reasonable to compare the relative reactivity of these two isomers with ozone based on 
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the ratio of product ion intensity to the precursor ions. Both of the isomers showed the 
aldehyde ion as the base peak at m/z 650, whereas the precursor ion for each isomer had 
different relative intensity. For the PC (16:0/18:1(9Z)), the relative intensity of precursor 
ion (m/z 760) was ~20%, whereas the intensity of the counterpart ion was ~50% of the 
base peak for PC (18:1(9Z)/16:0) isomer. This observation suggests that ozonolysis rates 
of the C=C depends on the substitution position of the fatty acyl moiety, and that the C=C 
in the protonated ions for PC (16:0/18:1(9Z)) isomer reacts ~1.5x faster than that in the 
PC (18:1(9Z)/16:0). The same observation was made by Poad et al. when they compared  
the reaction rates using the OzID approach with the additional supplemental voltage.126  
 
 
Figure 24. OzID-MS Spectrum of (A) PC (16:0/18:1(9Z)) and (B) PC (18:1(9Z)/16:0) Obtained Under 
Optimized OzID Settings: Trap Wave Height = 0.2 V, Trap Wave Velocity = 8 m/s, Transfer Wave 
Height = 0.4 V and Transfer Wave Velocity = 247 m/s, Trap Entrance = 7 V and Trap DC = 0.2 V. 
 
 
cis/trans Configurational Isomers 
The OzID-MS spectra obtained from the reaction of ozone with the [M+H]+ ions 
of the stereoisomeric PC (18:1(9E)/18:1(9E)) and PC (18:1(9Z)/18:1(9Z)) (m/z 786.58) 
are shown in Fig. 8. The spectra were obtained under the same OzID settings as described 
in the analysis of PC (16:0/18:1(9Z)). Since the C=C position is at n-9, the expected 
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neutral losses for the aldehyde (m/z 676) and Criegee ions (m/z 692, weak) are 110 Da 
and 94 Da when there is a cleavage of only one C=C from either of the fatty acyls. 
Moreover, we observed the abundant neutral losses of 220 Da, which is dual aldehyde 
(m/z 566) from the cleavage of double bonds from both sn-1 and sn-2 acyl chains. 
Comparing the OzID-MS spectra of the two configurational isomers in Fig.25 A & B, it 
is also interesting to note that the relative abundance of the OzID aldehyde products 
resulted from the cleavage of two double bonds (m/z 566) and one double bond (m/z 676) 
differed significantly between the cis- and trans- forms. The base peak in the OzID-MS 
spectrum of the trans-isomer was at m/z 566 (Fig. 25B), whilst under the same 
conditions, the cis-isomer spectrum presented a base peak at m/z 676 (Fig. 25A). This 
clearly indicates the trans- isomer has a higher reaction rate with ozone. Similar 
observations have been reported by Poad.et al for the OzID of the sodiated adducts of 
these phosphatidylcholine stereoisomers, in which the reaction rate of trans-isomers  to 
ozone is 2.5 times that of the cis-isomers. [31] Our observation is also in agreement with 
the known stability of trans-ozonide as supported by a higher steric hindrance imposed 
by cis-alkenes when the gas phase kinetics of ozone reaction with neutral cis- and trans- 
alkenes were measured.189, 190 This is also consistent with detailed theoretical calculations 
which show that product branching in ozonolysis reactions are sensitive to the structure 
of the primary ozonide, which in turn is influenced by the double-bond geometry. 
Interestingly, we observed an abundant product ion at m/z 552.2938, which is likely to be 
an aldehyde arising from further oxidation of the Criegee ion in the form of formaldehyde 
loss under high ozone concentrations, as suggested above. In addition, the signature ion 
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(m/z 184) from the phosphocholine head group loss can be observed, its low intensity and 
the facile cleavage under CID conditions further confirms the minimal collision energy 
applied in our experiments. 
Conclusions 
 The data presented here demonstrated that high quality OzID-MS spectra of 
protonated lipid ions can be obtained routinely from a traveling wave high resolution 
mass spectrometer. The modification of traveling wave height and velocity, as well as 
trap DC bias and entrance potential in the TriWave regions provided a significant 
enhancement in the ozonolysis efficiency in comparison to the default settings. As 
demonstrated, the relative abundances of the OzID characteristic aldehyde and Criegee 
ions can differentiate sn- positional and cis/trans isomers for standard lipids. In addition, 
the higher ozone concentration used in the current implementation of OzID further 
oxidizes the Criegee ions to form new product ions as a result of the loss of one 
formaldehyde from the metastable vinyl peroxide ions. Besides the enhancement of 
ozonolysis, the high mass accuracy achieved through a high-resolution measurement in  
Synapt G2 MS enables the assignment of OzID fragments without ambiguity.   
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Figure 25. OzID-MS Spectrum of (A) PC (18:1(9Z)/18:1(9Z)) and (B) PC (18:1(9E)/18:1(9E)) 
Obtained Under Optimized OzID Settings: Trap Wave Height =0.2 V, Trap Wave Velocity = 8 m/s, 
Transfer Wave Height = 0.4 V and Transfer Wave Velocity = 247 m/s, Trap Entrance = 7 V and 
Trap DC = 0.2 V. 
 
 
While our work was under review, implementation of OzID on a similar platform 
(Synapt G2 Si) has been reported,191 which explored traveling wave velocity and height 
for prolonged reaction time between Ozone and lipid ion in the IMS region. Although the 
trap and transfer regions are shorter in dimension compared to the IMS region and higher 
vacuum (1.0 e-2 mbar in trap and 1.2 e-4 mbar in transfer with IMS off) is also present in 
these regions, by creating an ion dam to trap ions to elongate their reaction time with 
Ozone, we achieved the highest efficiency OzID reported to date without sacrificing 
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spectrum acquisition rate (total trapping time is only 16.65 ms). On the other hand, Poad 
et al. implemented OzID in the high pressure (~ 3 mbar) IMS cell, significant 
improvement in OzID efficiency has been achieved during ion transmission through this 
region (20 - 200 ms) for its practical application in LC-MS based lipid analysis. This, 
together with the manipulation of OzID reaction in the trap and transfer region detailed in 
our work, makes the Q-IMS-TOF MS a very versatile platform to implement this C=C 
specific dissociation technique for unsaturated lipid isomer analysis.  
Acknowledgement 
This work was supported by the National Institutes of Health grant (GM 104678). 
The authors thank the Triad Mass Spectrometry Facility at the UNCG Chemistry and 
Biochemistry Department and Dr. Daniel Todd for help with this work. The authors also 
thank reviewers of this manuscript for their insightful comments.
 
 
 
76 
CHAPTER V 
SERUM ISOMERIC LIPID IDENTIFICATION FACILITATED BY LIQUID  
CHROMATOGRAPHY-OZONE INDUCED DISSOCIATION-MASS  
SPECTROMETRY 
This chapter is intended for submission to journal Rapid Communication in Mass 
Spectrometry and is presented in that style. 
 
 
Introduction 
Blood plasma and serum contain a vast array of biomolecules that are either as 
systemic response to disease or being secreted or leaked from pathological tissues into 
circulation. The dysregulation of these biomolecules reflects the disease status, as such, 
they are being suggested as biomarkers to either diagnose the onset of disease or monitor 
the therapeutic outcome.131, 155, 192, 193 As one of the major compositions of human serum, 
lipids have been proposed as biomarkers for various diseases, including cancers,194 
diabetes,33 Alzheimer’s disease,32 etc.28, 157, 195, 196 Lipids have enormous structural 
diversity, with variations in backbone, headgroup, fatty acyl composition and their 
positions on the backbone, as well as the location and stereochemistry of C=C 
unsaturation. It is known that the function of lipids depends on their structures,28 
therefore, better understanding the roles lipid biomarkers play in disease pathogenesis 
requires detailed, unambiguous elucidation of their structures.80, 156 
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 Majority of the lipids can be easily fragmented using collision-induced 
disassociation (CID) or higher energy collision-induced dissociation (HCD)- tandem 
mass spectrometry, 80, 141 which reveals the head group information and the composition 
of fatty acyls, if both positive and negative ionization modes are used in combination.120 
Although CID/HCD fragments can indicate the degree of unsaturation of the fatty acyls, 
they are not useful to determine the double bond positions. As a result, most of the 
plasma/serum lipidome profiled in the past reported only the summed composition of 
carbon number and double bonds of the fatty acyls.156, 197 
Various CID-MS/MS-based approaches were developed to determine the position 
of C=Cs in lipids, such as dissociation of Paternò–Büchi reaction or epoxide products 
resulted from photochemical or chemical derivatization of C=C.108, 109, 198, 199 Ozone-
induced dissociation mass spectrometry (OzID-MS), on the other hand, does not require 
any derivatization of lipids, and relies on gas-phase ozonolysis reaction inside mass 
analyzer to pinpoint the C=C position using characteristic Criegee and aldehyde ions.114, 
118, 119, 123 The simplicity of spectrum interpretation is a clear advantage, but the efficiency 
of the ozonolysis reaction is an issue in the earlier implementations of this technology, 
which prevented it from being integrated into high throughput lipidomics workflows.  
We have previously increased the OzID efficiency in the shotgun analysis of 
phospholipids and applied the high-efficiency OzID-MS to elucidate detailed structures 
of sphingolipids in porcine brain sample.118, 119 To leverage both the power of LC 
separation and OzID-MS in the determination of C=C unsaturation, others have coupled 
LC with OzID-MS in a few instrument configurations.123, 125, 191, 200 Here we report the 
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coupling of UPLC with OzID-MS in a high-resolution Synapt G2 mass spectrometer, the 
high-pressure ion mobility cell enabled high ozonolysis efficiency for effective coupling 
with LC separation, which facilitated clear differentiation of isomeric lipids in human 
serum.   
Materials and Methods 
Materials 
All solvents used were Optima LC/MS grade and purchased from Thermo Fisher 
Scientific. Formic acid and ammonium formate were purchased from Sigma-Aldrich. 
Oxygen gas was provided by Airgas. Synthetic lipid standards including PC 16:0/18:1, 
PC 18:1/18:1, LPC 18:0, SM d18:1/12:0, SM d18:1/18:1, and TG 22:1/22:1/22:1 were 
acquired from Avanti Polar Lipids (Alabaster, AL). Human sera were purchased frozen 
from BioIVT (Westbury, NY, USA). 
Sample Preparation 
Individual lipid standard solutions were prepared at 15 µM in 2-
propanol/acetonitrile/water (65/35/5, v/v/v) with 10 mM ammonia formate and 0.1% 
formic acid, for direct infusion ESI-MS experiments. The lipid standard mixture for LC-
MS analyses was prepared in the same solution and at the same concentration of 15 µM 
for each lipid.  
The total lipids of human serum were extracted using methanol/chloroform 
according to a modified Folch method as reported previously.63, 73 After extraction of the 
lower organic phase containing lipids, the solution was dried under a stream of nitrogen 
and finally reconstituted in 100µL of 2-propanol/acetonitrile/water (65/35/5, v/v/v) with 
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10 mM ammonium formate and 0.1% formic acid. All lipid standards and lipid extract 
were stored at -80°C until analysis. 
Reversed-Phase Liquid Chromatography 
All chromatography was performed using a Waters Acquity UPLC system 
(Waters, Milford MA, USA) coupled with a high-resolution time of flight mass 
spectrometer.  Lipid extract and standard mixtures were analyzed using a core-shell 
Accucore C30 column (1.5 x 2.1 mm, Thermo Fisher Scientific) at 40°C. A binary 
solvent system of A (ACN:water, 60:40, v/v) and B (IPA:ACN, 90:10, v/v), both 
containing 10 mM ammonium formate and 0.1% formic acid and the following gradients 
were used: 0-5 min with 30% - 43% B; 5.1-14 min, 50-70% B; 14.1-21 min, 70-99% B; 
21.1-24, 99% B; 24-24.1 mins, 99-30% B; 24.1-31 min, 30% B. The flow rate was set to 
350 µL/min and the injection volume was 5 µL. 
Mass Spectrometry 
Mass spectra were acquired using a Synapt G2-HDMS (Waters, Wilmslow, UK). 
The typical parameter settings for ionization were: source capillary voltage 2.70 kV; 
sample cone voltage 50 V; source temperature 40°C; the cone gas flow rate 50 L/h. 
Precursor ions were mass selected in the quadrupole, passed through the trap region to 
enter and react with ozone gas in the IMS cell, then transmitted through the transfer 
region with or without collisional dissociation before reaching the TOF detector. MS 
 spectra were acquired at a rate of 1Hz.  
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Figure 26. Schematic of Traveling Wave Q-TOF HDMS Synapt G2 MS Modified to Allow OzID to 
Replace Nitrogen Gas in IMS Cell. Red region in the IMS cell indicated the He cell with He gas 
remained as default setting. 
 
 
The nitrogen gas inlet of the mass spectrometer was connected to a stainless-steel 
T union to accept both nitrogen and ozone with each line having its own shutoff valve. 
This inlet supplies drift gas to the IMS cell as configured in Fig. 26. The gas flow was 
maintained at 62 mL/min, which resulted in pressue in the IMS region as 2.13 mbar. The 
effective ozone concentration during OzID was at 6.1%. The transmission time for ions 
in the IMS cell was controlled by varying the amplitude and velocity of the traveling 
wave.  
Results  
OzID-MS studies in the Synapt G2 and G2-Si HDMS mass spectrometer can be 
implemented in either trap/transfer or IMS regions of the instrument.118, 119, 191 The 
significant difference between the trap/transfer cell versus the IMS cell is the gas 
pressure. At the default settings, the pressure at trap/transfer region is 0.018 mbar and 
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T-Wave Ion 
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IMS region 3 mbar,  ~200 fold higher in the latter as required for ion-mobility separation 
applications.185 Noted the helium cell is designed to maintain the ion transmission while 
limiting the fragmentation and ion losses when ions transmitted into the high-pressure 
IMS cell. Helium pressure was set as default throughout this study and maintained at 
1000 mbar.  
 In this study, we implemented the OzID-MS in the IMS cell, and coupled it to the 
front end LC separation for analysis of blood serum lipids. Parameters for OzID-MS were 
first optimized using lipid standard PC 16:0/18:1 in direct infusion and mixture of lipid 
standards in LC separation conditions. Then, we focused on using LC-OzID-MS to 
elucidate C=C positions to differentiate isomeric lipids in human serum, where LPC, PC, 
SM, and TG lipid classes are dominant with isomeric species and it can be challenging to  
distinguish if using traditional LC-CID-MS/MS alone.   
 
 
Figure 27. Analysis of PC 16:0/18:1(n-9) in A) OzID-MS of IMS cell Under The Default Setting  and 
B) Under The Optimization Setting with Ozone as The Mobility Gas (setting listed in the method).  
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To optimize the conditions for OzID, a solution of synthetic standard PC 
16:0/18:1 was directly infused into the ESI source operating in positive ion mode. The 
precursor ion, observed at m/z 760.58 as the [M+H]+, was subsequently mass selected for 
gas phase ozonolysis under the default settings. As previously reported, lowering 
traveling wave amplitude and velocity in the reaction region can increase the efficiency 
of OzID by prolonging the ozonolysis time.119, 191 Therefore, these two parameters were 
lowered to 21.6 V and 8 m/s, respectively. Under these settings, we calculated the 
targeted ions interacted with O3 in the IMS for approximately 33 ms instead of ~386 µs 
as under the default settings. However, a drop in signal intensity was encountered as a 
result of ion scattering when operating at these low settings.185, 186, 201 Thus, further 
optimization was done on the pressure of the IMS cell, by varying the flow rate of helium 
and IMS gas.  These optimized settings offered a high-quality OzID-MS mass spectra of 
PC 16:0/18:1. As shown in Figure 27B, m/z 650 is the aldehyde ion resulted from 
ozonolysis because of the neutral loss of 110 Da from the precursor ion; m/z at 636 is 
differed by 30 Da from the Criegee product (m/z 666), suggesting it to be the further 
oxidation product of vinyl peroxide of Criegee ion as observed previously.119, 202 These 
two product ions at m/z 650 and 636 can be observed clearly in the spectrum without 
zooming; at 26%, the relative intensity is especially high for the m/z 650 ion. This result 
indicates a higher OzID-MS efficiency was achieved than previous experiments 
conducted in the same region.191   
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LC-OzID-MS of Lipid Standards Mixture 
The design of the instrument to have two collision cells in the front and back of 
the IMS, can offer CID capability without interfering the ozonolysis reaction. Hence, we 
can explore CID (Transfer cell) and OzID (IMS cell) either individually or in 
combination for the same precursor ion .  
A mixture of lipid standards was analyzed using LC-OzID-CID-MS to determine 
the double bond positions of lipids and to validate the OzID settings optimized in the 
direct infusion experiments. The mixture contains PC 16:0/18:1, PC 18:1/18:1, LPC 18:0, 
SM d18:1/12:0, SM d18:1/18:1 and TG 22:1/22:1/22:1, which were separated on a 
reversed phase Accucore C30 column. Based on the choice of salts, the abundant adducts 
for PC was [M+H]+, and for TG was [M+NH4]+.  
The targeted analyte was mass selected by the quadrupole and transmitted through 
the trap cell for ion activation in IMS cell, where the gas phase ozonolysis took place. 
After the formed ozonide fragmented into the unique OzID product ions, both unreacted 
precursor ions and product ions left the IMS cell to enter the transfer cell, which was set 
to 16 eV to produce the lipid class-characteristic CID products. This unique set up allows 
us to generate both OzID and CID ions in a single spectrum. While OzID can determine 
the C=C double bond location based on the neutral loss from the methyl end of the fatty 
acyl, the CID products can assist in annotating lipid classes based on their unique head 
group-specific ions.  
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The total ion chromatogram (TIC) constructed from the abundance of all ions 
detected in the OzID scans of targeted masses of lipid standards were presented in Fig. 
28A. Integration of OzID scans obtained across each of the chromatographic peaks gave 
the OzID mass spectra, and XIC of unique OzID products from different spectra was 
showed in Figure 28B. As seen, XIC at a particular m/z of OzID product ions aligned 
perfectly with the TIC of the precursor ions.   
Fig. 28C showed clear evidence that OzID is only selective to the unsaturated 
lipids, as no OzID products were observed since LPC 18:0 doesn’t contain any C=C for 
ozonolysis reaction. Fig. 28D showed the OzID-MS spectra of SM d18:1/12:0 without 
any evidence of product ion resulted from cleavage of C=C at n-14 on the long chain 
base. Fig. 3E showed the OzID-CID-MS spectrum of SM d18:1/18:1; m/z at 184 is the 
fragment of choline generated by CID. OzID-MS product was observed clearly at m/z 
619, which corresponds to the NL of 110 of n-9 position on the fatty acyl chain 18:1. The 
poor efficiencies of OzID in the unsaturated long chain base observed in SM standards 
agree with what we reported previously.112, 118  
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Figure 28. XIC of The Targeted Lipid Standards at The Known m/z. (A), and The XIC of OzID 
Products for The Unsaturated Lipid Standards (B). Integration of OzID Scans Obtained Across Each 
of The Chromatographic Peaks gave The OzID Mass Spectra Showed in here. OzID-MS of the 
following standards: C) LPC 18:1, D) SM d18:1/12:0, E) SM d18:1/18:1, F) PC 16:0/18:1, G) PC 
18:1/18:1. 
 
 
Fig. 28F and 28G showed the OzID of PC 16:0/18:1 and PC 18:1/18:1, 
respectively. M/z 184.04 was observed in both spectra, which is the diagnostic ions of 
choline head group for PC/SM class under the CID condition. It is of note that the 
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relative intensity of this ion (m/z 184) is lower in PC class than the ones from SM (Fig. 
28D and 28E), which differentiates the two lipid classes. Distinguished OzID product 
ions were observed in the respective spectrum at m/z 650 and m/z 676. Both product ions 
confirmed C=C at n-9 for both PC standards because of the 110 Da neutral loss from their 
respective precursor ions. In Fig. 28G, ion at m/z 566 showed a NL of 110 and 220 from 
m/z 676 and precursor ion at m/z 786, respectively. This ion reflects the OzID cleavage of 
two double bonds at the same location (n-9 ) of different fatty acyl chain. Also of note 
that a similar pattern and identical OzID product ions were generated using this LC-
OzID-MS approach when compared with the data acquired previously using direct 
infusion and OzID implemented in the trap cell.119  
LC-OzID-CID-MS Of Isomeric Lipids In Human Serum: OzID-MS Provides 
Informative Compositions Of Fatty Acyls In Serum Phosphatidylcholine 
PC is one of the major lipid classes in human serum, and many isomers exist that 
are structurally very similar and challenging to differentiate.38, 156 Taking advantage of 
the reactivity of PC lipids with ozone, we explored using RPLC-OzID-MS to confidently 
identify conformational isomers and double bond positional isomers of PC in human 
serum. OzID-MS confidently characterized the position and degree of unsaturation in  
fatty acyl chains of the interested lipids.  
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Figure 29. A) XIC of m/z at 784 was extracted (solid black line), and XIC of OzID Products at m/z 
674, 676 and m/z 636 (color coded lines), Represented for Parent Ion PC (18:1_18:2) and PC 
(16:0_20:3), respectively at 12.00 min and 12.27 min; B) OzID-MS spectra of PC (18:1_18:2) Showed 
The Result of Two Possible Double Bond Positions on a Fatty Acyl Contains a Mono-unsaturated DB 
at n-6 and n-9 at m/z 716 and m/z 674, while a pair of ions at m/z 676 and 716 indicated a 
polyunsaturared double bonds at n-6 and 9 on the other acyl; C) OzID-MS spectra of 
PC(16:0_20:3(n-6,9,12)). 
 
 
For instance, PC 36:3 can be composed of two isomers: PC 18:1_18: 2 and PC 
16:0_20:3, with the fatty acyl composition identified from LC-CID-MS/MS under 
negative ionization mode. When the corresponding [M+H]+ ion (m/z 784.59) was 
selected in LC-OzID-MS analysis under positive ionization mode, as shown in Fig. 29A, 
two closely eluting chromatographic peaks appeared (black line). The OzID-MS spectra 
for the peak at 12.00 min showed major products at m/z 674 and 716, corresponding to 
NL of 110 and 68 Da from the precursor ion, indicating mono-unsaturated double bond at 
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n-9 and n-6 position in fatty acyls (Fig. 29B, solid squares). Interestingly, we also 
observed ion at m/z 676, which cannot be the [M+2]+ isotopic peak of m/z 674 since it 
did not follow the isotopic distribution pattern. The appearance of m/z 676 and its 
corresponding neutral loss of 108 from precursor ion indicate that di-unsaturated C=Cs 
exist in the lipid species and one of the C=C is at n-9 position.121 Based on these two 
lines of evidence, we assigned this isomer to be PC (18:1_18:2) with the C=C in FA 18:1 
at n-9 and C=C in FA 18:2 as n-6 and n-9, respectively. OzID-MS spectrum of the later 
eluting isomer is shown in Fig. 29C, which is significantly different from the patterns 
observed in Fig. 29B. Three OzID products were observed at m/z 716, 676, 636 
correspondings to neutral losses of 68, 108, 148 from the m/z 784 precursor ion. These 
neutral losses correspond to C=Cs at n-6, n-9 and n-12 in poly-unsaturated fatty acyl, 
therefore the 2nd chromatographic peak was assigned as PC 16:0_20:3.  
OzID-CID-MS Resolves The Double Bond Position Isomers Of PC In Serum Lipid 
Extract 
RPLC has been known to resolve different PC isomers, especially for sn-
positional isomers when the length of the two fatty acyls varies to a large degree.72 
However, resolving double bond positional isomers remains as the major challenge in 
lipidomic analysis, which can result in unambiguous structure assignment for lipids 
derived from complex biological extracts. The data presented above primarily showcased 
using OzID-MS to determine the degree of unsaturation and the location of C=C in fatty 
acyls of lipids, here we show that for certain C=C positional isomers, OzID-MS can help 
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to differentiate them. Moreover, the highly OzID efficiency setting resolved the co-
elution of these peaks, giving us an additional orthogonal separation.  
An example is Fig. 30 , which is LC-OzID-MS analysis of precursor ion m/z 
788.6209 from human serum lipid extracts (Fig. 30). Under the high OzID efficiency we 
obtained, each scan can provide a high level of confidence for structural elucidation of 
double bond positional isomers. Two product ions, m/z 678 and 706 dominated in two 
subsequent scans, which is the neutral loss of 110 and 82 Da from the precursor ion, 
respectively. Hence, based on the accurate mass of the precursor and the OzID product 
ions, we confidently assigned these two spectra to be double bond position isomers of PC 
18:0_18:1 at n-9 and n-7, respectively (Fig. 30B and 30C). Moreover, in Fig. 30B one 
can see the appearance of both OzID product ions at m/z 678 and 706 because XIC of 
these two product ions shown PC 18:0_18:1(n-9) cannot be fully resolved from PC 
18:0_18:1(n-7). RPLC-MS chromatogram clearly showed the coelution of these two 
isomers. Without OzID, it is impossible to acknowledge the presence of these two  
isomers. 
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Figure 30. LC-OzID-MS of PC 18:0_18:1. A) XIC of the parent ion at m/z 788 (solid black line); XIC 
of OzID product ions m/z 678  and m/z 706 (color coded);  mass spectra of B) PC(18:0_18:1) 
indicated a mono- double bond at n-7; mass spectra of C) PC 18:0_18:1 indicated a mono-double 
bond at n-9, coeluted with its double bond positional isomer at n-7. 
 
 
OzID-CID-MS Resolves The Double Bond Position Isomers Of LPC In Serum Lipid 
Extract 
LPC presents another interesting case to determine the double bond positional 
isomers. Shown in Fig. 31A is LC-OzID-MS analysis of m/z 522.3642, corresponding to 
LPC 18:1. Fig. 31B and 31C were acquired at 3.11 min and 3.15 min, respectively. OzID 
product ions were observed at m/z 440 and 412, corresponding to neutral losses of 82 and 
110 Da, expected for a monounsaturated double bond at n-9 or n-7, respectively. Taken 
the data together, they suggested two double bond positional isomers of LPC 18:1  
presented in the human serum sample, namely LPC 18:1(n-7) and LPC 18:1(n-9).   
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Figure 31. LC-OzID-MS of LPC 18:1. A) is the XIC of m/z 522 (black solid line), of m/z 440 (green 
line), of m/z 412 (blue line); B) OzID mass spectra of LPC 18:1 revealed the double bond at n-7; 
OzID mass spectra of LPC 18:1 revealed the double bond at n-9. 
 
 
Discussion 
LC-OzID-MS has been implemented on QTrap and Synapt G2 Si mass 
spectrometers, 115, 191 in particular in the latter case, high duty cycle that is compatible 
with high-resolution LC separation was achieved. The results presented here confirmed 
the practicality of implementing LC-OzID-MS on an IMS cell-equipped mass 
spectrometer for high OzID efficiency, in addition to the benefit of performing OzID and 
CID concurrently for more informed structural elucidation of lipids due to the unique 
configuration of Synapt G2 system. With this, as illustrated in this work, isomeric species 
in a complex matrix of serum lipid extract, previously masked or unidentified by LC-
CID-MS/MS based approaches, now can be differentiated and structurally identified with 
more certainty.  
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Unlike the work of Blanksby and co-workers that primarily used sodiated adducts 
for OzID-MS, our focus for LC-OzID-MS-based lipidomics is on the protonated and 
ammonium adducts, for which we have already developed high throughout workflows for 
comprehensive profiling of the lipidome in complex biological samples.63, 73  Despite the 
generally lower efficiency of OzID product ions from protonated/ammonium adducts,114 
we achieved higher OzID reaction efficiency, which is compareable to OzID data of 
metal ion lipids, as demonstrated by presence of abundant OzID product ions without 
spectrum magnification. This result greatly facilitated data interpretation for biomedical 
applications of OzID-MS.  
 Differential reactivity of C=C with ozone were observed in the long chain base 
and in the fatty acyl when analyzing SM, with the latter one having much higher yield, 
while the former one almost no reactivity. This observation is similar to what we have 
reported previously on OzID-MS of glycosphingolipids, where the ozone reactivity with 
C=C of fatty acyl is eight times higher than that of long chain base.118 The differential 
reactivity likely can be explained by charged-induced fragmentation mechanism, where 
the gas phase conformation of protonated SM induces hydrogen bonding to their allylic 
alcohol, this results into limited interaction between C=C of the long chain base, ozone 
and the charge.112, 118  
Taken together, by utilizing the high pressure IMS cell in Synapt G2 as the 
reaction chamber for ozonolysis and the unique capability of concurrent OzID and CID, 
LC-OzID-CID-MS implemented here has largely overcome the deficiencies of LC and 
LC-CID-MS/MS in resolving C=C positional isomers in human serum lipids. Together 
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with the work reported by others, application of OzID-MS to high throughput LC-MS 
based lipidomics has become a reality, and more detailed structural characterization of 
the lipidome will establish unequivocally the lipid structure and biological function and 
uncover new biology at the system level. 
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CHAPTER VI 
IDENTIFICATION OF SERUM LIPID MARKERS TO TYPE 1 DIABETES 
PROGRESSION 
Introduction 
 Type 1 diabetes  (T1D)  is a chronic childhood autoimmune disease. T1D is 
characterized as insulin deficiency due to the selective death of pancreatic b-cells. 
Although both genetic and environmental factors have been considered as the possible 
pathogenic mechanisms of the disease, their exact etiology remains unknown.15, 203-205 
The currently detectable signal indicating the initiation of autoimmune attack in T1D is 
the appearance of autoantibodies. However, it might be too late for therapeutic 
intervention when seroconversion of islet autoimmunity is detectable. Hence, biomarkers 
that reflect and predate the disease progression, while provide an insight into the 
underlying causes of disease are of great need.15, 18, 19  
 Lipids have recently emerged as promising markers for T1D.22, 23, 25-27, 206, 207. As 
the main component of the cell membrane, lipids are typically secreted into the 
bloodstream carrying information of tissue or cell health. Multiple evidences suggest a 
disturbance of lipid profile in T1D patients, and lipids can even indicate the appearance 
of islet autoantibodies.23, 26 For example, phosphatidylcholines  (PC)  are down-regulated 
at birth, and triacylglycerol  (TG)  and ether phospholipids are also decreased with the 
progression of T1D.27 A recent study also showed increasing level of proinflammatory 
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lysophosphatidylcholine  (LPC)  several months prior to the seroconversion of 
autoantibody positivity.207 Another report found that higher concentrations of odd-chain 
TG and polyunsaturated glycerophospholipids are in those who developed T1D and were 
positive to autoantibody tests.24 Therefore, profiling lipids at different T1D stages could 
uncover lipid markers indicating the natural progression of the disease, and changes of 
some of these markers may even predate the process of seroconversion to islet 
autoimmunity.  
The main biofluid sample used for T1D studies is human blood plasma and 
serum. Different lipidomic analysis strategies were introduced to discover and 
characterize lipid markers of T1D.25, 26, 75, 208 These studies have not only expanded our 
knowledge of the dysregulated lipidome of T1D, but also provided insightful information 
that can help understanding the underlying pathology, diagnose the disease at the earlier 
stage and, potentially predict the progression of this disease. However, limitations in 
technologies used to measure the lipidome led to an ambiguous structure characterization 
of lipid markers. 
 Most of the T1D studies were focusing on cross-sectional characterization of 
serum/plasma lipidome after T1D is diagnosed. These blood-derived samples were often 
collected at a single time and reflected late stage of the disease after the development of 
hyperglycemia. Recently, a lipidomic study containing a series of samples collected 
chronologically between ages 0 to 3, reported some distinct lipid profile observed at the 
very young age of T1D patients.25 Despite the importance of this result, the sampling 
time points were inconsistent which may not truly capture the progressive nature of T1D.  
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 To identify the biomarkers for T1D progression, samples that contains the 
temporal changes of lipids during the different developmental stages of T1D is required. 
In this respect, the longitudinally collected serum samples were carefully selected from a 
well-characterized T1D cohort - Diabetes Autoimmunity Study in the Young 
(DAISY).142, 209 Moreover, a comprehensive lipidomic workflow, and advanced software 
such as Progenesis QI were used to analyze, process, and identify human serum lipids in 
T1D samples.63 As a result, we accurately profiled the temporal changes of lipidome 
during the natural progression of T1D, and further investigated the significant differences 
between T1D and healthy controls at a young age, and identified a panel of potential lipid 
markers predicting the development of islet autoimmunity after the age of three. 
Experimental Section 
Sample And Study Design 
 Participants were selected from the Diabetes Autoimmunity Study in the Young  
DAISY  cohort, with T1D susceptible HLC-DR/DQ alleles through genotyping at birth 
and followed prospectively. Informed consent was obtained from the parents of each 
study subject. The Colorado Multiple Institutional Review Board and the University of  
North Carolina at Greensboro approved all study protocols, respectively. 
Islet autoantibodies  GAA, BDC512, MIAA, and ZnT8  were measured at the 
Barbara David Center in Denver. In total, 292 serum samples of 75 subjects from three 
groups: Healthy control, T1D and AB group. T1D group contains children who 
developed islet autoantibodies and progressed to T1D; AB group are children who 
developed islet autoimmunity but have not yet progressed to T1D. Healthy controls are 
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children who have not developed islet autoantibodies or T1D and are frequency matched 
on age to the combined case groups. Venous non-fasting blood samples were collected at 
each study visit and plasma and separated and stored at -80˚. Three to four longitudinal 
samples were collected from 1995 to 2011. Frozen serum samples were transferred to our 
lab for sample processing and measurement. At the end, 90, 106 and 104 samples from 
T1D, AB and Healthy control group, respectively, were processed according to the  
experimental workflow Fig. 32 .  
 
 
Figure 32. The Overal Work Flow of The AMT Approach. Samples from the DAISY Cohort was 
Pooled together to Create a Comprehensive Human Serum Lipidome Library using the Offline  2D-
LC-MS/MS Aproach. Subsequently, a high throughput analysis of individual samples was done using 
the identical RPLC-MS/MS conditions used to generate the human serum AMT library. Raw data 
was processed by matching features with the AMT library before further statistical analysis. 
 
 
Analysis Of Molecular Lipids 
 All reagents and chemicals used in this study were purchased from Sigma Aldrich  
St. Louism, MO , and lipid standards were purchased from Avanti polar lipids. A total of 
292 serum samples were randomized and extracted using a Folch’s procedure that 
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previously published.63, 73 All the samples were prepared in the same batch by the same 
researcher to minimize the variations in sample preparation. For each sample, 25 µL of 
serum sample were performed Folch’s method using 125 µL methanol/chloroform 
(1:2,v/v), 190 uL of organic layer were collected, dried under nitrogen gas and 
reconstituted in 50 uL of IPA/ACN/H2O ( 60/35/5; v/v/v) for the subsequent high 
throughput analysis using RPLC-MS/MS. 
Quantitative LC-MS/MS Analysis 
 The samples were analyzed using an ultrahigh performance liquid 
chromatography coupled with a hybrid Q-orbitrap high resolution mass spectrometer 
(UHPLC-QEHF). The separation was performed using an Accucore C30 column 
(ThermoFisher Scientific). The column oven temperature was 40˚C and the gradient was 
delivered at a flow rate of 350 µL/min with mobile A  (ACN:H2O)  and B (IPA:ACN), 
respectively, both containing 10 mM NH3HCO3 and 0.1% HCOOH. The sample tray set 
at 15˚C with the injection volume of 5 µL.63 
 The following parameters were used in electrospray ionization: the spray voltage, 
the capillary temperature and the heater temperature were at 3 kV, 350 °C and 400 °C, 
respectively, for both ionization modes; the S-Lens RF level was set at 50. The Orbitrap 
mass analyzer was operated at a resolving power of 120,000 in full-scan mode  scan 
range: 114 – 1700 m/z; automatic gain control target: 1e6  and of 30,000 in the Top20 
data-dependent MS2 mode  HCD fragmentation with stepped normalized collision 
energy: 25 and 30 in positive ion mode, and 20, 24 and 28 in negative ion mode; 
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maximum ion injection time: 100 ms; isolation window: 1 m/z; automatic gain control 
target: 1e5 with dynamic exclusion setting of 15 s. 
Database Search For Identification 
 All raw files obtained from LC-MS/MS analysis were analyzed using Progenesis 
QI ver 2.3 separately in positive and negative ion mode, search against in-house curated 
human serum lipids database. The parameter for peak detection was 400<m/z<1200, 
RPLC retention time between 1-25 min, peak sensitivity was set at 0.04% base peak. 
Peak alignment was set at default for all the files in each mode. Progenesis QI detected 
the features in the chromatogram, assigned the identification and extracted the peak area 
for each feature. Raw data was exported in excel format for subsequent statistical 
analysis. 
Statistical Analysis 
 Data normalization was done using Perseus software ver 1.6.2.2  
https://maxquant.org/perseus/  and Metaboanalyst. Raw data was imported in the 
software without any missing value, then log2 transformation, and mean centering 
normalization. An ANOVA test with FDR <0.05 was adapted from significant analysis. 
Volano’s plot and Hierarchical clustering was done to observe and obtain the changes 
within and from three groups. Linear mixed model, t-test and ANOVA were done using 
SAS ver 9.4 (SAS Institute, Cary, NC, USA). Separation model of PLS-DA and OPLS-
DA was done using SIMCA ver 16 (Umetrics, Umea, Sweden). 
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Results  
Comprehensive Coverage Of Human Serum Lipidome  
Human serum from 75 subjects belonging to three groups  T1D, AB and controls  
were used in this study, with relatively matching of race, gender and age. Our 
identification approach is based on the accurate mass and time (AMT) tag approach, 
which relies on the uniqueness of the measured molecular mass and LC elution time for a 
specific molecule in the context of a particular biological system. A schematic 
representation of experimental design and workflow is indicated in Fig.32. The strategy 
implicitly makes use of the fact that many possible species are masked from being 
identified in 1D-LC system because of undersampling issue in data dependent MS/MS 
scans, but they can be identified in high confidence when sample matrix is greatly 
simplified, such as using an offline LC to fractionate samples. Therefore, a species 
previously identified using the off-line 2D-LC-MS/MS approach will most likely be the 
same species observed at the same m/z and retention time in the 2nd dimensional LC-
MS/MS.  
Previously, pooled samples of these subjects were used to establish a 
comprehensive human serum lipid library containing the structural information, as well 
as the accurate mass and the reliable retention time. This informative serum lipid library 
served as the database for the feature identification purpose of this study. Moreover, 
utilizing the fragmentation pattern of lipid standards analyzed in the identical platform, 
the in-silico fragmentation of serum lipids was generated to assist in the high confident 
identification of DAISY samples. This strategy takes advantage of the accurate mass 
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measurements from high resolution MS, the reproducible retention time information 
obtained from high efficiency Accucore C30 column, and MS/MS level confirmation of 
lipids to provide extensive coverage and confidence in identification of lipid molecular 
species from serum. In total, 327 and 229 lipid species were commonly identified in 
positive and negative ion mode, respectively, with high confidence in every sample of 
this study, which belong to the following lipid classes: CE, DG, LPC, PC, PE, TG, Cer, 
SM and plasmanyl and plasmenyl lipids. The structures of these lipids were determined at 
the level of head groups, compositions and positions of fatty acyl chains. In comparison, 
a vast majority of earlier T1D studies using LC-MS based lipidomics only acquired the 
data in positive ion mode, which limit the level of identification to lipid class and total  
number of carbon and double bond for most of the glycerol phospholipids.  
 
 
Figure 33. Hierarchical Clustering Plots Showing Age Dependence of Serum Lipidome, using Lipids 
Identified from Healthy Control Samples in Positive Ionization Mode.  A , plotted in two year-
intervals of age. Group 1: 0-2 years, group 2: 2-4 years, group 3: 4-6 years, group 4, 6-8 years, group 
5, 8-10 years, group 6, 10-14 years, group 7, >14 years.  B , plotted in sampling time points. 
A B 
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Influences Of Age On The Human Serum Lipidome 
 We analyzed serum lipids prospectively in three groups of samples:  T1D, AB and 
Healthy Controls. Statistical modeling was applied to study the temporal changes of 
lipids in healthy children. Overall, more than 60% of healthy control serum lipids 
identified in this study had age-dependent expression trends (Fig. 32A). As shown in 
Fig.32, one could observe the changes that occurred after the subject reaching two years 
old. Whilst lipids in TG class showed downregulation following the maturity of the 
subjects, lipid species belonging to PC and SM classes showed upregulation. We 
observed a decreasing level of plasmalogen lipids after the first time point, and a 
dysregulated profile of PE. In addition, we performed heatmap analysis of the lipidomic 
changes according to the sampling time points, as matched to the time points of the T1D 
group (Fig. 32B),  and similar lipid profile changes were observed with respect to age.  
Identical tests were done on the data collected from the negative ionization mode and 
similar trends of changes in lipid classes were observed (Fig. 33).  This result highlighted 
the major challenge in a longitudinal study, i.e. whether the temporal changes observed 
for lipids truly reflect the underlying pathological conditions or are associated with age 
during a child’s development. Hence, the data were statistically analyzed while taking 
age into consideration as detailed below. 
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Figure 34. Hierarchical Clustering Plots Showing Age Dependence of Serum Lipidome, using Lipids 
Identified from Healthy Control Samples in Negative Ionization Mode.  A , plotted in two year-
intervals of age. Group 1: 0-2 years, group 2: 2-4 years, group 3: 4-6 years, group 4, 6-8 years, group 
5, 8-10 years, group 6, 10-14 years, group 7, >14 years.  B , plotted in sampling time points. 
 
 
Distinct T1D Lipdome At A Young Age  
 We compared the serum lipidome of T1D, AB, and Healthy Controls at the first 
time point, which were acquired at the earliest time point possible for the individual 
subject considering the constraints of clinical enrollment. A volcano plot using t-test and 
FDR < 0.05 revealed a list of lipids with significant changes within four fold (Fig.34)  In 
agreement with the literature, we observed a lower level of TG, but a higher level of SM 
and PC species in the T1D group.24, 27 Similar comparison were also made between the 
two groups of samples at the other time points (2, 3 and 4); however, we didn’t observe 
A B 
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any significant changes in these time points between the two groups. When we compared 
the two groups of samples belongs to AB and healthy control at different time points, 
significant changes were observed at time point 2. In contrast with observation in T1D 
when compared with healthy controls, AB groups has a higher level of TG and lower 
level of PC and SM (Fig. 35) . This is an interesting observation for AB group because a 
series of sample at time point 2 was collected a few months to a year prior to the 
appearance of the first autoantibody. Overall, the most significant changes were obtained  
in the time point one, which is promising to identify biomarkers for early diagnosis.  
 
 
Figure 35. Volcano Plot Revealed a Significant Different Level of Lipids when comparing T1D with 
Control at the 1st Time Point. Each dot is one lipid species. Horizontal axis is the differences in term 
of lipid levels, and vertical axis is the p-value. Most of the TG have a lower abundance in T1D and 
can be seen on the upper left side of the plot. The PC and SM are observed on the upper right side. 
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Figure 36. Volcano Plot Revealed a Significant Different Level of Lipids when comparing AB with 
Control at Time Point 2. Each dot is one lipid species. Horizontal axis is the differences in term of 
lipid levels, and vertical axis is the p-value. Most of the TG have a lower abundance in healthy 
control, and can be seen on the upper right side of the plot.  The PC and SM are higher abundance in 
AB, and observed on the upper left side of the plot. 
 
 
Although the total separation between three groups from  <3 years of age wasn’t 
achieved, PLS-DA plot shows the separation between T1D versus non-T1D  (AB and 
healthy controls) (Fig. 36) . Based on the VIP score and the p-FDR value, we identified a 
panel of lipids in both positive and negative ion mode which distinguish T1D from the 
other two groups  (Table 2). The average concentrations of these species were plotted in 
Fig. 37, which clearly showed these significantly changed lipids have a higher 
concentration in T1D compared to the other two groups in positive and negative mode, 
respectively, with healthy control samples having the lowest level of potential lipid 
markers listed in Table 2.  
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Table 2. A Panel of Lipids with Significant Differences in T1D Group as Compared to the AB and 
Healthy Control Groups. Data in both negative and positive modes were used in the analysis. 
Significant changes were designated as adjusted p-FDR <0.05 and VIP >1.3. 
 
Mode Accepted_Compound_ID pfdr_p VIP from 
PLSDA 
negative PC O-18:0/20:3 0.012 1.93 
negative PE 18:0p/20:3 0.012 2.17 
negative SM d43:1 0.012 1.88 
negative LPC 0:0/17:1 0.023 1.58 
negative LPC 15:0/0:0 0.023 1.84 
negative PC 16:0/22:4 0.023 1.56 
negative PE 18:0p/22:5 0.023 1.65 
negative PI 22:5/18:0 0.023 1.39 
negative SM d35:1 0.023 1.41 
negative PC 15:0/18:1 0.024 1.37 
negative PC 16:0/17:1 0.025 1.37 
negative LPC 17:0/0:0 0.025 1.64 
negative PC 15:0/16:1 0.025 1.31 
negative PC 15:0/18:2 0.025 1.35 
negative PC 18:0/20:3 0.025 1.31 
negative PC O-18:0/22:4 0.025 1.67 
negative PI 22:4/18:0 0.025 1.34 
negative SM d33:2 0.025 1.32 
negative SM d37:2 0.025 1.33 
negative SM d41:3 0.025 1.46 
negative SM d43:2 0.025 1.37 
negative PE P-20:0/20:3 0.025 1.99 
negative SM d43:3 0.025 1.32 
negative SM d43:2 0.038 1.94 
negative LPE 18:1 0.046 1.46 
positive PC 17:0_20:3 0.012 1.80 
positive PC 15:0/20:3 0.012 1.70 
positive PC P-18:1/22:4 0.015 1.68 
positive PC 16:0/22:4 0.023 1.61 
positive PC 17:0/22:5 0.023 1.40 
positive PC P-20:0/18:2 0.023 1.51 
positive PE 18:0_18:1 0.023 2.47 
positive PE P-18:0/20:3 0.023 1.81 
positive SM d45:5 0.023 1.42 
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positive PC 17:0/20:5 0.023 1.40 
positive PC 18:0/20:3 0.024 1.46 
positive SM d35:2 0.024 1.37 
positive LPC 15:0/0:0 0.025 1.67 
positive LPC 17:0/0:0 0.025 1.53 
positive LPE 18:1 0.025 1.82 
positive PC 15:0/18:1 0.025 1.35 
positive PC 15:0/18:2 0.025 1.34 
positive PC 15:0/20:4 0.025 1.32 
positive PC 17:0/18:1 0.025 1.32 
positive PC 18:0/22:4 0.025 1.37 
positive PC 20:4_17:0 0.025 1.32 
positive PC O-16:0/20:3 0.025 1.67 
positive SM d37:2 0.025 1.31 
positive TG 12:0_14:0_14:0 0.025 1.37 
positive TG 18:1_12:0_12:0 0.025 1.44 
positive PC 18:0/22:5 0.025 1.35 
positive TG 18:1/12:0/14:0 0.028 1.45 
positive TG 16:0/12:0/18:1 0.028 1.34 
positive LPC 0:0/16:1 0.045 1.32 
positive TG 18:2/15:0/20:5 0.049 1.53 
 
 
 
 
Figure 37. PLS-DA Plot showing Separation between T1D  (red)  and non-T1D groups at <3 years 
age, The Latter contains both AB and Healthy Controls  (blue) .  
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Temporal Expression Patterns Of Serum Lipids In T1D, AB, And Healthy Controls 
 When comparing the temporal changes within each group, we recognized some 
patterns.The linear mixed model was used to observe the temporal change of each subject 
over time, with p-FDR<0.1, we identified 11 lipids with significant temporal changes in 
all groups. Comparing to the AB and Healthy controls, potential biomarkers in T1D 
group listed in Table 4 showed distinguished profile at the earliest time point. In the 
example in Fig.38, PI 22:5/18:6 and PC 18:0/20:3 were examined over 20 years of study. 
Both lipids indicated a higher level at the young age in T1D samples, and a gradual 
decrease chronologically. Both AB and healthy control groups showed an alternate  
profile observed during the development of these subjects.  
 
 
Figure 38. The Average Lipid Level of Potential Markers listed in Table 2. Heatmap revealed a 
significant higher level of lipids in T1D group observed in A) positive mode and B) negative ion 
mode. 
 
A B 
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Table 3. List of Candidate Lipids with a Temporal Change Across all the Subjects and Samples. 
Linear Mixed Model used The Adjust p-FDR <0.1 to identify lipids with significant changes. The 
level and trend of lipid in T1D were compared to Healthy Controls and AB. 
 
Mode Accepted_Compound_ID pfdr_p Starting 
Level in T1D 
Trend in T1D 
negative Cer d18:2/20:0 0.083 high slightly increase 
negative Cer d18:2/22:0 0.023 high slightly increase 
negative PC 18:0/20:3 0.092 high slightly increase 
negative PE 16:0p/20:4 0.083 low decrease 
negative PE 18:0p/20:4 0.063 high decrease 
negative PE P-20:0/20:4 0.021 low decrease 
positive PE P-20:0/20:4 0.063 low decrease 
negative PI 22:4/18:0 0.083 high decrease 
negative PI 22:5/18:0 0.063 high decrease 
negative SM d41:2 0.023 high decrease 
negative SM d41:3 0.079 high decrease 
 
 
Lipid Profile Of Children Under The Age Of Three Can Predict The Development  
Of Islet Autoimmunity  
 
 
Figure 39. Temporal Change of PI 22:5/18:0 and PC 18:0/20:3 Recorded in Negative Ion Mode. 
Linear mixed model was performed with p-FDR<0.1. Each point is one sample, and the color of the 
line and point are color coded to the group. The plot revealed the normalized level of lipids vs the 
clinical age of sample. The predicted level of lipid in each plot is the linear regression line, with their 
slop reflects their alternation over time. 
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Additional analyses were performed to predict the onset of islet autoimmunity 
after the age of three when comparing healthy control group and the group developed 
islet autoimmunity  (T1D and AB group). OPLS-DA scores plot (Fig. 39) showed the 
separation between controls and non-control  T1D and AB , with a validated Q2=0.02, 
which passed the permutation test in predicting if the subject will develop the 
autoantibody after 3 years of age. With this data, we identified a panel of potential lipid 
markers that can predict if the patients will develop islet autoantibodies after 3 years of  
age (Table 4).  
 
 
Figure 40. OPLS-DA Scores Plot of Control and non-control group ( AB and T1D ). Each dot is one 
subject. Subjects anticipated in this test contained sample that gave a negative antibody positivity 
prior to three years of age, but later give the positive result to the antibody assay when the subject is 
> 3 years old. Color coded to refect the group, Control group is green , non-control is yellow . 
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Table 4. List of Candidate Markers that can Predict the Appearance of Islet Autoantibodies after 
The Age of Three. VIP score >1.3, and the mean value for each group represents the up-or down-
regulated level in each group. 
 
Mode Accepted_Compound_ID Control_MEAN non_Control_MEAN VIP from OPLS-DA 
negative Cer d16:1/16:0 -2.37 -1.88 2.10 
negative Cer d16:1/24:0 2.85 3.07 2.36 
negative Cer d17:1/22:0 -0.79 -0.32 2.90 
negative Cer d18:1/18:0 -0.23 0.02 2.13 
negative Cer d18:2/20:0 -3.30 -2.82 3.01 
negative Cer d18:2/22:0 0.60 1.08 3.74 
negative Cer d18:2/24:0 1.94 2.08 1.85 
negative LPE 18:1 1.57 1.35 1.53 
negative LPI 20:4 -1.90 -2.11 1.63 
negative PC 16:0/22:4 5.23 5.38 1.77 
negative PC 18:0/18:0 -0.90 -0.60 2.48 
negative PC 18:0/20:2 3.71 3.96 2.32 
negative PC 18:0/20:3 6.17 6.37 2.09 
negative PC 18:0/22:3 -0.89 -0.63 2.36 
negative PC 22:0/18:2 -1.47 -1.09 1.59 
negative PC O-18:0/18:1 1.36 1.67 2.29 
negative PC O-18:0/22:4 1.23 1.36 1.58 
negative PC P-16:0/16:0 1.96 1.77 1.76 
negative PE 16:0p/20:4 4.10 3.85 2.43 
negative PE 16:0p/22:6 2.89 2.71 1.58 
negative SM d33:1 3.63 3.86 1.64 
negative SM d37:1 1.98 2.12 1.77 
negative SM d38:1 5.73 5.94 1.64 
negative SM d39:1 4.39 4.73 2.45 
negative SM d39:2 1.33 1.52 2.03 
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negative SM d40:1 6.67 6.93 2.60 
negative SM d40:2 6.27 6.42 2.03 
negative SM d41:1 5.65 5.88 2.69 
negative SM d41:2 4.54 4.72 2.10 
negative SM d41:2 3.46 3.69 2.34 
negative SM d41:3 1.08 1.25 1.75 
negative SM d42:2 5.65 5.85 1.68 
negative SM d43:2 0.67 0.80 1.95 
positive Cer d18:2/24:0 -2.92 -2.65 2.11 
positive Cer d40:1 -2.48 -2.19 2.28 
positive Cer d41:1 -2.37 -2.20 1.93 
positive LPC 0:0/18:3 -2.40 -2.63 1.82 
positive LPC 18:2/0:0 4.51 4.22 2.03 
positive LPC 20:4/0:0 1.40 1.20 1.65 
positive LPE 16:0 -2.94 -3.09 1.62 
positive LPE 18:1 -1.84 -2.07 1.75 
positive LPE 18:2 -0.80 -1.13 1.92 
positive LPE 20:4 -1.82 -2.09 2.01 
positive PC 16:0/22:4 4.95 5.17 2.32 
positive PC 17:0_20:3 0.20 0.49 1.69 
positive PC 18:0/18:0 -1.59 -1.31 1.61 
positive PC 18:0/20:2 2.90 3.20 2.67 
positive PC 18:0/20:3 5.70 6.01 2.70 
positive PC 18:0/22:5 2.85 3.06 1.53 
positive PC 19:0/18:2 1.17 1.31 1.84 
positive PC O-20:0/20:3 -1.34 -1.04 1.88 
positive PE P-16:0/20:4 1.75 1.56 1.91 
positive PE P-16:0/22:6 0.58 0.40 1.62 
positive PE P-20:0/20:4 -0.76 -1.04 1.65 
 
 
 
113 
positive SM d33:1 1.75 2.06 1.70 
positive SM d37:1 0.55 0.90 2.10 
positive SM d38:1 4.54 4.85 1.85 
positive SM d39:1 2.52 2.87 2.08 
positive SM d39:2 -1.16 -0.89 1.68 
positive SM d40:1 5.18 5.46 1.86 
positive SM d41:1 3.90 4.14 2.01 
positive SM d41:2 1.63 1.85 1.84 
positive SM d41:3 -0.33 -0.10 1.59 
positive SM d41:4 0.60 1.05 1.91 
positive SM d42:4 3.53 3.77 2.23 
positive SM d43:4 2.19 2.43 1.68 
positive SM d43:5 -0.27 0.03 1.55 
 
 
Discussion 
 The AMT approach has been more widely used in proteomics for high throughput 
and accurate identification of peptides,139, 141, 210, 211 very rarely it has been applied in 
lipidomics.26 Using this approach and our in-house curated human serum library, we 
profiled lipidome level changes of serum lipids from three longitudinally collected 
sample sets related to T1D. To our knowledge, this is the first application of AMT 
approach to high throughput lipidomics, most of the lipids identified in our study contain 
the composition of fatty acyl chains and their sn-positions on the glycerol backbone, 
which provides at a high level of confidence in structural annotation of serum lipidome. 
 Dyslipidemia is well-established in diabetes mellitus. Previous work by others 
showed that most distinct changes of lipidome occurred in T1D children younger than 3 
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months old.25 In this respect, we had similar findings in this DAISY cohort that most 
significant changes occurred at young age  <3 years  when comparing T1D and non-T1D 
groups. It is of note that it is difficult to observe change in lipids during the development 
of a chronic disease due to age as  the major confounding factor, as we clearly 
demonstrated the lipidome levels are age dependent. Nonetheless, our data highly 
suggested the most pronounced changes happened at the earliest time point of patients, 
which is < 3 years of age. Oresic and co-workers found SM levels were low in T1D 
group compared to other groups at a younger age, and persistently lower over time when 
compared to the other groups.25 In contrast, our data suggested a higher level of SM 
lipids at the younger age, decreasing during the development of the disease. The 
discrepancy may arise from the different cohort of samples were used, which differ in 
geographical location and other confounders, such as diets, genotypes, etc. This point can 
be further illustrated with two studies conducted by the same authors with opposite 
results. While one study revealed decreased levels of PC, SM and LPC in serum,212 the 
second study showed increased SM and PC in T1D when compared to control samples.213 
These contradictions suggest the needed rigorousness in study design, including sample 
collection, but it is difficult to achieve for infant <1 year of age, i.e. most of the samples 
were collected non-fasting, and the diet-intake can significantly influence the serum 
lipidome. In this respect, previous study has shown children with different diets could 
result in higher concentration of odd chain TGs and polyunsaturated FA-containing 
phospholipids.214 Hence, it is critical to have samples from the same study cohort for a 
fair and comprehensive comparison. Despite these limitations, we identified a panel of 
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lipids that can predict islet autoimmunity, as well as differentiate between three groups of 
samples earlier than 3 years of age. 
Sample storage conditions also had a big influence on the integrity of samples.215 
Multiple studies had confirmed temperature and chemicals used in sample storage can 
affect degradation of lipids. The preanalytical variables include the storage condition 
immediately after sample collection, the storage condition pre- and post-transportation. 
Investigation on the variances of free-thaw cycles and sample storage condition found 
that a stable period for human plasma/serum sample is within 3 years at a temperature <-
20°C, and <10 freeze-thaw cycles.216 The samples used in our study were stored around 
4-25 years inside -80°C freezer prior to transportation to our laboratory. Although we 
have minimized freeze-thaw cycles during sample preparation, we do not know to which 
extent long term storage can affect lipid stability. To our knowledge, effect of very long 
term storage on lipid degradation under deep freezing conditions has not been studied. 
Considering the heterogeneity of lipid levels within individuals and the limitations of 
long term sample storage in longitudinal cohorts, comparing the relative abundance of 
lipids cross-sectionally at different stages of disease development  is still a valid approach 
for biomarker identification.  
 In summary, this research identified distinct changes in serum lipidome for 
subjects in the younger age who developed T1D or islet autoimmunity.  It also suggests 
that, for better uncovering the longitudinal changes of different lipid profiles, a more 
rigorous age-matching between groups and with equal years of interval is desired to 
eliminate age as a confounding factor. While the list of lipid markers still needs to be 
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validated using other cohort of samples for their utilities in T1D diagnosis, nevertheless, 
the AMT approach we developed can be adapted to other large scale high throughput 
lipidomics studies, and the temporal changes of serum lipidome during childhood would 
also serve as a valuable resource for pediatric disease research. 
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CHAPTER VII 
CONCLUDING REMARKS 
 
 
Type 1 diabetes (T1D) is a well-known chronic disease occurs most frequently in 
children. Due to the unknown etiology and autoimmune nature of the disease, a late 
clinical diagnosis results in serious complications and financial burden. The current 
biomarker studies in T1D are mostly limited to cross-sectional comparisons at the disease 
onset, and in general do not reflect what happened at the early stages of this disorder. 
Recently, dysregulated lipid metabolism were observed in T1D, both at the overt disease 
stage and prior to development of islet autoimmunity, a key step in the natural 
progression of this autoimmune-mediated disease. Since function of lipids are determined 
by their structures, it is critical to comprehensively and accurately determine the structure 
of lipids.  
In this dissertation, we developed novel analytical capabilities in structural 
elucidation of lipid molecules, particularly in determination of sn-position, and the 
location of unsaturation. A high throughput approach for lipidomics analysis was also 
developed to comprehensively quantify a large number of clinical samples, which has 
been used to profile the temporal changes of lipidome during the natural progression of 
T1D.  
Chapter III established a novel workflow for accurate identification of lipids in 
human serum. By adding the additional separation dimension of mixed mode-LC, the 
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approach overcame the challenges in the one dimension RPLC-MS/MS approach and 
provided high confidence in structural identification, particularly for the isomeric and 
isobaric species existed within the same lipid class or between classes. The human serum 
lipids were identified with accurate mass and RPLC retention time, which were curated 
into an in-house data base for high throughput analysis of lipids from the same biological 
specimen. Identification of these lipid species were further confirmed at the fatty acyl 
level using tandem mass spectrometry in both positive and negative ion mode, with sn-
positional assignment determined for most of the lipid molecular species. Chapter IV and 
V advanced further in structural elucidation of lipids by providing information on the 
location of C=C unsaturation. This was accomplished inside the mass analyzer through a 
specific gas phase ion chemistry between ozone and unsaturated lipid ions. This ozone-
induced dissociation (OzID) process generates C=C location characteristic diagnostic 
fragmentation ions, which is highly valuable for structural elucidation at the level of C=C 
position. For the first time, we achieved the highest OzID efficiency with the protonated 
lipids in a high resolution traveling wave mass spectrometer, up to ~1000x more effective 
compared to previous reports. Moreover, the flexibility to implement OzID in a high gas 
pressure of the instrument made this technique compatible with LC separation for better 
resolving of isomeric unsaturated lipids. With OzID-MS, double bond positional isomers 
in human serum lipids can be elucidated. Using longitudinally collected human serum 
from individuals in T1D, AB and healthy control groups and the human serum lipid 
library curated in Chapter III, Chapter VI applied accurate mass and time tag approach 
for high throughput analysis and identification of candidate lipid markers that indicate 
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T1D progression. A significant difference was obtained in the lipid profile of T1D 
individuals at a younger age, however, the changes were normalized at later stages of this 
disease, which is in line with what reported by others using longitudinally collected 
samples.  
 In summary, we developed innovative methods for comprehensive 
characterization of lipids in human serum and high throughput analysis of human serum 
samples to identify T1D lipid biomarkers. While the panel of lipid markers still need to 
be validated in independent T1D cohorts for their values in predicting islet autoimmunity 
and early diagnosis of T1D, the advanced analytical capabilities we developed in C=C 
unsaturation determination and in AMT-based high throughput analysis of lipidome 
changes in human serum can be applied to other human diseases. In addition, the 
temporal changes of lipids during childhood development would also be valuable for 
researches in other pediatric diseases. 
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Table S1. Human Serum Lipid Library Including Accurate Mass and RPLC Retention 
Time. 
 
Compound 
ID 
Compound name Class Calc 
Mass 
Formula RPLC 
retention 
time (min) 
1 Cer(d16:0/22:0) Cer 595.59003 C38H77O3N11 15.88 
2 Cer(d16:1/16:0) Cer 509.4808 C32 H63 O3 N1 10.44 
3 Cer(d16:1/24:0) Cer 621.606 C40 H79 O3 N1 16.73 
4 Cer(d17:1/16:0) Cer 523.4964 C33 H65 O3 N1 11.25 
5 Cer(d17:1/18:0) Cer 551.5277 C35 H69 O3 N1 12.91 
6 Cer(d17:1/22:0) Cer 607.5903 C39 H77 O3 N1 16.12 
7 Cer(d17:1/24:0) Cer 635.6216 C41 H81 O3 N1 17.15 
8 Cer(d18:0/16:0) Cer 539.5277 C34 H69 O3 N1 12.65 
9 Cer(d18:0/18:0) Cer 567.559 C36 H73 O3 N1 14.26 
10 Cer(d18:0/22:0) Cer 623.6216 C40 H81 O3 N1 16.99 
11 Cer(d18:0/24:0) Cer 651.6529 C42 H85 O3 N1 17.92 
12 Cer(d18:1/16:0) Cer 537.5121 C34 H67 O3 N1 12.07 
13 Cer(d18:1/18:0) Cer 565.5434 C36 H71 O3 N1 13.70 
14 Cer(d18:1/20:0) Cer 593.5747 C38 H75 O3 N1 15.28 
15 Cer(d18:1/22:0) Cer 621.606 C40 H79 O3 N1 16.42 
16 Cer(d18:1/24:0) Cer 649.6373 C42 H83 O3 N1 17.62 
17 Cer(d18:2/16:0) Cer 535.4964 C34 H65 O3 N1 10.69 
18 Cer(d18:2/18:0) Cer 563.5277 C36 H69 O3 N1 12.36 
19 Cer(d18:2/20:0) Cer 591.559 C38 H73 O3 N1 14.02 
20 Cer(d18:2/22:0) Cer 619.5903 C40 H77 O3 N1 15.59 
21 Cer(d18:2/24:0) Cer 647.6216 C42 H81 O3 N1 16.85 
22 Cer(d34:0) Cer 539.5277 C34 H69 O3 N1 12.96 
23 Cer(d36:0) Cer 567.559 C36 H73 O3 N1 14.26 
24 Cer(d38:0) Cer 595.5903 C38 H77 O3 N1 16.05 
25 Cer(d40:0) Cer 623.6216 C40 H81 O3 N1 17.19 
26 Cer(d40:1) Cer 621.606 C40 H79 O3 N1 16.62 
27 Cer(d42:3) Cer 645.606 C42H79O3N1 15.40 
28 Cer(d44:1) Cer 677.6686 C44 H87 O3 N1 17.99 
29 CE(18:1) ChE 650.60015 C45 H78 O2 21.22 
30 CE(18:2) ChE 648.5845 C45 H76 O2 20.75 
31 CE(20:3) ChE 674.60015 C47 H78 O2 20.83 
32 CE(20:4) ChE 672.5845 C47 H76 O2 20.45 
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33 CE(22:6) ChE 696.5845 C49 H76 O2 20.20 
34 DG(12:0/18:2) DG 536.4441 C33 H60 O5 10.52 
35 DG(16:0/0:0/18:2) DG 592.5067 C37 H68 O5 13.72 
36 DG(16:0/18:1) DG 594.5223 C37 H70 O5 14.89 
37 DG(16:1/18:1) DG 592.5067 C37 H68 O5 13.48 
38 DG(16:1/18:2) DG 590.491 C37 H66 O5 12.26 
39 DG(16:1/18:3) DG 588.4754 C37 H64 O5 11.20 
40 DG(18:0/18:1) DG 622.5536 C39 H74 O5 16.29 
41 DG(18:1/0:0/16:0) DG 594.5223 C37 H70 O5 14.99 
42 DG(18:1/0:0/18:1) DG 620.538 C39 H72 O5 15.06 
43 DG(18:1/18:1) DG 620.538 C39 H72 O5 15.24 
44 DG(18:1/18:3) DG 616.5067 C39 H68 O5 12.76 
45 DG(18:1/20:3) DG 640.5067 C41 H68 O5 13.67 
46 DG(18:1/20:4) DG 642.5223 C41 H70 O5 15.21 
47 DG(18:1/20:4) DG 642.5223 C41 H70 O5 13.42 
48 DG(18:1/22:4) DG 670.5536 C43 H74 O5 14.52 
49 DG(18:1/22:5) DG 668.538 C43 H72 O5 13.98 
50 DG(18:1/22:6) DG 666.5223 C43 H70 O5 12.99 
51 DG(18:2/0:0/18:1) DG 618.5223 C39 H70 O5 13.79 
52 DG(18:2/0:0/18:2) DG 616.5067 C39 H68 O5 12.57 
53 DG(18:2/18:1) DG 618.5223 C39 H70 O5 14.03 
54 DG(18:2/18:3) DG 614.491 C39 H66 O5 11.53 
55 DG(18:2/20:4) DG 640.5067 C41 H68 O5 13.67 
56 DG(18:2/20:5) DG 638.491 C41 H66 O5 11.18 
57 DG(18:2/22:4) DG 668.538 C43 H72 O5 13.35 
58 DG(18:2/22:5) DG 666.5223 C43 H70 O5 12.78 
59 DG(20:2/18:2) DG 644.538 C41 H72 O5 16.46 
60 DG(20:3/18:1) DG 644.538 C41 H72 O5 14.14 
61 DG(22:6/18:2) DG 664.5067 C43 H68 O5 11.82 
62 LPC(0:0/14:0) LPC 467.3012 C22 H46 O7 N1 P1 1.54 
63 LPC(0:0/15:0) LPC 481.3168 C23 H48 O7 N1 P1 1.86 
64 LPC(0:0/16:1) LPC 493.3168 C24 H48 O7 N1 P1 1.79 
65 LPC(0:0/17:0) LPC 509.3481 C25 H52 O7 N1 P1 2.60 
66 LPC(0:0/17:1) LPC 507.3325 C25 H50 O7 N1 P1 2.16 
67 LPC(0:0/18:0) LPC 523.3638 C26 H54 O7 N1 P1 3.46 
68 LPC(0:0/18:1) LPC 521.3481 C26 H52 O7 N1 P1 2.42 
69 LPC(0:0/18:2) LPC 519.3325 C26 H50 O7 N1 P1 1.84 
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70 LPC(0:0/18:3) LPC 517.3168 C26 H48 O7 N1 P1 1.62 
71 LPC(0:0/20:0) LPC 551.3951 C28 H58 O7 N1 P1 5.28 
72 LPC(0:0/20:1) LPC 549.3794 C28 H56 O7 N1 P1 3.61 
73 LPC(0:0/20:2) LPC 547.3638 C28 H54 O7 N1 P1 2.64 
74 LPC(0:0/20:3) LPC 545.3481 C28 H52 O7 N1 P1 2.08 
75 LPC(0:0/20:4) LPC 543.3325 C28 H50 O7 N1 P1 1.79 
76 LPC(0:0/20:5) LPC 541.3168 C28 H48 O7 N1 P1 1.55 
77 LPC(0:0/22:5) LPC 569.3481 C30 H52 O7 N1 P1 1.90 
78 LPC(0:0/22:6) LPC 567.3325 C30 H50 O7 N1 P1 1.68 
79 LPC(0:0/P-16:1) LPC 477.3219 C24 H48 O6 N1 P1 2.25 
80 LPC(0:0/P-18:1) LPC 505.3532 C26 H52 O6 N1 P1 3.03 
81 LPC(0:0/P-18:2) LPC 503.3376 C26 H50 O6 N1 P1 2.63 
82 LPC(12:0/0:0) LPC 439.2699 C20 H42 O7 N1 P1 1.24 
83 LPC(14:0/0:0) LPC 467.3012 C22 H46 O7 N1 P1 1.66 
84 LPC(14:1/0:0) LPC 465.2855 C22 H44 O7 N1 P1 1.32 
85 LPC(15:0/0:0) LPC 481.3168 C23 H48 O7 N1 P1 2.01 
86 LPC(16:0/0:0) LPC 495.3325 C24 H50 O7 N1 P1 2.45 
87 LPC(16:1/0:0) LPC 493.3168 C24 H48 O7 N1 P1 2.67 
88 LPC(16:2/0:0) LPC 491.3012 C24 H46 O7 N1 P1 1.52 
89 LPC(17:0/0:0) LPC 509.3481 C25 H52 O7 N1 P1 3.05 
90 LPC(17:1/0:0) LPC 507.3325 C25 H50 O7 N1 P1 2.53 
91 LPC(18:0/0:0) LPC 523.3638 C26 H54 O7 N1 P1 3.78 
92 LPC(18:1/0:0) LPC 521.3481 C26 H52 O7 N1 P1 2.63 
93 LPC(18:2/0:0) LPC 519.3325 C26 H50 O7 N1 P1 1.98 
94 LPC(18:3/0:0) LPC 517.3168 C26 H48 O7 N1 P1 1.10 
95 LPC(20:0/0:0) LPC 551.3951 C28 H58 O7 N1 P1 5.71 
96 LPC(20:1/0:0) LPC 549.3794 C28 H56 O7 N1 P1 3.91 
97 LPC(20:2/0:0) LPC 547.3638 C28 H54 O7 N1 P1 2.86 
98 LPC(20:3/0:0) LPC 545.3481 C28 H52 O7 N1 P1 2.23 
99 LPC(20:4/0:0) LPC 543.3325 C28 H50 O7 N1 P1 1.90 
100 LPC(22:0/0:0) LPC 579.4264 C30 H62 O7 N1 P1 7.46 
101 LPC(22:2/0:0) LPC 575.3951 C30 H58 O7 N1 P1 4.25 
102 LPC(22:5/0:0) LPC 569.3481 C30 H52 O7 N1 P1 2.27 
103 LPC(22:6/0:0) LPC 567.3325 C30 H50 O7 N1 P1 1.81 
104 LPC(O-16:0/0:0) LPC 481.3532 C24 H52 O6 N1 P1 2.94 
105 LPC(O-18:0/0:0) LPC 509.3845 C26 H56 O6 N1 P1 4.56 
106 LPC(O-20:0/0:0) LPC 537.4158 C28 H60 O6 N1 P1 6.63 
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107 LPC(P-16:0/0:0) LPC 479.3376 C24 H50 O6 N1 P1 2.85 
108 LPC(P-18:0/0:0) LPC 507.3689 C26 H54 O6 N1 P1 3.12 
109 LPC(P-18:1/0:0) LPC 505.3532 C26 H52 O6 N1 P1 2.30 
110 LPC(P-18:2/0:0) LPC 503.3376 C26 H50 O6 N1 P1 2.40 
111 LPC(P-20:0/0:0) LPC 535.4002 C28 H58 O6 N1 P1 4.66 
112 LPC(P-20:1/0:0) LPC 533.3845 C28 H56 O6 N1 P1 3.41 
113 LPE(14:0) LPE 425.2542 C19 H40 O7 N1 P1 1.73 
114 LPE(16:0) LPE 453.2855 C21 H44 O7 N1 P1 2.38 
115 LPE(16:1) LPE 451.2699 C21 H42 O7 N1 P1 1.87 
116 LPE(17:0) LPE 467.3012 C22 H46 O7 N1 P1 3.22 
117 LPE(18:0) LPE 481.3168 C23 H48 O7 N1 P1 4.00 
118 LPE(18:1) LPE 479.3012 C23 H46 O7 N1 P1 2.58 
119 LPE(18:2) LPE 477.2855 C23 H44 O7 N1 P1 1.93 
120 LPE(18:3) LPE 475.2699 C23 H42 O7 N1 P1 1.67 
121 LPE(20:2) LPE 505.3168 C25 H48 O7 N1 P1 3.02 
122 LPE(20:3) LPE 503.3012 C25 H46 O7 N1 P1 2.35 
123 LPE(20:4) LPE 501.2855 C25 H44 O7 N1 P1 1.87 
124 LPE(20:5) LPE 499.2699 C25 H42 O7 N1 P1 1.61 
125 LPE(22:4) LPE 529.3168 C27 H48 O7 N1 P1 2.69 
126 LPE(22:5) LPE 527.3012 C27 H46 O7 N1 P1 2.37 
127 LPE(22:6) LPE 525.2855 C27 H44 O7 N1 P1 1.88 
128 LPG(16:0) LPG 484.2801 C22 H45 O9 N0 P1 2.31 
129 LPG(18:0) LPG 512.3114 C24 H49 O9 N0 P1 3.54 
130 LPG(18:2) LPG 508.2801 C24 H45 O9 N0 P1 1.87 
131 LPI(18:0) LPI 600.3275 C27 H53 O12 N0 
P1 
3.25 
132 LPI(18:1) LPI 598.3118 C27 H51 O12 N0 
P1 
2.28 
133 LPI(18:2) LPI 596.2962 C27 H49 O12 N0 
P1 
1.75 
134 LPI(20:3) LPI 622.3118 C29 H51 O12 N0 
P1 
1.96 
135 LPI(20:4) LPI 620.2962 C29 H49 O12 N0 
P1 
1.70 
136 PC(12:0/18:2) PC 701.4996 C38 H72 O8 N1 P1 8.00 
137 PC(14:0/14:0) PC 677.4996 C36 H72 O8 N1 P1 8.94 
138 PC(14:0/15:0) PC 691.5152 C37 H74 O8 N1 P1 9.34 
139 PC(14:0/17:0) PC 719.5465 C39 H78 O8 N1 P1 10.88 
140 PC(14:0/18:2) PC 729.5309 C40 H76 O8 N1 P1 9.43 
141 PC(14:0/20:3) PC 755.5465 C42 H78 O8 N1 P1 9.78 
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142 PC(14:0/20:4) PC 753.5309 C42 H76 O8 N1 P1 9.24 
143 PC(14:0_12:0) PC 649.4683 C34 H68 O8 N1 P1 7.50 
144 PC(14:0_16:1) PC 703.5152 C38 H74 O8 N1 P1 9.10 
145 PC(15:0/14:0) PC 691.5152 C37 H74 O8 N1 P1 9.66 
146 PC(15:0/16:0) PC 719.5465 C39 H78 O8 N1 P1 11.22 
147 PC(15:0/16:1) PC 717.5309 C39 H76 O8 N1 P1 9.85 
148 PC(15:0/18:1) PC 745.5622 C41 H80 O8 N1 P1 11.37 
149 PC(15:0/18:2) PC 743.5465 C41 H78 O8 N1 P1 10.19 
150 PC(15:0/20:3) PC 769.5622 C43 H80 O8 N1 P1 10.59 
151 PC(15:0/20:4) PC 767.5465 C43 H78 O8 N1 P1 9.99 
152 PC(15:0/22:5) PC 793.5622 C45 H80 O8 N1 P1 10.11 
153 PC(15:0_22:6) PC 791.5465 C45 H78 O8 N1 P1 9.63 
154 PC(16:0/14:0) PC 705.5309 C38 H76 O8 N1 P1 10.45 
155 PC(16:0/15:0) PC 719.5465 C39 H78 O8 N1 P1 10.88 
156 PC(16:0/16:0) PC 733.5622 C40 H80 O8 N1 P1 11.99 
157 PC(16:0/16:1) PC 731.5465 C40 H78 O8 N1 P1 10.61 
158 PC(16:0/17:0) PC 747.5778 C41 H82 O8 N1 P1 12.45 
159 PC(16:0/17:1) PC 745.5622 C41 H80 O8 N1 P1 12.22 
160 PC(16:0/17:1) PC 745.5622 C41 H80 O8 N1 P1 12.23 
161 PC(16:0/18:1) PC 759.5778 C42 H82 O8 N1 P1 12.13 
162 PC(16:0/18:2) PC 757.5622 C42 H80 O8 N1 P1 10.95 
163 PC(16:0/18:3) PC 755.5465 C42 H78 O8 N1 P1 10.20 
164 PC(16:0/19:1) PC 773.5935 C43 H84 O8 N1 P1 12.91 
165 PC(16:0/19:2) PC 771.5778 C43 H82 O8 N1 P1 11.53 
166 PC(16:0/20:3) PC 783.5778 C44 H82 O8 N1 P1 11.35 
167 PC(16:0/20:5) PC 779.5465 C44 H78 O8 N1 P1 9.81 
168 PC(16:0/22:4) PC 809.5935 C46 H84 O8 N1 P1 11.82 
169 PC(16:0/22:5) PC 807.5778 C46 H82 O8 N1 P1 10.85 
170 PC(16:0_20:4) PC 781.5622 C44 H80 O8 N1 P1 10.75 
171 PC(16:1/18:1) PC 757.5622 C42 H80 O8 N1 P1 11.21 
172 PC(16:1/18:2) PC 755.5465 C42 H78 O8 N1 P1 9.61 
173 PC(16:1/18:2) PC 755.5465 C42 H78 O8 N1 P1 9.60 
174 PC(16:1/18:3) PC 753.5309 C42 H76 O8 N1 P1 8.88 
175 PC(16:1/20:3) PC 781.5622 C44 H80 O8 N1 P1 9.92 
176 PC(16:1/20:4) PC 779.5465 C44 H78 O8 N1 P1 9.40 
177 PC(16:1/20:5) PC 777.5309 C44 H76 O8 N1 P1 8.50 
178 PC(16:2/18:2) PC 753.5309 C42 H76 O8 N1 P1 9.24 
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179 PC(17:0/16:0) PC 747.5778 C41 H82 O8 N1 P1 12.79 
180 PC(17:0/18:1) PC 773.5935 C43 H84 O8 N1 P1 12.91 
181 PC(17:0/18:2) PC 771.5778 C43 H82 O8 N1 P1 11.77 
182 PC(17:0/20:2) PC 799.6091 C45 H86 O8 N1 P1 12.99 
183 PC(17:0/20:5) PC 793.5622 C45 H80 O8 N1 P1 10.38 
184 PC(17:0/22:5) PC 821.5935 C47 H84 O8 N1 P1 11.63 
185 PC(17:0_20:3) PC 797.5935 C45 H84 O8 N1 P1 11.91 
186 PC(17:0_20:3) PC 797.5935 C45 H84 O8 N1 P1 12.17 
187 PC(17:0_20:4) PC 795.5778 C45 H82 O8 N1 P1 11.27 
188 PC(17:1/18:2) PC 769.5622 C43 H80 O8 N1 P1 10.35 
189 PC(17:1/20:4) PC 793.5622 C45 H80 O8 N1 P1 10.38 
190 PC(18:0/16:0) PC 761.5935 C42 H84 O8 N1 P1 13.57 
191 PC(18:0/18:0) PC 789.6248 C44 H88 O8 N1 P1 15.06 
192 PC(18:0/18:1) PC 787.6091 C44 H86 O8 N1 P1 13.69 
193 PC(18:0/18:2) PC 785.5935 C44 H84 O8 N1 P1 12.55 
194 PC(18:0/18:3) PC 783.5778 C44 H82 O8 N1 P1 11.87 
195 PC(18:0/20:2) PC 813.6248 C46 H88 O8 N1 P1 13.89 
196 PC(18:0/20:4) PC 809.5935 C46 H84 O8 N1 P1 12.34 
197 PC(18:0/20:5) PC 807.5778 C46 H82 O8 N1 P1 11.36 
198 PC(18:0/22:3) PC 839.6404 C48 H90 O8 N1 P1 14.49 
199 PC(18:0/22:4) PC 837.6248 C48 H88 O8 N1 P1 13.38 
200 PC(18:0/22:5) PC 835.6091 C48 H86 O8 N1 P1 12.92 
201 PC(18:1/18:1) PC 785.5935 C44 H84 O8 N1 P1 12.26 
202 PC(18:1/18:2) PC 783.5778 C44 H82 O8 N1 P1 11.35 
203 PC(18:1/20:3) PC 809.5935 C46 H84 O8 N1 P1 11.82 
204 PC(18:1/20:4) PC 807.5778 C46 H82 O8 N1 P1 11.12 
205 PC(18:1/22:0) PC 843.6717 C48 H94 O8 N1 P1 16.49 
206 PC(18:1/22:4) PC 835.6091 C48 H86 O8 N1 P1 11.97 
207 PC(18:1/22:5) PC 833.5935 C48 H84 O8 N1 P1 11.21 
208 PC(18:1/22:6) PC 831.5778 C48 H82 O8 N1 P1 10.51 
209 PC(18:1_22:2) PC 839.6404 C48 H90 O8 N1 P1 13.98 
210 PC(18:2/18:2) PC 781.5622 C44 H80 O8 N1 P1 9.92 
211 PC(18:2/20:3) PC 807.5778 C46 H82 O8 N1 P1 10.33 
212 PC(18:2/20:4) PC 805.5622 C46 H80 O8 N1 P1 9.72 
213 PC(18:2p/20:2) PC 793.5985 C46 H84 O7 N1 P1 13.53 
214 PC(18:3/16:1) PC 753.5309 C42 H76 O8 N1 P1 8.68 
215 PC(18:3/18:2) PC 779.5465 C44 H78 O8 N1 P1 8.96 
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216 PC(18:3/18:3) PC 777.5309 C44 H76 O8 N1 P1 8.06 
217 PC(18:4/20:3) PC 803.5465 C46 H78 O8 N1 P1 9.29 
218 PC(19:0/18:2) PC 799.6091 C45 H86 O8 N1 P1 13.35 
219 PC(20:0/18:2) PC 813.6248 C46 H88 O8 N1 P1 14.15 
220 PC(20:0/18:2) PC 813.6248 C46 H88 O8 N1 P1 14.13 
221 PC(20:0/20:3) PC 839.6404 C48 H90 O8 N1 P1 14.49 
222 PC(20:0/20:4) PC 837.6248 C48 H88 O8 N1 P1 13.92 
223 PC(20:0/22:6) PC 861.6248 C50 H88 O8 N1 P1 13.54 
224 PC(20:1/18:2) PC 811.6091 C46 H86 O8 N1 P1 12.69 
225 PC(20:1/20:4) PC 835.6091 C48 H86 O8 N1 P1 12.41 
226 PC(20:1/22:6) PC 859.6091 C50 H86 O8 N1 P1 11.94 
227 PC(20:1_18:1) PC 813.6248 C46 H88 O8 N1 P1 13.65 
228 PC(20:2/20:1) PC 839.6404 C48 H90 O8 N1 P1 14.20 
229 PC(20:3/20:4) PC 831.5778 C48 H82 O8 N1 P1 10.24 
230 PC(20:4/20:3) PC 831.5778 C48 H82 O8 N1 P1 10.09 
231 PC(20:4/20:4) PC 829.5622 C48 H80 O8 N1 P1 9.41 
232 PC(20:4/22:6) PC 853.5622 C50 H80 O8 N1 P1 9.09 
233 PC(20:4_17:0) PC 795.5778 C45 H82 O8 N1 P1 11.56 
234 PC(20:5/18:2) PC 803.5465 C46 H78 O8 N1 P1 8.80 
235 PC(22:0/18:2) PC 841.6561 C48 H92 O8 N1 P1 15.62 
236 PC(22:0/20:4) PC 865.6561 C50 H92 O8 N1 P1 15.41 
237 PC(22:4/20:4) PC 857.5935 C50 H84 O8 N1 P1 10.51 
238 PC(22:5/20:4) PC 855.5778 C50 H82 O8 N1 P1 10.02 
239 PC(22:6/17:0) PC 819.5778 C47 H82 O8 N1 P1 10.87 
240 PC(22:6/18:0) PC 833.5935 C48 H84 O8 N1 P1 11.96 
241 PC(22:6_16:0) PC 805.5622 C46 H80 O8 N1 P1 10.39 
242 PC(24:0/18:2) PC 869.6874 C50 H96 O8 N1 P1 16.81 
243 PC(24:0/20:4) PC 893.6874 C52 H96 O8 N1 P1 16.65 
244 PC(24:0/20:5) PC 891.6717 C52 H94 O8 N1 P1 16.81 
245 PC(O-16:0/14:0) PC 691.5516 C38 H78 O7 N1 P1 11.43 
246 PC(O-16:0/16:0) PC 719.5829 C40 H82 O7 N1 P1 13.00 
247 PC(O-16:0/16:1) PC 717.5672 C40 H80 O7 N1 P1 11.63 
248 PC(O-16:0/18:1) PC 745.5985 C42 H84 O7 N1 P1 13.08 
249 PC(O-16:0/18:2) PC 743.5829 C42 H82 O7 N1 P1 11.94 
250 PC(O-16:0/20:3) PC 769.5985 C44 H84 O7 N1 P1 12.32 
251 PC(O-16:0/20:4) PC 767.5829 C44 H82 O7 N1 P1 11.71 
252 PC(O-16:0/22:4) PC 795.6142 C46 H86 O7 N1 P1 12.79 
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253 PC(O-16:0/22:5) PC 791.5829 C46 H82 O7 N1 P1 11.53 
254 PC(O-16:0/22:6) PC 791.5829 C46 H82 O7 N1 P1 11.30 
255 PC(O-18:0/16:0) PC 747.6142 C42 H86 O7 N1 P1 14.58 
256 PC(O-18:0/18:1) PC 773.6298 C44 H88 O7 N1 P1 14.69 
257 PC(O-18:0/18:2) PC 771.6142 C44 H86 O7 N1 P1 13.55 
258 PC(O-18:0/20:3) PC 797.6298 C46 H88 O7 N1 P1 13.93 
259 PC(O-18:0/20:4) PC 795.6142 C46 H86 O7 N1 P1 13.32 
260 PC(O-18:0/22:4) PC 823.6455 C48 H90 O7 N1 P1 14.36 
261 PC(O-18:0/22:5) PC 821.6298 C48 H88 O7 N1 P1 13.25 
262 PC(O-18:0/22:6) PC 819.6142 C48 H86 O7 N1 P1 12.91 
263 PC(O-20:0/18:2) PC 799.6455 C46 H90 O7 N1 P1 15.11 
264 PC(O-20:0/20:4) PC 823.6455 C48 H90 O7 N1 P1 14.87 
265 PC(O-20:0/22:4) PC 851.6768 C50 H94 O7 N1 P1 15.81 
266 PC(O-20:0/22:6) PC 847.6455 C50 H90 O7 N1 P1 14.47 
267 PC(O-20:e/18:1) PC 801.6611 C46 H92 O7 N1 P1 16.10 
268 PC(P-16:0/14:0) PC 689.5359 C38 H76 O7 N1 P1 11.19 
269 PC(P-16:0/16:0) PC 717.5672 C40 H80 O7 N1 P1 12.78 
270 PC(P-16:0/18:1) PC 743.5829 C42 H82 O7 N1 P1 12.87 
271 PC(P-16:0/18:2) PC 741.5672 C42 H80 O7 N1 P1 11.69 
272 PC(P-16:0/20:2) PC 769.5985 C44 H84 O7 N1 P1 14.59 
273 PC(P-16:0/20:3) PC 767.5829 C44 H82 O7 N1 P1 13.11 
274 PC(P-16:0/20:4) PC 765.5672 C44 H80 O7 N1 P1 11.44 
275 PC(P-16:0/22:6) PC 789.5672 C46 H80 O7 N1 P1 11.04 
276 PC(P-16:1/20:3) PC 765.5672 C44 H80 O7 N1 P1 11.91 
277 PC(P-16:1/21:4) PC 777.5672 C45 H80 O7 N1 P1 10.88 
278 PC(P-16:1/24:7) PC 813.5672 C48 H80 O7 N1 P1 10.55 
279 PC(P-18:0/16:0) PC 745.5985 C42 H84 O7 N1 P1 13.05 
280 PC(P-18:0/18:1) PC 771.6142 C44 H86 O7 N1 P1 13.19 
281 PC(P-18:0/18:2) PC 769.5985 C44 H84 O7 N1 P1 11.99 
282 PC(P-18:0/20:4) PC 793.5985 C46 H84 O7 N1 P1 11.77 
283 PC(P-18:0/22:4) PC 821.6298 C48 H88 O7 N1 P1 12.83 
284 PC(P-18:0/22:5) PC 819.6142 C48 H86 O7 N1 P1 11.87 
285 PC(P-18:0/22:6) PC 817.5985 C48 H84 O7 N1 P1 11.37 
286 PC(P-18:1/18:1) PC 769.5985 C44 H84 O7 N1 P1 12.97 
287 PC(P-18:1/18:2) PC 767.5829 C44 H82 O7 N1 P1 12.05 
288 PC(P-18:1/20:4) PC 791.5829 C46 H82 O7 N1 P1 11.53 
289 PC(P-18:1/22:2) PC 823.6455 C48 H90 O7 N1 P1 14.88 
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290 PC(P-18:1/22:4) PC 819.6142 C48 H86 O7 N1 P1 13.94 
291 PC(P-18:1/22:5) PC 817.5985 C48 H84 O7 N1 P1 11.64 
292 PC(P-18:1/24:7) PC 841.5985 C50 H84 O7 N1 P1 11.87 
293 PC(P-20:0/18:2) PC 797.6298 C46 H88 O7 N1 P1 13.94 
294 PC(P-20:0/20:4) PC 821.6298 C48 H88 O7 N1 P1 13.56 
295 PC(P-20:0/22:4) PC 849.6611 C50 H92 O7 N1 P1 14.28 
296 PE(16:0/18:1) PE 717.5309 C39 H76 O8 N1 P1 12.56 
297 PE(16:0/18:2) PE 715.5152 C39 H74 O8 N1 P1 11.38 
298 PE(16:0/20:4) PE 739.5152 C41 H74 O8 N1 P1 11.16 
299 PE(16:0/20:5) PE 737.4996 C41 H72 O8 N1 P1 10.18 
300 PE(16:0/22:4) PE 767.5465 C43 H78 O8 N1 P1 12.22 
301 PE(16:1/18:1) PE 715.5152 C39 H74 O8 N1 P1 11.15 
302 PE(17:0/18:2) PE 729.5309 C40 H76 O8 N1 P1 12.18 
303 PE(17:0_18:1) PE 731.5465 C40 H78 O8 N1 P1 13.34 
304 PE(17:1/20:4) PE 751.5152 C42 H74 O8 N1 P1 10.96 
305 PE(17:1/22:6) PE 775.5152 C44 H74 O8 N1 P1 10.59 
306 PE(17:1_18:2) PE 727.5152 C40 H74 O8 N1 P1 11.21 
307 PE(18:0/16:0) PE 719.5465 C39 H78 O8 N1 P1 13.99 
308 PE(18:0/20:3) PE 769.5622 C43 H80 O8 N1 P1 13.52 
309 PE(18:0/20:4) PE 767.5465 C43 H78 O8 N1 P1 12.76 
310 PE(18:0/20:5) PE 765.5309 C43 H76 O8 N1 P1 11.77 
311 PE(18:0/22:4) PE 795.5778 C45 H82 O8 N1 P1 13.77 
312 PE(18:0/22:5) PE 793.5622 C45 H80 O8 N1 P1 13.33 
313 PE(18:0_18:1) PE 745.5622 C41 H80 O8 N1 P1 14.10 
314 PE(18:1/18:1) PE 743.5465 C41 H78 O8 N1 P1 12.67 
315 PE(18:1/20:2) PE 769.5622 C43 H80 O8 N1 P1 13.35 
316 PE(18:1/22:5) PE 791.5465 C45 H78 O8 N1 P1 11.87 
317 PE(18:1/22:6) PE 789.5309 C45 H76 O8 N1 P1 10.89 
318 PE(18:1_18:2) PE 741.5309 C41 H76 O8 N1 P1 11.49 
319 PE(18:2/18:2) PE 739.5152 C41 H74 O8 N1 P1 10.30 
320 PE(18:2/20:4) PE 763.5152 C43 H74 O8 N1 P1 10.08 
321 PE(18:2_18:0) PE 743.5465 C41 H78 O8 N1 P1 12.98 
322 PE(20:1/20:4) PE 793.5622 C45 H80 O8 N1 P1 12.59 
323 PE(22:6/16:0) PE 763.5152 C43 H74 O8 N1 P1 10.78 
324 PE(22:6/18:0) PE 791.5465 C45 H78 O8 N1 P1 12.37 
325 PE(O-16:0/18:2) PE 701.5359 C39 H76 O7 N1 P1 12.41 
326 PE(O-16:0/20:4) PE 725.5359 C41 H76 O7 N1 P1 12.24 
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327 PE(O-16:0/22:4) PE 753.5672 C43 H80 O7 N1 P1 13.23 
328 PE(O-16:0/22:6) PE 749.5359 C43 H76 O7 N1 P1 11.76 
329 PE(O-18:0/18:1) PE 731.5829 C41 H82 O7 N1 P1 15.11 
330 PE(O-18:0/18:2) PE 729.5672 C41 H80 O7 N1 P1 14.00 
331 PE(O-18:0/22:4) PE 781.5985 C45 H84 O7 N1 P1 14.76 
332 PE(O-18:0/22:6) PE 777.5672 C45 H80 O7 N1 P1 13.38 
333 PE(P-16:0/18:0) PE 703.5516 C39 H78 O7 N1 P1 13.53 
334 PE(P-16:0/18:3) PE 697.5046 C39 H72 O7 N1 P1 11.13 
335 PE(P-16:0/20:4) PE 723.5203 C41 H74 O7 N1 P1 11.90 
336 PE(P-16:0/20:5) PE 721.5046 C41 H72 O7 N1 P1 10.90 
337 PE(P-16:0/22:6) PE 747.5203 C43 H74 O7 N1 P1 11.49 
338 PE(P-16:0p/18:1) PE 701.5359 C39 H76 O7 N1 P1 13.35 
339 PE(P-16:0p/18:2) PE 699.5203 C39 H74 O7 N1 P1 12.16 
340 PE(P-18:0/16:0) PE 703.5516 C39 H78 O7 N1 P1 14.79 
341 PE(P-18:0/18:1) PE 729.5672 C41 H80 O7 N1 P1 14.87 
342 PE(P-18:0/18:2) PE 727.5516 C41 H78 O7 N1 P1 13.75 
343 PE(P-18:0/20:1) PE 757.5985 C43 H84 O7 N1 P1 16.11 
344 PE(P-18:0/20:3) PE 753.5672 C43 H80 O7 N1 P1 14.27 
345 PE(P-18:0/20:4) PE 751.5516 C43 H78 O7 N1 P1 13.50 
346 PE(P-18:0/22:5) PE 777.5672 C45 H80 O7 N1 P1 14.05 
347 PE(P-18:0/22:7) PE 773.5359 C45 H76 O7 N1 P1 11.85 
348 PE(P-18:1/18:1) PE 727.5516 C41 H78 O7 N1 P1 13.43 
349 PE(P-18:1/18:2) PE 725.5359 C41 H76 O7 N1 P1 12.24 
350 PE(P-18:1/20:3) PE 751.5516 C43 H78 O7 N1 P1 12.98 
351 PE(P-18:1/20:4) PE 749.5359 C43 H76 O7 N1 P1 11.99 
352 PE(P-18:1/22:5) PE 775.5516 C45 H78 O7 N1 P1 13.10 
353 PE(P-18:1/22:6) PE 773.5359 C45 H76 O7 N1 P1 11.59 
354 PE(P-18:2/18:2) PE 723.5203 C41 H74 O7 N1 P1 11.05 
355 PE(P-18:2/20:4) PE 747.5203 C43 H74 O7 N1 P1 10.79 
356 PE(P-18:2/22:6) PE 771.5203 C45 H74 O7 N1 P1 10.40 
357 PE(P-20:0/18:1) PE 757.5985 C43 H84 O7 N1 P1 16.24 
358 PE(P-20:0/18:2) PE 755.5829 C43 H82 O7 N1 P1 15.27 
359 PE(P-20:0/20:3) PE 781.5985 C45 H84 O7 N1 P1 15.59 
360 PE(P-20:0/20:4) PE 779.5829 C45 H82 O7 N1 P1 15.02 
361 PE(P-20:0/22:5) PE 805.5985 C47 H84 O7 N1 P1 15.52 
362 PE(P-20:0/22:6) PE 803.5829 C47 H82 O7 N1 P1 14.64 
363 PE(P-20:1/18:1) PE 755.5829 C43 H82 O7 N1 P1 14.82 
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364 PE(P-20:1/20:4) PE 777.5672 C45 H80 O7 N1 P1 13.75 
365 PE(P-20:1/22:6) PE 801.5672 C47 H80 O7 N1 P1 13.05 
366 PG(16:0/18:1) PG 748.5254 C40 H77 O10 N0 
P1 
11.55 
367 PG(16:0/18:2) PG 746.5098 C40 H75 O10 N0 
P1 
10.48 
368 PG(16:0/20:4) PG 770.5098 C42 H75 O10 N0 
P1 
10.30 
369 PG(18:0/18:1) PG 776.5567 C42 H81 O10 N0 
P1 
13.07 
370 PG(18:1/18:2) PG 772.5254 C42 H77 O10 N0 
P1 
10.61 
371 PI(16:0/16:0) PI 810.5258 C41 H79 O13 N0 
P1 
11.11 
372 PI(16:0/18:1) PI 836.5415 C43 H81 O13 N0 
P1 
11.27 
373 PI(16:0/18:2) PI 834.5258 C43 H79 O13 N0 
P1 
10.14 
374 PI(16:0/20:3) PI 860.5415 C45 H81 O13 N0 
P1 
10.27 
375 PI(17:0/18:2) PI 848.5415 C44 H81 O13 N0 
P1 
10.91 
376 PI(17:0/20:3) PI 874.5571 C46 H83 O13 N0 
P1 
11.30 
377 PI(17:0/20:4) PI 872.5415 C46 H81 O13 N0 
P1 
10.74 
378 PI(17:0_18:1) PI 850.5571 C44 H83 O13 N0 
P1 
12.04 
379 PI(18:0/18:2) PI 862.5571 C45 H83 O13 N0 
P1 
11.69 
380 PI(18:0/20:3) PI 888.5728 C47 H85 O13 N0 
P1 
12.09 
381 PI(18:0/20:4) PI 886.5571 C47 H83 O13 N0 
P1 
11.49 
382 PI(18:0_18:1) PI 864.5728 C45 H85 O13 N0 
P1 
12.81 
383 PI(18:1/18:1) PI 862.5571 C45 H83 O13 N0 
P1 
11.39 
384 PI(18:1_18:2) PI 860.5415 C45 H81 O13 N0 
P1 
10.27 
385 PI(18:2/18:2) PI 858.5258 C45 H79 O13 N0 
P1 
9.15 
386 PI(18:2/20:4) PI 882.5258 C47 H79 O13 N0 
P1 
9.63 
387 PI(20:2/18:0) PI 862.5571 C45 H83 O13 N0 
P1 
11.83 
388 PI(20:4/16:0) PI 858.5258 C45 H79 O13 N0 
P1 
9.97 
389 PI(20:4/18:1) PI 884.5415 C47 H81 O13 N0 
P1 
10.33 
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390 PI(20:4/20:1) PI 912.5728 C49 H85 O13 N0 
P1 
11.56 
391 PI(22:4/18:0) PI 914.5884 C49 H87 O13 N0 
P1 
12.53 
392 PI(22:5/16:0) PI 884.5415 C47 H81 O13 N0 
P1 
10.57 
393 PI(22:5/18:0) PI 912.5728 C49 H85 O13 N0 
P1 
12.10 
394 PI(22:6/16:0) PI 882.5258 C47 H79 O13 N0 
P1 
9.63 
395 PI(22:6/18:1) PI 908.5415 C49 H81 O13 N0 
P1 
9.99 
396 PS(20:0/20:4) PS 839.5676 C46 H82 O10 N1 
P1 
12.40 
397 PS(20:0p/18:2) PS 799.5727 C44 H82 O9 N1 P1 13.34 
398 PS(20:0p/20:4) PS 823.5727 C46 H82 O9 N1 P1 13.10 
399 PS(38:6p) PS 791.5101 C44 H74 O9 N1 P1 11.90 
400 SM(d17:1/23:3) SM 780.6145 C45 H85 O6 N2 P1 14.08 
401 SM(d22:1/18:2) SM 782.6302 C45 H87 O6 N2 P1 12.60 
402 SM(d28:0) SM 620.4893 C33 H69 O6 N2 P1 6.62 
403 SM(d28:1) SM 618.4737 C33 H67 O6 N2 P1 5.78 
404 SM(d29:1) SM 632.4893 C34 H69 O6 N2 P1 6.67 
405 SM(d30:0) SM 648.5206 C35 H73 O6 N2 P1 7.90 
406 SM(d30:1) SM 646.505 C35 H71 O6 N2 P1 7.32 
407 SM(d30:2) SM 644.4893 C35 H69 O6 N2 P1 6.13 
408 SM(d31:1) SM 660.5206 C36 H73 O6 N2 P1 8.02 
409 SM(d32:0) SM 676.5519 C37 H77 O6 N2 P1 9.38 
410 SM(d32:1) SM 674.5363 C37 H75 O6 N2 P1 8.79 
411 SM(d32:2) SM 672.5206 C37 H73 O6 N2 P1 7.55 
412 SM(d32:4) SM 668.4893 C37 H69 O6 N2 P1 7.34 
413 SM(d33:0) SM 690.5676 C38 H79 O6 N2 P1 10.17 
414 SM(d33:1) SM 688.5519 C38 H77 O6 N2 P1 9.57 
415 SM(d33:2) SM 686.5363 C38 H75 O6 N2 P1 9.02 
416 SM(d33:2) SM 686.5363 C38 H75 O6 N2 P1 8.35 
417 SM(d33:4) SM 682.505 C38 H71 O6 N2 P1 8.02 
418 SM(d34:0) SM 704.5832 C39 H81 O6 N2 P1 10.99 
419 SM(d34:1) SM 702.5676 C39 H79 O6 N2 P1 10.36 
420 SM(d34:2) SM 700.5519 C39 H77 O6 N2 P1 9.04 
421 SM(d34:3) SM 698.5363 C39 H75 O6 N2 P1 7.95 
422 SM(d34:3) SM 698.5363 C39 H75 O6 N2 P1 9.38 
423 SM(d34:4) SM 696.5206 C39 H73 O6 N2 P1 8.81 
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424 SM(d34:5) SM 694.505 C39 H71 O6 N2 P1 7.55 
425 SM(d35:0) SM 718.5989 C40 H83 O6 N2 P1 11.47 
426 SM(d35:0) SM 718.5989 C40 H83 O6 N2 P1 11.82 
427 SM(d35:1) SM 716.5832 C40 H81 O6 N2 P1 11.21 
428 SM(d35:1) SM 716.5832 C40 H81 O6 N2 P1 10.84 
429 SM(d35:2) SM 714.5676 C40 H79 O6 N2 P1 9.86 
430 SM(d35:2) SM 714.5676 C40 H79 O6 N2 P1 10.17 
431 SM(d35:3) SM 712.5519 C40 H77 O6 N2 P1 8.70 
432 SM(d35:4) SM 710.5363 C40 H75 O6 N2 P1 9.57 
433 SM(d36:0) SM 732.6145 C41 H85 O6 N2 P1 12.63 
434 SM(d36:1) SM 730.5989 C41 H83 O6 N2 P1 12.01 
435 SM(d36:2) SM 728.5832 C41 H81 O6 N2 P1 10.67 
436 SM(d36:3) SM 726.5676 C41 H79 O6 N2 P1 9.47 
437 SM(d36:4) SM 724.5519 C41 H77 O6 N2 P1 8.17 
438 SM(d36:5) SM 722.5363 C41 H75 O6 N2 P1 9.24 
439 SM(d36:5) SM 722.5363 C41 H75 O6 N2 P1 9.04 
440 SM(d37:0) SM 746.6302 C42 H87 O6 N2 P1 13.48 
441 SM(d37:1) SM 744.6145 C42 H85 O6 N2 P1 12.94 
442 SM(d37:1) SM 744.6145 C42 H85 O6 N2 P1 12.48 
443 SM(d37:2) SM 742.5989 C42 H83 O6 N2 P1 11.53 
444 SM(d37:2) SM 742.5989 C42 H83 O6 N2 P1 11.26 
445 SM(d37:3) SM 740.5832 C42 H81 O6 N2 P1 10.01 
446 SM(d37:4) SM 738.5676 C42 H79 O6 N2 P1 11.21 
447 SM(d37:4) SM 738.5676 C42 H79 O6 N2 P1 10.84 
448 SM(d37:5) SM 736.5519 C42 H77 O6 N2 P1 9.85 
449 SM(d38:0) SM 760.6458 C43 H89 O6 N2 P1 14.29 
450 SM(d38:1) SM 758.6302 C43 H87 O6 N2 P1 13.76 
451 SM(d38:1) SM 758.6302 C43 H87 O6 N2 P1 13.63 
452 SM(d38:2) SM 756.6145 C43 H85 O6 N2 P1 12.35 
453 SM(d38:3) SM 754.5989 C43 H83 O6 N2 P1 11.04 
454 SM(d38:3) SM 754.5989 C43 H83 O6 N2 P1 10.75 
455 SM(d38:4) SM 752.5832 C43 H81 O6 N2 P1 9.51 
456 SM(d38:5) SM 750.5676 C43 H79 O6 N2 P1 10.67 
457 SM(d38:6) SM 748.5519 C43 H77 O6 N2 P1 9.47 
458 SM(d39:0) SM 774.6615 C44 H91 O6 N2 P1 15.11 
459 SM(d39:1) SM 772.6458 C44 H89 O6 N2 P1 14.58 
460 SM(d39:2) SM 770.6302 C44 H87 O6 N2 P1 13.18 
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461 SM(d39:2) SM 770.6302 C44 H87 O6 N2 P1 12.83 
462 SM(d39:3) SM 768.6145 C44 H85 O6 N2 P1 11.97 
463 SM(d39:3) SM 768.6145 C44 H85 O6 N2 P1 11.76 
464 SM(d39:3) SM 768.6145 C44 H85 O6 N2 P1 11.52 
465 SM(d39:4) SM 766.5989 C44 H83 O6 N2 P1 12.47 
466 SM(d39:4) SM 766.5989 C44 H83 O6 N2 P1 12.93 
467 SM(d39:5) SM 764.5832 C44 H81 O6 N2 P1 11.25 
468 SM(d40:0) SM 788.6771 C45 H93 O6 N2 P1 15.73 
469 SM(d40:1) SM 786.6615 C45 H91 O6 N2 P1 15.20 
470 SM(d40:2) SM 784.6458 C45 H89 O6 N2 P1 13.60 
471 SM(d40:2) SM 784.6458 C45 H89 O6 N2 P1 14.08 
472 SM(d40:3) SM 782.6302 C45 H87 O6 N2 P1 12.29 
473 SM(d40:4) SM 780.6145 C45 H85 O6 N2 P1 13.95 
474 SM(d40:4) SM 780.6145 C45 H85 O6 N2 P1 10.97 
475 SM(d40:5) SM 778.5989 C45 H83 O6 N2 P1 10.42 
476 SM(d40:6) SM 776.5832 C45 H81 O6 N2 P1 10.76 
477 SM(d40:7) SM 774.5676 C45 H79 O6 N2 P1 9.05 
478 SM(d41:1) SM 800.6771 C46 H93 O6 N2 P1 15.59 
479 SM(d41:2) SM 798.6615 C46 H91 O6 N2 P1 14.77 
480 SM(d41:2) SM 798.6615 C46 H91 O6 N2 P1 14.31 
481 SM(d41:3) SM 796.6458 C46 H89 O6 N2 P1 13.04 
482 SM(d41:4) SM 794.6302 C46 H87 O6 N2 P1 14.59 
483 SM(d41:5) SM 792.6145 C46 H85 O6 N2 P1 10.81 
484 SM(d42:1) SM 814.6928 C47 H95 O6 N2 P1 16.52 
485 SM(d42:2) SM 812.6771 C47 H93 O6 N2 P1 15.52 
486 SM(d42:2) SM 812.6771 C47 H93 O6 N2 P1 15.01 
487 SM(d42:3) SM 810.6615 C47 H91 O6 N2 P1 13.79 
488 SM(d42:4) SM 808.6458 C47 H89 O6 N2 P1 12.71 
489 SM(d42:4) SM 808.6458 C47 H89 O6 N2 P1 15.33 
490 SM(d42:4) SM 808.6458 C47 H89 O6 N2 P1 12.51 
491 SM(d42:5) SM 806.6302 C47 H87 O6 N2 P1 11.59 
492 SM(d42:6) SM 804.6145 C47 H85 O6 N2 P1 10.57 
493 SM(d42:6) SM 804.6145 C47 H85 O6 N2 P1 10.29 
494 SM(d42:7) SM 802.5989 C47 H83 O6 N2 P1 9.94 
495 SM(d42:7) SM 802.5989 C47 H83 O6 N2 P1 11.19 
496 SM(d42:7) SM 802.5989 C47 H83 O6 N2 P1 9.29 
497 SM(d42:8) SM 800.5832 C47 H81 O6 N2 P1 16.82 
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498 SM(d43:1) SM 828.7084 C48 H97 O6 N2 P1 17.07 
499 SM(d43:1) SM 828.7084 C48 H97 O6 N2 P1 16.82 
500 SM(d43:2) SM 826.6928 C48 H95 O6 N2 P1 15.40 
501 SM(d43:2) SM 826.6928 C48 H95 O6 N2 P1 15.71 
502 SM(d43:2) SM 826.6928 C48 H95 O6 N2 P1 16.20 
503 SM(d43:3) SM 824.6771 C48 H93 O6 N2 P1 14.55 
504 SM(d43:3) SM 824.6771 C48 H93 O6 N2 P1 14.19 
505 SM(d43:4) SM 822.6615 C48 H91 O6 N2 P1 15.93 
506 SM(d43:4) SM 822.6615 C48 H91 O6 N2 P1 13.48 
507 SM(d43:5) SM 820.6458 C48 H89 O6 N2 P1 14.32 
508 SM(d43:6) SM 818.6302 C48 H87 O6 N2 P1 13.42 
509 SM(d43:7) SM 816.6145 C48 H85 O6 N2 P1 11.95 
510 SM(d43:8) SM 814.5989 C48 H83 O6 N2 P1 10.81 
511 SM(d44:1) SM 842.7241 C49 H99 O6 N2 P1 17.31 
512 SM(d44:1) SM 842.7241 C49 H99 O6 N2 P1 17.05 
513 SM(d44:1) SM 842.7241 C49 H99 O6 N2 P1 17.54 
514 SM(d44:2) SM 840.7084 C49 H97 O6 N2 P1 16.77 
515 SM(d44:2) SM 840.7084 C49 H97 O6 N2 P1 16.06 
516 SM(d44:2) SM 840.7084 C49 H97 O6 N2 P1 16.31 
517 SM(d44:3) SM 838.6928 C49 H95 O6 N2 P1 15.26 
518 SM(d44:4) SM 836.6771 C49 H93 O6 N2 P1 14.03 
519 SM(d44:5) SM 834.6615 C49 H91 O6 N2 P1 12.88 
520 SM(d44:6) SM 832.6458 C49 H89 O6 N2 P1 11.61 
521 SM(d44:6) SM 832.6458 C49 H89 O6 N2 P1 12.03 
522 SM(d44:7) SM 830.6302 C49 H87 O6 N2 P1 10.74 
523 SM(d44:7) SM 830.6302 C49 H87 O6 N2 P1 12.21 
524 SM(d44:7) SM 830.6302 C49 H87 O6 N2 P1 13.06 
525 SM(d44:8) SM 828.6145 C49 H85 O6 N2 P1 11.27 
526 SM(d44:8) SM 828.6145 C49 H85 O6 N2 P1 11.58 
527 SM(d45:4) SM 850.6928 C50 H95 O6 N2 P1 17.07 
528 SM(d45:4) SM 850.6928 C50 H95 O6 N2 P1 16.82 
529 SM(d45:5) SM 848.6771 C50 H93 O6 N2 P1 16.21 
530 SM(d45:5) SM 848.6771 C50 H93 O6 N2 P1 15.71 
531 SM(d45:5) SM 848.6771 C50 H93 O6 N2 P1 15.41 
532 SM(d45:6) SM 846.6615 C50 H91 O6 N2 P1 14.54 
533 SM(d45:6) SM 846.6615 C50 H91 O6 N2 P1 14.20 
534 SM(d46:5) SM 862.6928 C51 H95 O6 N2 P1 16.31 
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535 SM(d46:6) SM 860.6771 C51 H93 O6 N2 P1 15.28 
536 SM(d46:7) SM 858.6615 C51 H91 O6 N2 P1 14.07 
537 SM(d46:8) SM 856.6458 C51 H89 O6 N2 P1 12.89 
538 TG(10:0_10:0_12:0) TG 582.4859 C35 H66 O6 13.55 
539 TG(10:0_10:0_18:1) TG 664.5642 C41 H76 O6 16.42 
540 TG(10:0_10:0_18:2) TG 662.5485 C41 H74 O6 15.40 
541 TG(10:0_10:0_18:3) TG 660.5329 C41 H72 O6 14.38 
542 TG(10:0_12:0_12:0) TG 610.5172 C37 H70 O6 14.94 
543 TG(10:0_12:0_14:1) TG 636.5329 C39 H72 O6 15.20 
544 TG(10:0_12:0_18:1) TG 692.5955 C43 H80 O6 17.34 
545 TG(10:0_12:0_18:2) TG 690.5798 C43 H78 O6 16.52 
546 TG(10:0_12:0_18:3) TG 688.5642 C43 H76 O6 15.69 
547 TG(10:0_12:0_20:4) TG 714.5798 C45 H78 O6 17.33 
548 TG(10:0_12:0_20:5) TG 712.5642 C45 H76 O6 16.52 
549 TG(10:0_18:1_22:6) TG 820.6581 C53 H88 O6 17.84 
550 TG(10:0_18:2_18:2) TG 770.6424 C49 H86 O6 17.67 
551 TG(10:0_18:2_18:3) TG 768.6268 C49 H84 O6 17.05 
552 TG(10:0_18:3_18:3) TG 766.6111 C49 H82 O6 17.71 
553 TG(10:0_18:3_22:6) TG 816.6268 C53 H84 O6 17.29 
554 TG(12:0_12:0_12:0) TG 638.5485 C39 H74 O6 16.24 
555 TG(12:0_12:0_14:0) TG 666.5798 C41 H78 O6 17.28 
556 TG(12:0_12:0_17:1) TG 706.6111 C44 H82 O6 17.77 
557 TG(12:0_12:0_18:2) TG 718.6111 C45 H82 O6 17.45 
558 TG(12:0_12:0_18:3) TG 716.5955 C45 H80 O6 16.81 
559 TG(12:0_12:0_18:3) TG 716.5955 C45 H80 O6 18.12 
560 TG(12:0_12:0_20:4) TG 742.6111 C47 H82 O6 18.12 
561 TG(12:0_12:0_20:5) TG 740.5955 C47 H80 O6 17.45 
562 TG(12:0_14:0_14:0) TG 694.6111 C43 H82 O6 18.12 
563 TG(12:0_14:0_18:2) TG 746.6424 C47 H86 O6 18.25 
564 TG(12:0_14:0_18:3) TG 744.6268 C47 H84 O6 17.71 
565 TG(12:0_14:0_18:3) TG 744.6268 C47 H84 O6 18.82 
566 TG(12:0_14:0_20:4) TG 770.6424 C49 H86 O6 18.81 
567 TG(12:0_14:1_20:5) TG 766.6111 C49 H82 O6 17.59 
568 TG(12:0_17:1_18:2) TG 786.6737 C50 H90 O6 18.61 
569 TG(12:0_18:2_18:2) TG 798.6737 C51 H90 O6 18.36 
570 TG(12:0_18:2_18:3) TG 796.6581 C51 H88 O6 17.85 
571 TG(12:0_18:2_20:5) TG 820.6581 C53 H88 O6 18.37 
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572 TG(12:0_18:2_22:6) TG 846.6737 C55 H90 O6 17.89 
573 TG(12:0_18:3_18:3) TG 794.6424 C51 H86 O6 17.29 
574 TG(12:0_18:3_20:5) TG 818.6424 C53 H86 O6 17.84 
575 TG(14:0_14:0_20:4) TG 798.6737 C51 H90 O6 19.39 
576 TG(14:0_14:0_22:6) TG 822.6737 C53 H90 O6 18.50 
577 TG(14:0_17:1_18:2) TG 814.705 C52 H94 O6 19.21 
578 TG(14:0_18:2_18:3) TG 824.6894 C53 H92 O6 18.56 
579 TG(14:0_18:2_20:5) TG 848.6894 C55 H92 O6 18.99 
580 TG(14:0_18:3_20:4) TG 848.6894 C55 H92 O6 19.31 
581 TG(14:0_20:5_20:5) TG 870.6737 C57 H90 O6 18.36 
582 TG(15:0_10:0_14:0) TG 680.5955 C42 H80 O6 17.57 
583 TG(15:0_10:0_18:1) TG 734.6424 C46 H86 O6 18.35 
584 TG(15:0_12:0_14:0) TG 708.6268 C44 H84 O6 18.36 
585 TG(15:0_12:0_14:0) TG 708.6268 C44 H84 O6 18.50 
586 TG(15:0_12:0_18:1) TG 762.6737 C48 H90 O6 18.99 
587 TG(15:0_12:0_18:2) TG 760.6581 C48 H88 O6 18.59 
588 TG(15:0_14:0_14:0) TG 736.6581 C46 H88 O6 18.99 
589 TG(15:0_14:0_16:0) TG 764.6894 C48 H92 O6 19.56 
590 TG(15:0_14:0_18:1) TG 790.705 C50 H94 O6 19.66 
591 TG(15:0_14:0_18:2) TG 788.6894 C50 H92 O6 19.15 
592 TG(15:0_14:0_18:3) TG 786.6737 C50 H90 O6 18.78 
593 TG(15:0_16:0_16:0) TG 792.7207 C50 H96 O6 20.07 
594 TG(15:0_16:0_18:1) TG 818.7363 C52 H98 O6 20.04 
595 TG(15:0_16:0_18:2) TG 816.7207 C52 H96 O6 19.65 
596 TG(15:0_16:1_18:3) TG 812.6894 C52 H92 O6 19.01 
597 TG(15:0_18:1_18:1) TG 844.752 C54 H100 O6 18.91 
598 TG(15:0_18:1_18:2) TG 842.7363 C54 H98 O6 19.73 
599 TG(15:0_18:1_20:5) TG 864.7207 C56 H96 O6 19.62 
600 TG(15:0_18:1_22:6) TG 890.7363 C58 H98 O6 19.35 
601 TG(15:0_18:2_18:2) TG 840.7207 C54 H96 O6 19.29 
602 TG(15:0_18:2_18:3) TG 838.705 C54 H94 O6 19.69 
603 TG(15:0_18:2_20:5) TG 862.705 C56 H94 O6 19.30 
604 TG(15:0_18:2_22:6) TG 888.7207 C58 H96 O6 18.91 
605 TG(15:0_8:0_16:0) TG 680.5955 C42 H80 O6 17.74 
606 TG(16:0_10:0_22:6) TG 794.6424 C51 H86 O6 17.80 
607 TG(16:0_12:0_18:1) TG 776.6894 C49 H92 O6 19.39 
608 TG(16:0_12:0_18:3) TG 772.6581 C49 H88 O6 19.41 
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609 TG(16:0_14:0_14:0) TG 750.6737 C47 H90 O6 19.29 
610 TG(16:0_14:0_18:1) TG 804.7207 C51 H96 O6 19.91 
611 TG(16:0_14:0_18:3) TG 800.6894 C51 H92 O6 19.09 
612 TG(16:0_14:0_20:4) TG 826.705 C53 H94 O6 19.30 
613 TG(16:0_14:0_22:6) TG 850.705 C55 H94 O6 19.11 
614 TG(16:0_14:1_18:3) TG 798.6737 C51 H90 O6 18.71 
615 TG(16:0_16:0_16:0) TG 806.7363 C51 H98 O6 20.40 
616 TG(16:0_16:0_17:0) TG 820.752 C52 H100 O6 20.51 
617 TG(16:0_16:0_17:1) TG 818.7363 C52 H98 O6 20.54 
618 TG(16:0_16:0_18:1) TG 832.752 C53 H100 O6 20.37 
619 TG(16:0_16:0_20:4) TG 854.7363 C55 H98 O6 19.83 
620 TG(16:0_16:0_20:5) TG 852.7207 C55 H96 O6 20.01 
621 TG(16:0_16:0_24:0) TG 918.8615 C59 H114 O6 21.88 
622 TG(16:0_16:1_18:1) TG 830.7363 C53 H98 O6 20.00 
623 TG(16:0_16:1_18:2) TG 828.7207 C53 H96 O6 19.65 
624 TG(16:0_17:0_18:1) TG 846.7676 C54 H102 O6 20.48 
625 TG(16:0_17:1_18:1) TG 844.752 C54 H100 O6 20.53 
626 TG(16:0_18:1_18:1) TG 858.7676 C55 H102 O6 20.35 
627 TG(16:0_18:1_20:4) TG 880.752 C57 H100 O6 20.34 
628 TG(16:0_18:1_20:5) TG 878.7363 C57 H98 O6 19.98 
629 TG(16:0_18:2_18:2) TG 854.7363 C55 H98 O6 19.55 
630 TG(16:0_18:2_18:3) TG 852.7207 C55 H96 O6 19.19 
631 TG(16:0_18:2_20:4) TG 878.7363 C57 H98 O6 19.37 
632 TG(16:0_18:2_20:5) TG 876.7207 C57 H96 O6 19.59 
633 TG(16:0_18:2_22:4) TG 906.7676 C59 H102 O6 19.81 
634 TG(16:0_18:2_22:5) TG 904.752 C59 H100 O6 19.64 
635 TG(16:0_18:2_22:6) TG 902.7363 C59 H98 O6 19.20 
636 TG(16:0_18:3_20:5) TG 874.705 C57 H94 O6 19.18 
637 TG(16:0_20:4_22:6) TG 926.7363 C61 H98 O6 19.02 
638 TG(16:0_20:5_22:6) TG 924.7207 C61 H96 O6 18.61 
639 TG(16:0_20:5_22:6) TG 924.7207 C61 H96 O6 19.21 
640 TG(16:0_22:5_22:6) TG 952.752 C63 H100 O6 19.22 
641 TG(16:0_22:6_22:6) TG 950.7363 C63 H98 O6 18.81 
642 TG(16:1_12:0_20:4) TG 796.6581 C51 H88 O6 18.91 
643 TG(16:1_12:0_20:5) TG 794.6424 C51 H86 O6 18.27 
644 TG(16:1_14:1_16:1) TG 772.6581 C49 H88 O6 18.27 
645 TG(16:1_17:1_18:1) TG 842.7363 C54 H98 O6 18.28 
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646 TG(16:1_18:2_18:2) TG 852.7207 C55 H96 O6 19.02 
647 TG(16:1_18:2_18:3) TG 850.705 C55 H94 O6 18.80 
648 TG(16:1_18:2_22:6) TG 900.7207 C59 H96 O6 18.61 
649 TG(16:1_18:3_20:5) TG 872.6894 C57 H92 O6 18.80 
650 TG(16:2_18:2_18:3) TG 848.6894 C55 H92 O6 18.36 
651 TG(17:0_18:1_18:1) TG 872.7833 C56 H104 O6 20.56 
652 TG(17:0_18:1_18:2) TG 870.7676 C56 H102 O6 20.11 
653 TG(17:0_18:1_20:4) TG 894.7676 C58 H102 O6 20.07 
654 TG(17:0_18:2_20:4) TG 892.752 C58 H100 O6 19.64 
655 TG(18:0_12:0_16:0) TG 778.705 C49 H94 O6 19.93 
656 TG(18:0_16:0_16:0) TG 834.7676 C53 H102 O6 20.82 
657 TG(18:0_16:0_17:0) TG 848.7833 C54 H104 O6 20.92 
658 TG(18:0_16:0_18:0) TG 862.7989 C55 H106 O6 21.20 
659 TG(18:0_16:0_18:1) TG 860.7833 C55 H104 O6 20.79 
660 TG(18:0_16:0_20:4) TG 882.7676 C57 H102 O6 20.79 
661 TG(18:0_16:0_22:6) TG 906.7676 C59 H102 O6 20.16 
662 TG(18:0_17:0_18:0) TG 876.8146 C56 H108 O6 21.31 
663 TG(18:0_17:0_18:1) TG 874.7989 C56 H106 O6 20.96 
664 TG(18:0_17:0_20:4) TG 896.7833 C58 H104 O6 20.54 
665 TG(18:0_18:0_18:0) TG 890.8302 C57 H110 O6 21.56 
666 TG(18:0_18:0_18:1) TG 888.8146 C57 H108 O6 21.17 
667 TG(18:0_18:1_18:1) TG 886.7989 C57 H106 O6 20.77 
668 TG(18:0_18:1_20:0) TG 916.8459 C59 H112 O6 21.53 
669 TG(18:0_18:1_20:4) TG 908.7833 C59 H104 O6 20.29 
670 TG(18:0_18:1_20:4) TG 908.7833 C59 H104 O6 20.75 
671 TG(18:0_18:1_22:0) TG 944.8772 C61 H116 O6 21.86 
672 TG(18:0_18:1_22:5) TG 934.7989 C61 H106 O6 20.43 
673 TG(18:0_18:1_22:6) TG 932.7833 C61 H104 O6 20.13 
674 TG(18:0_18:1_22:6) TG 932.7833 C61 H104 O6 20.51 
675 TG(18:0_18:1_24:0) TG 972.9085 C63 H120 O6 22.16 
676 TG(18:0_20:0_22:0) TG 974.9241 C63 H122 O6 22.45 
677 TG(18:0_20:4_22:4) TG 958.7989 C63 H106 O6 20.11 
678 TG(18:0_20:4_22:6) TG 954.7676 C63 H102 O6 19.59 
679 TG(18:0_22:0_22:0) TG 1002.9554 C65 H126 O6 22.73 
680 TG(18:1_12:0_12:0) TG 720.6268 C45 H84 O6 18.12 
681 TG(18:1_12:0_14:0) TG 748.6581 C47 H88 O6 18.82 
682 TG(18:1_12:0_18:1) TG 802.705 C51 H94 O6 19.40 
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683 TG(18:1_12:0_18:2) TG 800.6894 C51 H92 O6 18.90 
684 TG(18:1_12:0_20:5) TG 822.6737 C53 H90 O6 18.89 
685 TG(18:1_14:0_17:1) TG 816.7207 C52 H96 O6 20.08 
686 TG(18:1_14:0_18:1) TG 830.7363 C53 H98 O6 19.89 
687 TG(18:1_14:0_18:2) TG 828.7207 C53 H96 O6 19.47 
688 TG(18:1_14:0_18:3) TG 826.705 C53 H94 O6 18.99 
689 TG(18:1_14:0_20:4) TG 852.7207 C55 H96 O6 19.87 
690 TG(18:1_17:1_18:1) TG 870.7676 C56 H102 O6 18.90 
691 TG(18:1_17:1_18:2) TG 868.752 C56 H100 O6 20.10 
692 TG(18:1_18:1_18:1) TG 884.7833 C57 H104 O6 20.34 
693 TG(18:1_18:1_18:2) TG 882.7676 C57 H102 O6 19.95 
694 TG(18:1_18:1_22:0) TG 942.8615 C61 H114 O6 21.51 
695 TG(18:1_18:1_22:4) TG 934.7989 C61 H106 O6 20.16 
696 TG(18:1_18:1_22:5) TG 932.7833 C61 H104 O6 19.80 
697 TG(18:1_18:1_22:6) TG 930.7676 C61 H102 O6 20.16 
698 TG(18:1_18:2_18:2) TG 880.752 C57 H100 O6 19.55 
699 TG(18:1_18:2_20:2) TG 908.7833 C59 H104 O6 20.16 
700 TG(18:1_18:2_20:4) TG 904.752 C59 H100 O6 19.39 
701 TG(18:1_18:2_20:4) TG 904.752 C59 H100 O6 20.08 
702 TG(18:1_18:2_22:0) TG 940.8459 C61 H112 O6 21.23 
703 TG(18:1_18:2_22:5) TG 930.7676 C61 H102 O6 19.40 
704 TG(18:1_18:2_22:6) TG 928.752 C61 H100 O6 18.72 
705 TG(18:1_18:3_24:0) TG 966.8615 C63 H114 O6 21.32 
706 TG(18:1_20:3_20:4) TG 930.7676 C61 H102 O6 20.28 
707 TG(18:1_20:4_20:4) TG 928.752 C61 H100 O6 19.82 
708 TG(18:1_20:4_22:0) TG 964.8459 C63 H112 O6 21.09 
709 TG(18:1_20:4_24:0) TG 992.8772 C65 H116 O6 21.46 
710 TG(18:2_14:1_17:1) TG 812.6894 C52 H92 O6 18.75 
711 TG(18:2_17:1_18:2) TG 866.7363 C56 H98 O6 19.30 
712 TG(18:2_17:1_22:6) TG 914.7363 C60 H98 O6 18.90 
713 TG(18:2_18:2_18:2) TG 878.7363 C57 H98 O6 19.11 
714 TG(18:2_18:2_20:4) TG 902.7363 C59 H98 O6 18.95 
715 TG(18:2_18:2_22:6) TG 926.7363 C61 H98 O6 18.71 
716 TG(18:2_18:2_22:6) TG 926.7363 C61 H98 O6 19.37 
717 TG(18:2_20:4_22:6) TG 950.7363 C63 H98 O6 18.50 
718 TG(18:2_22:6_22:6) TG 974.7363 C65 H98 O6 18.27 
719 TG(18:3_14:1_18:2) TG 822.6737 C53 H90 O6 18.13 
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720 TG(18:3_17:1_18:2) TG 864.7207 C56 H96 O6 18.88 
721 TG(18:3_18:2_18:2) TG 876.7207 C57 H96 O6 18.68 
722 TG(18:3_18:2_18:3) TG 874.705 C57 H94 O6 18.23 
723 TG(18:3_18:2_18:3) TG 874.705 C57 H94 O6 18.59 
724 TG(18:3_18:2_20:5) TG 898.705 C59 H94 O6 18.06 
725 TG(18:3_18:2_20:5) TG 898.705 C59 H94 O6 18.69 
726 TG(18:3_18:2_20:5) TG 898.705 C59 H94 O6 19.00 
727 TG(18:3_18:2_22:6) TG 924.7207 C61 H96 O6 18.26 
728 TG(18:3_18:3_20:3) TG 900.7207 C59 H96 O6 18.80 
729 TG(18:3_18:3_20:5) TG 896.6894 C59 H92 O6 18.21 
730 TG(20:0_18:1_18:1) TG 914.8302 C59 H110 O6 20.72 
731 TG(20:0_18:1_18:1) TG 914.8302 C59 H110 O6 21.14 
732 TG(20:0_18:1_18:2) TG 912.8146 C59 H108 O6 20.84 
733 TG(20:1_18:1_18:1) TG 912.8146 C59 H108 O6 20.72 
734 TG(20:5_14:1_18:2) TG 846.6737 C55 H90 O6 18.55 
735 TG(20:5_17:1_18:2) TG 888.7207 C58 H96 O6 18.74 
736 TG(20:5_17:1_18:2) TG 888.7207 C58 H96 O6 19.31 
737 TG(20:5_18:2_18:2) TG 900.7207 C59 H96 O6 19.38 
738 TG(20:5_18:2_22:6) TG 948.7207 C63 H96 O6 18.04 
739 TG(20:5_18:2_22:6) TG 948.7207 C63 H96 O6 18.70 
740 TG(22:0_18:2_18:2) TG 938.8302 C61 H110 O6 20.93 
741 TG(22:5_17:1_18:2) TG 916.752 C60 H100 O6 19.35 
742 TG(22:5_18:2_18:2) TG 928.752 C61 H100 O6 19.19 
743 TG(24:0_18:2_20:5) TG 988.8459 C65 H112 O6 21.31 
744 TG(8:0_10:0_10:0) TG 526.4233 C31 H58 O6 10.44 
745 TG(8:0_10:0_12:0) TG 554.4546 C33 H62 O6 12.01 
746 TG(8:0_10:0_18:2) TG 634.5172 C39 H70 O6 13.99 
747 TG(8:0_10:0_20:5) TG 656.5016 C41 H68 O6 13.99 
748 TG(8:0_12:0_18:3) TG 660.5329 C41 H72 O6 16.41 
749 TG(8:0_14:0_20:5) TG 712.5642 C45 H76 O6 16.84 
750 TG(8:0_18:2_18:2) TG 742.6111 C47 H82 O6 16.85 
751 TG(8:0_18:2_18:3) TG 740.5955 C47 H80 O6 16.10 
752 TG(8:0_8:0_10:0) TG 498.392 C29 H54 O6 8.97 
753 TG(8:0_8:0_8:0) TG 470.3607 C27 H50 O6 7.58 
 
 
